var title_f30_57_31632="Diagnostic Reed-Sternberg cell";
var content_f30_57_31632=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F69090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F69090&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagnostic Reed-Sternberg cell in Hodgkin lymphoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 189px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A diagnostic Reed-Sternberg cell is seen in the center, and many mononucleated and multinucleated Reed-Sternberg variants are seen throughout the field.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Weiss LM, Warnke RA, Hansmann ML, et al, Pathology of Hodgkin Lymphoma. In: Hodgkin Lymphoma, 2nd ed, Hoppe RT, Mauch PT, Armitage JO, et al, (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2007. Copyright &copy; 2007 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31632=[""].join("\n");
var outline_f30_57_31632=null;
var title_f30_57_31633="Pharm prog antags and SPRMs";
var content_f30_57_31633=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F63978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F63978&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Modified McPhail test for progesterone antagonists and SPRMs",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 569px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immature rabbits were primed with 5 mg/day estradiol benzoate over 6 days and then treated with test substances over 7 days. They were sacrificed on day 8. Progesterone agonistic effects are shown in A and antagonistic effects are shown in B. J 1042 is also a SPRM.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced and modified with permission from: Elger, W, et al. Endocrine pharmacological characterization of progesterone antagonists and progesterone receptor modulators with respect to PR-agonistic and antagonistic activity. Steroids 2000; 65:713. Copyright &copy; 2000 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31633=[""].join("\n");
var outline_f30_57_31633=null;
var title_f30_57_31634="Pancreatic panniculitis";
var content_f30_57_31634=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83789&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic panniculitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Inflammatory nodules are present on the distal leg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31634=[""].join("\n");
var outline_f30_57_31634=null;
var title_f30_57_31635="Gadobutrol: Patient drug information";
var content_f30_57_31635=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gadobutrol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?38/14/39141?source=see_link\">",
"     see \"Gadobutrol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F12765549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Gadavist&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F5174308\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Gadovist&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029133\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700368",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, this drug may cause a very bad health problem. Call your doctor right away if you have joint stiffness, muscle weakness, very bad bone pain in the hips or ribs, yellow eyes, or very bad skin irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029135\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691291",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used during an MRI (magnetic resonance imaging) or MRA (magnetic resonance angiography) test.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029134\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702179",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gadobutrol or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029139\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698333",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Short-term pain after use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696432",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bad taste in your mouth. This most often goes back to normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698968",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Joint stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699012",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone pain in the hips or ribs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699049",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad skin irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695991",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11952 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-190.92.87.115-0E8DCFA2F5-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31635=[""].join("\n");
var outline_f30_57_31635=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12765549\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5174308\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029133\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029135\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029134\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029138\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029139\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029141\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029137\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029143\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?38/14/39141?source=related_link\">",
"      Gadobutrol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31636="Intracapsular versus extracapsular hip fractures";
var content_f30_57_31636=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F59744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F59744&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 548px\">",
"   <div class=\"ttl\">",
"    Intracapsular versus extracapsular hip fractures",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 528px; height: 349px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The prognosis of hip fractures varies by anatomic location. Intracapsular fractures are more likely to disrupt the blood supply to the femoral head, thereby increasing the risk of avascular necrosis, compared with extracapsular (or intertrochanteric) fractures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Anatomical Chart Company. Copyright &copy; 2009 Wolters Kluwer Health.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31636=[""].join("\n");
var outline_f30_57_31636=null;
var title_f30_57_31637="Acetaminophen and tramadol: Patient drug information";
var content_f30_57_31637=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Acetaminophen and tramadol: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?23/26/23975?source=see_link\">",
"     see \"Acetaminophen and tramadol: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F229717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Ultracet&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F1582162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Tramadol/Acet&reg;;",
"     </li>",
"     <li>",
"      CO Tramadol/Acet;",
"     </li>",
"     <li>",
"      JAMP-ACET-Tramadol;",
"     </li>",
"     <li>",
"      Mar-Tramadol/Acet;",
"     </li>",
"     <li>",
"      Pat-Tramadol/Acet;",
"     </li>",
"     <li>",
"      TEVA-Tramadol/Acetaminophen;",
"     </li>",
"     <li>",
"      Tramacet;",
"     </li>",
"     <li>",
"      Tramaphen-Odan",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10026483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3491790",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Acetaminophen may cause very bad liver problems. Your risk is higher if you take more than 4 grams of acetaminophen a day, drink beer, wine, or mixed drinks, or have liver disease. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10026485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10026484\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701428",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to acetaminophen, tramadol, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are addicted to drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701044",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink beer, wine, or mixed drinks or take any drugs that have alcohol.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703781",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10026489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696680",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid other sources of acetaminophen. An overdose may cause problems.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696699",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful if you have G6PD deficiency. Anemia may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697135",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a history of a drug or drinking problem, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697176",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have tried to take your own life, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698528",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a blood thinner, have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before you use other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10026490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698201",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the liver may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10026492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699000",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Poor pain control.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10026487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3927405",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take this drug with other strong pain drugs or if you are using a pain patch without talking to your doctor first.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694768",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take more than what your doctor told you to take. Liver problems may happen.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698543",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a pain diary.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10026488\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10026493\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10026494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12179 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.131.41.98-0FBBA5EC0B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31637=[""].join("\n");
var outline_f30_57_31637=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F229717\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1582162\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026483\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026485\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026484\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026489\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026490\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026492\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026487\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026488\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026493\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10026494\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?23/26/23975?source=related_link\">",
"      Acetaminophen and tramadol: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31638="Silicosis CXR PA I";
var content_f30_57_31638=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F79172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F79172&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Silicosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 350px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows multiple nodules, 3 to 5 mm in diameter, with a bias for the upper lobes. Note calcification in some of the pulmonary nodules and the hilar lymph nodes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31638=[""].join("\n");
var outline_f30_57_31638=null;
var title_f30_57_31639="Intrapartum fever";
var content_f30_57_31639=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Intrapartum fever",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Katherine T Chen, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31639/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/57/31639/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intrapartum fever (ie, fever during labor) can be due to an infectious or non-infectious etiology and can lead to a variety of maternal and neonatal sequelae. Numerous risk factors for intrapartum fever have been reported, such as nulliparity, prolonged labor, and premature rupture of membranes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/1\">",
"     1",
"    </a>",
"    ]. These characteristics describe women likely to develop intraamniotic infection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    receive epidural anesthesia, which are the two common causes of intrapartum fever.",
"   </p>",
"   <p>",
"    This topic will present an overview of the causes, evaluation, management, and sequelae of intrapartum fever.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     MECHANISM",
"    </span>",
"    &nbsp;&mdash;&nbsp;The vast majority of patients with elevated body temperature have fever, which occurs when the hypothalamic thermoregulatory center is reset at a higher temperature by \"endogenous pyrogens\" produced by specific host cells in response to infection, inflammation, injury, or antigenic challenge. These pyrogenic polypeptides include the cytokines interleukin (IL)-1 alpha and -1 beta, IL-6, tumor necrosis factor (TNF)-alpha and -beta, and interferon alpha [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a few instances in which an elevated temperature represents hyperthermia rather than fever. As an example, some pharmacologic agents (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?11/23/11640?source=see_link\">",
"     atropine",
"    </a>",
"    , the recreational drug \"ecstasy\") raise core temperature by blocking sweating or vasodilation without changing the normal hypothalamic set-point. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8361?source=see_link\">",
"     \"Pathophysiology and treatment of fever in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/25/2456?source=see_link\">",
"     \"Drug fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For the purposes of this discussion, the term fever will generally be used to describe maternal intrapartum temperature elevation from any mechanism.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever is defined as an elevation of body temperature above normal daily variation. The threshold for intrapartum fever is generally considered to be maternal temperature &ge;38 degrees Celsius [C] (100.4 degrees Fahrenheit [F]). This is based, in part, on a study of the normal parturient's temperature, which ranged from 34.6 to 37.6 degrees C (94.3 to 99.7 degrees F) upon admission to the labor unit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/4\">",
"     4",
"    </a>",
"    ]. There was a diurnal distribution, with a peak from midnight to 2 AM and a nadir from 11 AM to noon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PREVALENCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of intrapartum fever varies widely. This variation is due to several factors, including differences in ascertainment (prospective studies report higher rates than retrospective studies), differences in prevalence of risk factors in the populations studied, use of different diagnostic criteria, and temporal changes in obstetric practice (eg, increased use of intrapartum antibiotics). The range of findings is illustrated by the following examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A population-based study using data from birth and infant death certificates noted that intrapartum fever occurred in 1.6 percent of over 11 million singleton births in the United States between 1995 and 1997 [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intrapartum fever has been reported to develop in 10 to 34 percent of nulliparous women who have epidural anesthesia during labor [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/6-10\">",
"       6-10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MEASUREMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oral temperature measurement is most convenient for routine detection of maternal intrapartum fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/11\">",
"     11",
"    </a>",
"    ]. Maternal oral temperature is 0.2 to 0.9 degrees C (0.4 to 1.6 degrees F) lower than",
"    <span class=\"nowrap\">",
"     fetal/intrauterine",
"    </span>",
"    temperature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/11-15\">",
"     11-15",
"    </a>",
"    ]. However, hyperventilation, ice ingestion, and oxygen administration can affect oral temperature. Tympanic temperature is an alternative approach (0.3 to 0.6 degrees C [0.5 to 1 degrees F] higher than an oral temperature).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     History and physical",
"    </span>",
"    &nbsp;&mdash;&nbsp;A comprehensive review of the patient's history and a full physical examination should be performed to look for potential causes, both obstetrical and nonobstetrical, of fever.",
"   </p>",
"   <p>",
"    The history should focus on gathering the following information on risk factors for intrapartum fever: the length of labor, number of vaginal exams, length of rupture membranes, exposure to intrapartum devices (eg, intrauterine pressure catheter, fetal scalp electrode), any urinary tract or respiratory symptoms, use of epidural analgesia, and medication usage.",
"   </p>",
"   <p>",
"    The physical examination should include standard vital signs, auscultation of the lungs, and assessment of fundal tenderness, abdominal tenderness, costovertebral angle tenderness, and the character of amniotic fluid.",
"   </p>",
"   <p>",
"    The fetal heart rate and pattern should be evaluated. Fetal tachycardia may occur in response to maternal fever or intrauterine infection. However, a normal fetal heart rate and pattern do not reliably exclude",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    infection and no abnormal pattern is specific for intrauterine infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/16,17\">",
"     16,17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laboratory",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141696\">",
"    <span class=\"h3\">",
"     White blood cell (WBC) count and differential",
"    </span>",
"    &nbsp;&mdash;&nbsp;The value of an intrapartum WBC count is limited because high values normally occur during labor. Data from two series reported mean WBC counts in laboring patients of 10,000 to 16,000",
"    <span class=\"nowrap\">",
"     cells/microL,",
"    </span>",
"    with an upper level as high as 29,000",
"    <span class=\"nowrap\">",
"     cells/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]; the mean count increased linearly with the duration of elapsed labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/19\">",
"     19",
"    </a>",
"    ].However, when clinical concern about infection is high, leukocytosis (especially when accompanied by a left shift or bandemia) supports the diagnosis. We suggest obtaining a WBC count in patients who appear clinically ill or with a temperature greater than 39 degrees C.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141704\">",
"    <span class=\"h3\">",
"     Blood cultures",
"    </span>",
"    &nbsp;&mdash;&nbsp;The usefulness of blood cultures has not been studied specifically in intrapartum women and there are no published standards for when to obtain intrapartum cultures. In general, blood cultures are not routinely done in women with suspected intraamniotic infection. Potential indications for blood cultures include fever &ge;39 degrees Celsius, chills, hypothermia, leukocytosis with left shift, neutropenia, and the development of otherwise unexplained organ dysfunction (eg, renal failure, shock) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/20-22\">",
"     20-22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A study in which 1.8 percent of parturients had clinical indications for blood cultures reported that 5 percent of the cultures were positive and 42 bacterial strains representing 18 different bacterial species were isolated [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/23\">",
"     23",
"    </a>",
"    ]. Most blood cultures were positive for a single organism even though intrauterine infection is usually polymicrobial. Another study performed on male and female patients of all ages presenting to an emergency department determined the frequency of positive blood cultures increased almost two-fold in patients with temperature 38.3 to 39.3 degrees C (101 to 102.9 degrees F) and almost five-fold in patients with temperature greater than 39.4 degrees C (103 degrees F) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For intrauterine infection, blood cultures are useful for targeting antibiotic therapy if the patient does not respond to an empiric antibiotic regimen because of antibiotic resistance. Appropriate antibiotic therapy is important in bacteremic patients because untreated bacteremia can lead to sepsis and shock. However, these serious sequelae are rare in",
"    <span class=\"nowrap\">",
"     pregnant/postpartum",
"    </span>",
"    women in developed countries, who tend to be young and healthy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=see_link\">",
"     \"Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For suspected pyelonephritis, blood cultures are less useful than urine culture. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given these observations, we suggest blood cultures for women who appear clinically ill or with temperature greater than 39 degrees C. The treatment of intraamniotic infection is delivery and antibiotic therapy. Empiric therapy is effective in 85 to 90 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/26\">",
"     26",
"    </a>",
"    ]. Blood cultures could be useful for the small number of bacteremic patients who do not respond to empiric therapy and are thus at risk of developing sepsis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=see_link\">",
"     \"Blood cultures for the detection of bacteremia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141712\">",
"    <span class=\"h3\">",
"     Urine testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary dipstick testing is fast, convenient, and low in cost. It is considered positive if either leukocyte esterase or nitrite is detected: positive leukocyte esterase indicates pyuria and positive nitrite indicates the presence of enteric organisms that convert urinary nitrate to nitrite. For either finding, sensitivity and specificity for infection is 50 and 97 percent, respectively, thus there is a high false negative rate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/27\">",
"     27",
"    </a>",
"    ]. We suggest confirmation with urine microscopy and urine culture if the patient is clinically ill or with temperature greater than 39 degrees C. Urine culture is not practical as a first-line diagnostic test when a woman is in labor since results may take 24 to 48 hours after collection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24214?source=see_link\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141720\">",
"    <span class=\"h3\">",
"     Sputum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Testing sputum for a microbial diagnosis in women with suspected community acquired pneumonia is optional. For most patients, no testing is appropriate because empiric treatment is usually successful and the diagnosis of pneumonia is based on chest x-ray. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141728\">",
"    <span class=\"h3\">",
"     Testing for influenza",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women in labor with a flu-like illness should undergo diagnostic testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. A rapid antigen or immunofluorescence antibody test provides results soonest. In regions where the majority of circulating influenza viruses are known to be pandemic H1N1 influenza A, a positive result using one of these assays can be presumed to indicate infection with pandemic H1N1 influenza A, but a negative result does not exclude it. Antiviral treatment should not be delayed pending diagnostic testing results. Real-time reverse transcriptase polymerase chain reaction (rRT-PCR) testing specific for 2009 H1N1 is the most sensitive and specific test for diagnosis and should be performed if the rapid test is negative. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37305?source=see_link\">",
"     \"Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5528?source=see_link\">",
"     \"Diagnosis of seasonal influenza in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3141736\">",
"    <span class=\"h3\">",
"     Amniotic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amniocentesis may be performed in patients in preterm labor with intact membranes in order to diagnose subclinical intraamniotic infection, given tocolysis is generally not effective in this setting. It is rarely performed in patients in whom delivery within a few hours is expected. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link\">",
"     \"Intraamniotic infection (chorioamnionitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3146330\">",
"    <span class=\"h3\">",
"     Diagnostic markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 2012 systematic review of studies on intrapartum fever concluded that measurement of immunological markers (eg, C-reactive protein) in maternal serum is unreliable for detecting intrauterine infection in clinical practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/30\">",
"     30",
"    </a>",
"    ]. Although amniotic fluid IL-6 and IL-8 levels are significantly elevated with intraamniotic infection, optimal threshold values for diagnosis of intrauterine infection have not been established and these diagnostic markers are also not used clinically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of intrapartum fever depends on the etiology. General supportive measures include",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    , reduction in room temperature, reduction of clothing, and rehydration, as indicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Infectious etiologies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Intraamniotic infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraamniotic infection (IAI) refers to infection of the amniotic fluid, membranes, placenta,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    decidua. Clinically, the essential criterion for diagnosis of IAI is maternal fever, which is a manifestation of systemic inflammation. Other criteria (clinical and laboratory) are insensitive. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link&amp;anchor=H7#H7\">",
"     \"Intraamniotic infection (chorioamnionitis)\", section on 'Clinical presentation and diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For clinical research, the diagnosis of IAI is typically based upon the presence of maternal fever of greater than 38 degrees C (100.4 F)",
"    <strong>",
"     and",
"    </strong>",
"    at least two of the following conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/31\">",
"     31",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Maternal tachycardia (greater than 100",
"      <span class=\"nowrap\">",
"       beats/minute)",
"      </span>",
"     </li>",
"     <li>",
"      Fetal tachycardia (greater than 160",
"      <span class=\"nowrap\">",
"       beats/minute)",
"      </span>",
"     </li>",
"     <li>",
"      Uterine tenderness",
"     </li>",
"     <li>",
"      Foul odor of the amniotic fluid",
"     </li>",
"     <li>",
"      Maternal leukocytosis (greater than 15,000",
"      <span class=\"nowrap\">",
"       cells/cubic",
"      </span>",
"      millimeter)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Common maternal complications include labor abnormalities, need for cesarean delivery, uterine atony, postpartum hemorrhage, endometritis, and septic pelvic thrombophlebitis. Fetal complications include early onset neonatal sepsis, pneumonia, and meningitis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link\">",
"     \"Intraamniotic infection (chorioamnionitis)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Delivery is indicated after diagnosis of IAI. Prompt treatment with broad spectrum antibiotics reduces maternal and neonatal morbidity.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/51/13112?source=see_link\">",
"     Ampicillin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/10/36000?source=see_link\">",
"     gentamicin",
"    </a>",
"    is a common regimen, as well as beta lactams. Doses and alternative regimens are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link&amp;anchor=H14#H14\">",
"     \"Intraamniotic infection (chorioamnionitis)\", section on 'Maternal management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Urinary tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract infections (UTIs) are common in pregnant women and can complicate labor at term. Signs and symptoms of upper urinary tract symptoms include fever, flank pain, nausea, vomiting, and costovertebral angle tenderness with or without lower urinary tract symptoms such as dysuria, frequency, urgency, suprapubic pain, and hematuria.",
"   </p>",
"   <p>",
"    The treatment of acute pyelonephritis is intravenous antibiotic therapy until afebrile and asymptomatic for 24 to 48 hours followed by oral antibiotics for a course of 7 to 10 days. If symptoms persist more than 48 hours despite adequate intravenous antibiotic therapy, one must consider other conditions. The initial choice of antibiotics should be guided by local microbiology and susceptibility data. Parenteral beta lactams are the preferred antibiotics. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=see_link\">",
"     \"Urinary tract infections and asymptomatic bacteriuria in pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Respiratory tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper respiratory tract infection is common in pregnant women, especially in the winter, when the etiology is likely viral. The clinical manifestations of low grade fever, congestion, rhinorrhea, and cough are helpful in the diagnosis. Supportive treatment is indicated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36344?source=see_link\">",
"     \"Treatment of respiratory infections in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pneumonia classically presents with the sudden onset of rigors followed by fever, pleuritic chest pain, and cough productive of purulent sputum. The diagnosis of pneumonia is similar to that in nonpregnant individuals. A chest x-ray is usually required, but may be delayed until after delivery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=see_link\">",
"     \"Diagnostic approach to community-acquired pneumonia in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Antibiotic therapy is targeted to cover the infecting organisms typically associated with community acquired pneumonia in nonpregnant patients. Pregnant women may be treated safely with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/43/33456?source=see_link\">",
"     azithromycin",
"    </a>",
"    or azithromycin and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36344?source=see_link\">",
"     \"Treatment of respiratory infections in pregnant women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pregnant women are more likely to have complications from both seasonal and pandemic influenza. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/2/31786?source=see_link&amp;anchor=H22#H22\">",
"     \"Epidemiology of pandemic H1N1 influenza ('swine influenza')\", section on 'Pregnant women'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Diagnosis, treatment, and prevention of influenza are described in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5528?source=see_link\">",
"       \"Diagnosis of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22250?source=see_link\">",
"       \"Treatment of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=see_link\">",
"       \"Prevention of seasonal influenza in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=see_link\">",
"       \"Seasonal influenza vaccination in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Noninfectious etiologies",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Use of epidural analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Randomized trials and observational studies have consistently observed a frequent and significant association between the use of epidural analgesia and rise in maternal temperature. The etiology of the temperature increase is not clear, but may relate to thermoregulatory changes induced by epidural administration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39562?source=see_link&amp;anchor=H12559677#H12559677\">",
"     \"Adverse effects of neuraxial analgesia and anesthesia for obstetrics\", section on 'Intrapartum fever'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rise in maternal temperature correlates with the duration of epidural analgesia. In one study, there was no discernible effect during the initial four to five hours, but thereafter maternal temperature increased approximately 0.10 degrees C per hour [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because clinical and laboratory findings do not reliably distinguish between IAI and epidural-related maternal temperature elevation, antibiotics for treatment of IAI are usually administered.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Delivery in overheated room and dehydration",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the temperature of the surroundings becomes greater than that of the skin, the body is no longer able to lose heat by conduction or radiation. Instead, it gains heat from the environment by these same two mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/33\">",
"     33",
"    </a>",
"    ]. As discussed above, ancillary measures include reduction of room temperature, reduction of clothing, and rehydration.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Drug fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Drug fever is a diagnosis of exclusion. The timing of the onset of fever in relation to beginning a drug and the pattern of fever are frequently not helpful in making a diagnosis. However, since the median time to onset is about eight days, drug fever would rarely account for a newly developed intrapartum temperature elevation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/25/2456?source=see_link\">",
"     \"Drug fever\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     FETAL/NEONATAL ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;When maternal fever is due to an infectious process, peripartum transfer of the infection to the fetus or neonate is a major concern because of the potential for neonatal",
"    <span class=\"nowrap\">",
"     morbidity/mortality",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/5\">",
"     5",
"    </a>",
"    ]. Short-term adverse outcomes of intra-amniotic infection include neonatal sepsis, meningitis, and pneumonia. Potential long-term outcomes include neurodevelopmental delay and cerebral palsy. Appropriate intrapartum maternal antibiotic therapy reduces the risk of",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    infection (as well as maternal complications) and is the basis for intrapartum treatment of women colonized with group B streptococcus, with HIV infection, and with intraamniotic infection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19354?source=see_link\">",
"     \"Chemoprophylaxis for the prevention of neonatal group B streptococcal disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=see_link\">",
"     \"Intraamniotic infection (chorioamnionitis)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=see_link\">",
"     \"Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Elevated maternal body temperature may have",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    consequences even when infection is unlikely to be the cause. This risk was illustrated in a study of nulliparous term patients in spontaneous labor who were afebrile upon admission to the labor unit and whose neonates were not subsequently diagnosed as having an infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/6\">",
"     6",
"    </a>",
"    ]. Intrapartum temperature elevation in these women was attributed to epidural anesthesia. Compared to infants of women with no intrapartum temperature elevation, infants of women with temperature elevation were significantly more likely to have a low one minute Apgar score (&lt;7) (22.8 versus 8 percent), hypotonia (4.8 versus 0.5 percent), require bag and mask resuscitation (11.5 versus 3 percent), and be given oxygen therapy (8.2 versus 1.3 percent). These infants also had a three-fold increased risk of unexplained neonatal seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The long-term significance of these observations is unknown. The optimal management of presumed epidural-related maternal temperature elevation is also unknown. Interestingly, one study found that administration of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    650 mg per rectum every four hours beginning immediately after epidural placement did not prevent the maternal temperature elevation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/35\">",
"     35",
"    </a>",
"    ]. In another study, high dose maternal corticosteroids (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?30/25/31129?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    100 mg every four hours) prevented maternal temperature elevation (incidence of fever 2 versus 34 percent in untreated controls), but was associated with an increased risk of asymptomatic bacteremia in neonates (4 of 49 neonates versus 0 of 120 control neonates) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31639/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Intrapartum fever is generally considered to be maternal temperature &ge;38 degrees Celsius [C] (100.4 degrees Fahrenheit [F]). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Definition'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intrapartum fever is more prevalent in women who undergo epidural anesthesia than in the general obstetrical population. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Prevalence'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15\">",
"       'Use of epidural analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Maternal oral temperature is 0.2 to 0.9 degrees C (0.4 to 1.6 degrees F) lower than",
"      <span class=\"nowrap\">",
"       fetal/intrauterine",
"      </span>",
"      temperature. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Measurement'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The value of an intrapartum white blood cell (WBC) count is limited because high values normally occur during labor. However, when clinical concern about infection is high (eg, patient appears ill, temperature &ge;39 degrees Celsius), leukocytosis (especially when accompanied by a left shift or bandemia) supports the diagnosis. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Potential indications for blood cultures include fever &ge;39 degrees Celsius, chills, hypothermia, leukocytosis with left shift, neutropenia, and the development of otherwise unexplained organ dysfunction. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We perform urinary dipstick testing to look for urinary tract infection. We obtain confirmation with urine microscopy and urine culture if the patient is clinically ill or with temperature greater than 39 degrees Celsius. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The most common infection-related etiologies of intrapartum fever are intraamniotic infection, urinary tract infection, and respiratory infection. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Infectious etiologies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of epidural anesthesia is the most common cause of intrapartum fever at term. The maternal temperature elevation in these patients is often unrelated to infection. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Use of epidural analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      When maternal fever is due to an infectious process, peripartum transfer of the infection to the fetus or neonate is a major concern because of the potential for neonatal",
"      <span class=\"nowrap\">",
"       morbidity/mortality.",
"      </span>",
"      Appropriate intrapartum maternal antibiotic therapy reduces the risk of",
"      <span class=\"nowrap\">",
"       fetal/neonatal",
"      </span>",
"      infection, as well as maternal complications. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Fetal/Neonatal issues'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Elevated maternal body temperature may have",
"      <span class=\"nowrap\">",
"       fetal/neonatal",
"      </span>",
"      consequences even when infection is unlikely to be the cause. Infants of women with temperature elevation are at increased risk of having a low Apgar score, hypotonia, requiring bag and mask resuscitation, receiving oxygen therapy, and developing unexplained neonatal seizures. (See",
"      <a class=\"local\" href=\"#H18\">",
"       'Fetal/Neonatal issues'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/1\">",
"      Maayan-Metzger A, Mazkereth R, Shani A, Kuint J. Risk factors for maternal intrapartum fever and short-term neonatal outcome. Fetal Pediatr Pathol 2006; 25:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/2\">",
"      Smulian JC, Bhandari V, Vintzileos AM, et al. Intrapartum fever at term: serum and histologic markers of inflammation. Am J Obstet Gynecol 2003; 188:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/3\">",
"      Saper CB, Breder CD. The neurologic basis of fever. N Engl J Med 1994; 330:1880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/4\">",
"      Acker DB, Schulman EB, Ransil BJ, et al. The normal parturient's admission temperature. Am J Obstet Gynecol 1987; 157:308.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/5\">",
"      Petrova A, Demissie K, Rhoads GG, et al. Association of maternal fever during labor with neonatal and infant morbidity and mortality. Obstet Gynecol 2001; 98:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/6\">",
"      Lieberman E, Lang J, Richardson DK, et al. Intrapartum maternal fever and neonatal outcome. Pediatrics 2000; 105:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/7\">",
"      Yancey MK, Zhang J, Schwarz J, et al. Labor epidural analgesia and intrapartum maternal hyperthermia. Obstet Gynecol 2001; 98:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/8\">",
"      Sharma SK, Sidawi JE, Ramin SM, et al. Cesarean delivery: a randomized trial of epidural versus patient-controlled meperidine analgesia during labor. Anesthesiology 1997; 87:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/9\">",
"      Sharma SK, Alexander JM, Messick G, et al. Cesarean delivery: a randomized trial of epidural analgesia versus intravenous meperidine analgesia during labor in nulliparous women. Anesthesiology 2002; 96:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/10\">",
"      Ramin SM, Gambling DR, Lucas MJ, et al. Randomized trial of epidural versus intravenous analgesia during labor. Obstet Gynecol 1995; 86:783.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/11\">",
"      Banerjee S, Cashman P, Yentis SM, Steer PJ. Maternal temperature monitoring during labor: concordance and variability among monitoring sites. Obstet Gynecol 2004; 103:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/12\">",
"      Sciscione AC, Zainia T, Leet T, et al. A new device for measuring intrauterine temperature. Am J Obstet Gynecol 2001; 184:1431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/13\">",
"      Macaulay JH, Randall NR, Bond K, Steer PJ. Continuous monitoring of fetal temperature by noninvasive probe and its relationship to maternal temperature, fetal heart rate, and cord arterial oxygen and pH. Obstet Gynecol 1992; 79:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/14\">",
"      ADAMSON SK Jr, TOWELL ME. THERMAL HOMEOSTASIS IN THE FETUS AND NEWBORN. Anesthesiology 1965; 26:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/15\">",
"      Walker D, Walker A, Wood C. Temperature of the human fetus. J Obstet Gynaecol Br Commonw 1969; 76:503.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/16\">",
"      Buhimschi CS, Abdel-Razeq S, Cackovic M, et al. Fetal heart rate monitoring patterns in women with amniotic fluid proteomic profiles indicative of inflammation. Am J Perinatol 2008; 25:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/17\">",
"      Miyake H, Nakai A, Takeshita T. Fetal heart rate monitoring as a predictor of histopathologic chorioamnionitis in the third trimester. J Nippon Med Sch 2008; 75:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/18\">",
"      Molberg P, Johnson C, Brown TS. Leukocytosis in labor: what are its implications? Fam Pract Res J 1994; 14:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/19\">",
"      Acker DB, Johnson MP, Sachs BP, Friedman EA. The leukocyte count in labor. Am J Obstet Gynecol 1985; 153:737.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/20\">",
"      Bates DW, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis 1997; 176:1538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/21\">",
"      Leibovici L, Greenshtain S, Cohen O, et al. Bacteremia in febrile patients. A clinical model for diagnosis. Arch Intern Med 1991; 151:1801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/22\">",
"      Smith-Elekes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am 1993; 7:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/23\">",
"      Kankuri E, Kurki T, Carlson P, Hiilesmaa V. Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand 2003; 82:730.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/24\">",
"      Shapiro NI, Wolfe RE, Wright SB, et al. Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med 2008; 35:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/25\">",
"      Sheffield JS. Sepsis and septic shock in pregnancy. Crit Care Clin 2004; 20:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/26\">",
"      French LM, Smaill FM. Antibiotic regimens for endometritis after delivery. Cochrane Database Syst Rev 2004; :CD001067.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/27\">",
"      Hurlbut TA 3rd, Littenberg B. The diagnostic accuracy of rapid dipstick tests to predict urinary tract infection. Am J Clin Pathol 1991; 96:582.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/h1n1flu/guidance/obstetric.htm (accessed November 18, 2009).",
"    </li>",
"    <li>",
"     www.cdc.gov/h1n1flu/guidance/diagnostic_tests.htm (accessed November 18, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/30\">",
"      Evers AC, Nijhuis L, Koster MP, et al. Intrapartum fever at term: diagnostic markers to individualize the risk of fetal infection: a review. Obstet Gynecol Surv 2012; 67:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/31\">",
"      Newton ER. Chorioamnionitis and intraamniotic infection. Clin Obstet Gynecol 1993; 36:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/32\">",
"      Kuczkowski KM, Reisner LS. Anesthetic management of the parturient with fever and infection. J Clin Anesth 2003; 15:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/33\">",
"      Apantaku O, Mulik V. Maternal intra-partum fever. J Obstet Gynaecol 2007; 27:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/34\">",
"      Lieberman E, Eichenwald E, Mathur G, et al. Intrapartum fever and unexplained seizures in term infants. Pediatrics 2000; 106:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/35\">",
"      Goetzl L, Rivers J, Evans T, et al. Prophylactic acetaminophen does not prevent epidural fever in nulliparous women: a double-blind placebo-controlled trial. J Perinatol 2004; 24:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31639/abstract/36\">",
"      Goetzl L, Zighelboim I, Badell M, et al. Maternal corticosteroids to prevent intrauterine exposure to hyperthermia and inflammation: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 2006; 195:1031.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4453 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-93.125.6.160-7DBF348CA4-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31639=[""].join("\n");
var outline_f30_57_31639=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H19\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      MECHANISM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PREVALENCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MEASUREMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      History and physical",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laboratory",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141696\">",
"      - White blood cell (WBC) count and differential",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141704\">",
"      - Blood cultures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141712\">",
"      - Urine testing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141720\">",
"      - Sputum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141728\">",
"      - Testing for influenza",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3141736\">",
"      - Amniotic fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3146330\">",
"      - Diagnostic markers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ETIOLOGY AND MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Infectious etiologies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Intraamniotic infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Respiratory tract infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Noninfectious etiologies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Use of epidural analgesia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Delivery in overheated room and dehydration",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Drug fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      FETAL/NEONATAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/47/10999?source=related_link\">",
"      Acute complicated cystitis and pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/40/39562?source=related_link\">",
"      Adverse effects of neuraxial analgesia and anesthesia for obstetrics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/14/11494?source=related_link\">",
"      Blood cultures for the detection of bacteremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/57/19354?source=related_link\">",
"      Chemoprophylaxis for the prevention of neonatal group B streptococcal disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/27/37305?source=related_link\">",
"      Clinical manifestations and diagnosis of pandemic H1N1 influenza ('swine influenza')",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/25/5528?source=related_link\">",
"      Diagnosis of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/26/26026?source=related_link\">",
"      Diagnostic approach to community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/25/2456?source=related_link\">",
"      Drug fever",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/2/31786?source=related_link\">",
"      Epidemiology of pandemic H1N1 influenza ('swine influenza')",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/48/42761?source=related_link\">",
"      Intraamniotic infection (chorioamnionitis)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/10/8361?source=related_link\">",
"      Pathophysiology and treatment of fever in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15433?source=related_link\">",
"      Prenatal evaluation and intrapartum management of the HIV-infected patient in resource-rich settings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/13/44249?source=related_link\">",
"      Prevention of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/8/37002?source=related_link\">",
"      Seasonal influenza vaccination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/10/24744?source=related_link\">",
"      Sepsis and the systemic inflammatory response syndrome: Definitions, epidemiology, and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/31/36344?source=related_link\">",
"      Treatment of respiratory infections in pregnant women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/46/22250?source=related_link\">",
"      Treatment of seasonal influenza in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/40/43657?source=related_link\">",
"      Urinary tract infections and asymptomatic bacteriuria in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/41/24214?source=related_link\">",
"      Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31640="Glucagonoma and the glucagonoma syndrome";
var content_f30_57_31640=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Glucagonoma and the glucagonoma syndrome",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Peter M Rosenberg, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Stephen E Goldfinger, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     David M Nathan, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     David C Whitcomb, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31640/contributors\">",
"     Shilpa Grover, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/57/31640/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 9, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic glucagonoma syndrome associated with islet cell tumors of the pancreas (now termed pancreatic neuroendocrine tumors) was first described by Becker et al in 1942 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/1\">",
"     1",
"    </a>",
"    ], but the syndrome was not actually attributed to hypersecretion of glucagon until 1966 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/2\">",
"     2",
"    </a>",
"    ]. Its diverse systemic manifestations make it unique among pancreatic neuroendocrine tumors and provide subtle clues that may make early diagnosis possible if a high index of suspicion is maintained. The syndrome also illustrates the dramatic effects that can result from derangements in the regulation of basic metabolic pathways.",
"   </p>",
"   <p>",
"    This topic will review the pathology, epidemiology, clinical manifestations, diagnosis, and treatment of glucagonoma and the glucagonoma syndrome. Other pancreatic neuroendocrine tumors are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=see_link\">",
"     \"Insulinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3623?source=see_link\">",
"     \"Somatostatinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=see_link\">",
"     \"The VIPoma syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/969?source=see_link\">",
"     \"Clinical characteristics of carcinoid tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nearly all reported cases of the glucagonoma syndrome have been associated with tumors originating in the alpha cells of the pancreas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. These tumors demonstrate the typical characteristics of other pancreatic neuroendocrine tumors; they are usually encapsulated, firm nodules, varying in size from 2 cm up to 25 cm, and occur most often in the tail of the pancreas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link&amp;anchor=H12145093#H12145093\">",
"     \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\", section on 'Classification and nomenclature'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Histologically, the tumors consist of cords and nests of well-differentiated islet cells. Glucagon is usually detectable within the tumor cells by immunoperoxidase staining, and glucagon mRNA may be detected by in situ hybridization. Characteristic alpha cell granules may be seen on electron microscopy.",
"   </p>",
"   <p>",
"    Despite their benign histologic appearance, most pancreatic glucagonomas are malignant, as defined by their propensity to metastasize, which has usually occurred by the time of diagnosis. Unlike carcinoid tumors, however, liver metastases are not a prerequisite for the clinical syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9206?source=see_link\">",
"     \"Clinical features of the carcinoid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucagonomas are rare. In a series of 340 patients with pancreatic endocrine tumors, only 7 percent were glucagonomas [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/5\">",
"     5",
"    </a>",
"    ]. Patients typically present in their fifth decade [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. A female preponderance was initially suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/6\">",
"     6",
"    </a>",
"    ], but the most recent series finds an even distribution between men and women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. Rarely, glucagonoma may be associated with the multiple endocrine neoplasia syndrome, type 1 (MEN 1); such patients typically have a family history of pituitary, pancreatic islet cell, or parathyroid tumors. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43240?source=see_link\">",
"     \"Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The clinical syndrome classically associated with glucagonoma includes necrolytic migratory erythema (NME), cheilitis, diabetes mellitus, anemia, weight loss, diarrhea, venous thrombosis, and neuropsychiatric symptoms. Weight loss and NME are the most prevalent symptoms, occurring in approximately 65 to 70 percent of patients by the time of diagnosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. The rash may occasionally appear, prior to the onset of systemic symptoms, but most patients with rash usually have weight loss, diarrhea, sore mouth, weakness, mental status changes, or diabetes mellitus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Necrolytic migratory erythema",
"    </span>",
"    &nbsp;&mdash;&nbsp;NME, first named in 1973 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/7\">",
"     7",
"    </a>",
"    ], characteristically begins as erythematous papules or plaques involving the face, perineum, and extremities (",
"    <a class=\"graphic graphic_picture graphicRef73263 \" href=\"mobipreview.htm?17/32/17925\">",
"     picture 1",
"    </a>",
"    ). Over the ensuing 7 to 14 days, the lesions enlarge and coalesce. Central clearing then occurs, leaving bronze-colored, indurated areas centrally, with blistering, crusting, and scaling at the borders. The affected areas are often pruritic and painful.",
"   </p>",
"   <p>",
"    Skin biopsies obtained from the edge of the lesions reveal superficial necrolysis with separation of the outer layers of the epidermis and perivascular infiltration with lymphocytes and histiocytes. Multiple biopsies may be required to demonstrate these diagnostic findings. The same process often affects the mucous membranes, resulting in glossitis, angular cheilitis, stomatitis, and blepharitis. Hair thinning and dystrophic nails are also commonly observed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Diabetes mellitus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diabetes mellitus occurs in 75 to 95 percent of patients with glucagonoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. The hyperglycemia due to glucagonoma may be mild or moderate (median glycated hemoglobin level of 9.8 percent in one series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]), is easily controlled by diet, oral agents, or insulin, and is not associated with diabetic ketoacidosis, since beta cell function is preserved and insulin secretion is normal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Other symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastrointestinal symptoms associated with glucagonoma include abdominal pain, anorexia, diarrhea, and constipation. Diarrhea may reflect accompanying hypersecretion of gastrin, vasoactive intestinal peptide (VIP), serotonin, or calcitonin. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14504?source=see_link\">",
"     \"Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=see_link\">",
"     \"The VIPoma syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Venous thrombosis occurs in up to 30 percent of patients with glucagonoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/6\">",
"     6",
"    </a>",
"    ]. This association with thromboembolism appears to be unique among endocrine tumors. Neurologic symptoms associated with glucagonoma may include ataxia, dementia, optic atrophy, and proximal muscle weakness. A single case of reversible dilated cardiomyopathy associated with a glucagonoma has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Laboratory abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to hyperglucagonemia (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Serum glucagon'",
"    </a>",
"    below) and hyperglycemia, the glucagonoma syndrome has been associated with several less specific laboratory abnormalities. A normochromic, normocytic anemia is common, being present in up to 90 percent of patients in some series. It is probably due to the anemia of chronic disease, but a direct effect of glucagon on erythropoiesis has also been suggested [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Amino acid levels are markedly diminished in the serum of patients with glucagonoma. Glucagon, acting on the liver, increases both amino acid oxidation and gluconeogenesis from amino acid substrates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/9\">",
"     9",
"    </a>",
"    ]. Hypoaminoacidemia may be clinically important because it may be the cause of NME; in one patient, amino acid infusion led to an improvement in the characteristic rash [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS, LOCALIZATION, AND STAGING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many of the symptoms of glucagonoma discussed above are nonspecific. As a result, glucagonoma is often diagnosed relatively late in the course of the disease. NME, the characteristic skin lesion of the glucagonoma syndrome, is often the clue which leads to the correct diagnosis. While not pathognomonic for glucagonoma, the presence of NME should prompt further work-up for a pancreatic neuroendocrine tumor. In one report, glucagonomas had metastasized to bone, liver, or lymph nodes by the time of diagnosis of NME in 12 of 13 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Serum glucagon",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many conditions other than glucagonoma can induce \"physiologic\" elevations in the serum glucagon concentration. These include hypoglycemia, fasting, trauma, sepsis, acute pancreatitis, abdominal surgery, Cushing's syndrome, and renal and hepatic failure. However, these conditions are associated with only moderate elevations of glucagon, usually less than 500",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    (upper limit of normal &lt;100",
"    <span class=\"nowrap\">",
"     pg/mL)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. Idiopathic hyperglucagonemia syndrome, either familial or sporadic, is associated with a large molecular weight form of the peptide. In addition, other neuroendocrine tumors, such as carcinoid tumors, insulinomas, and gastrinomas, can secrete glucagon, although rarely in high enough levels to cause the classic clinical syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Glucagonoma, in contrast to the above conditions, is associated with markedly elevated serum concentrations of glucagon (&gt;500",
"    <span class=\"nowrap\">",
"     pg/mL),",
"    </span>",
"    multiple molecular weight forms of glucagon, and the classical clinical syndrome. One series reports a mean serum glucagon level of 1400",
"    <span class=\"nowrap\">",
"     pg/ml",
"    </span>",
"    among patients with confirmed glucagonoma, although the values ranged from 84 to 14,300",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. Glucagon levels are generally highest in patients with both NME and diabetes mellitus due to glucagonoma.",
"   </p>",
"   <p>",
"    However, some glucagonomas are associated with serum levels of the peptide in the \"physiologically elevated\" range, even in the presence of NME. Thus, in patients with the classic syndrome, a serum glucagon concentration below 500",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    does not exclude a glucagonoma. On the other hand, concentrations above 1000",
"    <span class=\"nowrap\">",
"     pg/mL",
"    </span>",
"    are virtually diagnostic of glucagonoma.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H390545\">",
"    <span class=\"h2\">",
"     Tumor localization",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Cross sectional imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    laboratory abnormalities suggesting the presence of glucagonoma should be followed by attempts to localize the tumor. Cross sectional imaging with helical, triple phase CT or MRI is the initial procedure of choice.",
"   </p>",
"   <p>",
"    Since the primary tumor is usually large by the time of diagnosis, it is localizable by CT in the majority of cases (86 percent in the most recent series) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. Intravenous contrast enhances the detection of smaller lesions, especially when images are obtained during the arterial phase. In addition, arterial phase and portal venous phase sequences can be used to maximize the conspicuity of liver metastases compared to the surrounding normal liver parenchyma.",
"   </p>",
"   <p>",
"    CT is also useful in identifying metastatic disease. However, as a result of its greater sensitivity for liver metastases, some physicians prefer MRI over CT for assessing the status of the liver. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link&amp;anchor=H12145107#H12145107\">",
"     \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\", section on 'Computed tomography'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link&amp;anchor=H12145114#H12145114\">",
"     \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\", section on 'Magnetic resonance imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Endoscopic ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Endoscopic ultrasound (EUS) can detect pancreatic tumors as small as 2 to 3 mm, provides accurate information on the local extent of disease, and allows transmucosal needle biopsy of pancreatic lesions. In the largest published series to date, EUS had a sensitivity of 82 percent and a specificity of 95 percent for the detection of pancreatic neuroendocrine tumors too small to be visualized by CT; one of the 37 patients in this series had a small glucagonoma which was accurately localized by EUS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We proceed with this diagnostic modality in either of two situations. After CT has revealed an apparently localized pancreatic tumor, EUS is useful for further examination of the regional extent of disease and for obtaining biopsy material. Even more importantly, when CT is unrevealing in a patient with clinical evidence of glucagonoma, EUS is the modality of choice for detecting and biopsying pancreatic neuroendocrine tumors too small for CT visualization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Other imaging modalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other imaging modalities are less useful for the diagnosis",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    localization of glucagonomas.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Angiography is highly sensitive for pancreatic neuroendocrine tumors given their hypervascularity, but it has largely been superseded as a diagnostic test by the improvements in contrast CT imaging. Angiography is now performed almost exclusively for embolization",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      infusion of chemotherapy via the hepatic artery.",
"     </li>",
"     <li>",
"      Transabdominal ultrasound is often able to visualize larger pancreatic neuroendocrine tumors, but lacks sensitivity, especially for smaller and more distal tumors.",
"     </li>",
"     <li>",
"      Somatostatin receptor scintigraphy using radiolabeled",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"       octreotide",
"      </a>",
"      is very sensitive for pancreatic neuroendocrine tumors, including glucagonomas. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link\">",
"       \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\"",
"      </a>",
"      .) However, technological advancements in CT and MRI over the past several decades have led to diminished utility of SRS as a component of the staging workup for pancreatic neuroendocrine tumors, particularly for glucagonomas, which are usually large by the time of diagnosis, and easily visualized on cross sectional imaging.",
"      <br/>",
"      <br/>",
"      However, SRS can identify clinically unsuspected extraabdominal metastases, and there may still be a role for SRS in the evaluation of a patient with glucagonoma if the finding of extraabdominal metastases would change patient management and the treatment plan. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=see_link&amp;anchor=H12145128#H12145128\">",
"       \"Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)\", section on 'Somatostatin-receptor scintigraphy (OctreoScan)'",
"      </a>",
"      .) Selective arterial stimulation and venous sampling is known to be useful for insulinoma and gastrinoma, but its usefulness for radiographically occult glucagonomas is less certain. However, at least one case report documents a case of glucagonoma that was diagnosed by arterial stimulation and venous sampling after calcium loading [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the primary tumor",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    metastases have been localized by CT or EUS, we proceed with needle biopsy to confirm the diagnosis. EUS-guided biopsy is the preferred method for localized disease. In comparison, a CT-guided liver biopsy is performed if liver metastases are present.",
"   </p>",
"   <p>",
"    As noted above, the histology will be diagnostic of a pancreatic neuroendocrine tumor. Immunohistochemical staining is required to confirm the presence of glucagon in the tumor cells. However, due to heterogeneous expression of glucagon, small needle biopsies may occasionally yield negative immunohistochemical stains for glucagon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;NME or NME-like lesions can be seen in a number of other disorders, including zinc deficiency, pellagra, kwashiorkor, end-stage liver disease, toxic epidermal necrolysis, pemphigus foliaceus, and pustular psoriasis. As noted above, hyperglucagonemia may be seen in various physiologic states and in association with other neuroendocrine tumors. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Serum glucagon'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Staging system",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pancreatic endocrine tumors such as glucagonomas are included in the combined American Joint Committee on Cancer",
"    <span class=\"nowrap\">",
"     (AJCC)/International",
"    </span>",
"    Union Against Cancer (UICC) TNM (tumor-node-metastasis) staging system for pancreatic tumors (",
"    <a class=\"graphic graphic_table graphicRef62155 \" href=\"mobipreview.htm?42/32/43532\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/15\">",
"     15",
"    </a>",
"    ]. Five- and ten-year survival rates for patients undergoing resection of pancreatic neuroendocrine tumors (both pancreatic neuroendocrine and carcinoid tumors) stratified by stage at presentation are presented in the following table (",
"    <a class=\"graphic graphic_table graphicRef80523 \" href=\"mobipreview.htm?4/42/4780\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of metastatic disease at the time of diagnosis varies from series to series, ranging from 50 to 100 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3,6\">",
"     3,6",
"    </a>",
"    ]. The most common site of metastasis is the liver, followed by regional lymph nodes, bone, adrenal gland, kidney, and lung.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;For the minority of cases in which the tumor is localized at the time of diagnosis, resection of the primary pancreatic tumor is indicated since it offers the chance of complete cure. Whether a simple enucleation, focal pancreatic resection, or Whipple procedure is performed is dictated by the site and extent of the tumor at the time of laparotomy.",
"   </p>",
"   <p>",
"    Rapid resolution of hyperglucagonemia and NME are typical after resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/17\">",
"     17",
"    </a>",
"    ]. However, even in cases deemed to be localized preoperatively, resection results in a complete cure rate of only about 30 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nutritional support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because patients with glucagonoma syndrome suffer from a prolonged catabolic state, nutritional support of some kind is an integral component of therapy.",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/40/42628?source=see_link\">",
"     Total parenteral nutrition",
"    </a>",
"    should be strongly considered preoperatively if resection is contemplated. In other cases, enteral feeding or supplements may be useful. Long-term resolution of NME has been achieved by intermittent infusions of amino and fatty acids in one patient, but without regression of tumor growth or other symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Radiation therapy for nonsurgical candidates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with external beam radiotherapy (RT) in the management of pancreatic neuroendocrine tumors is limited. Although pancreatic neuroendocrine carcinomas were previously considered to represent a radioresistant tumor, data from published case reports and small case series suggest that RT can produce high rates of symptomatic palliation and freedom from local progression in patients who are not candidates for surgical resection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/20-23\">",
"     20-23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Treatment for metastatic disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major issues in selecting the treatment strategy for patients with metastatic disease are the presence of symptoms from hormone production, and whether metastases are limited to the liver, the most commonly involved site. A general algorithmic approach to therapy is outlined in the figure (",
"    <a class=\"graphic graphic_algorithm graphicRef79461 \" href=\"mobipreview.htm?31/57/32671\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Octreotide and interferon alfa",
"    </span>",
"    &nbsp;&mdash;&nbsp;Somatostatin analogs such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    are highly effective for control of symptoms related to glucagon hypersecretion. Octreotide inhibits hormone secretion, reducing serum glucagon concentrations, and improving NME, diabetes, diarrhea, and neurologic symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3,24,25\">",
"     3,24,25",
"    </a>",
"    ]. The improvement in NME does not always correlate with the fall in serum glucagon, suggesting a possible direct effect of octreotide on NME. Somatostatin analogs are of uncertain benefit for asymptomatic patients; objective evidence of antitumor activity has not been clearly shown.",
"   </p>",
"   <p>",
"    Therapy is generally initiated with short-acting",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    50 mcg subcutaneously three times a day. The dose is increased gradually as needed to control symptoms. The patient is then rapidly transitioned to a long acting formulation. The duration of response ranges from 2 months to 3.5 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?7/34/7717?source=see_link\">",
"     Lanreotide",
"    </a>",
"    , a somatostatin analog, appears to have similar clinical efficacy as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    . Lanreotide is also available in a long-acting depot. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190948928#H190948928\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Octreotide and other somatostatin analogs'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Interferon alfa (IFNa) improves symptoms of hormonal hypersecretion in 40 to 50 percent of patients with pancreatic neuroendocrine tumors, induces tumor stabilization in 20 to 40 percent, and objective tumor regression in about 15 percent of patients (",
"    <a class=\"graphic graphic_table graphicRef78817 \" href=\"mobipreview.htm?34/9/34973\">",
"     table 3",
"    </a>",
"    ). Widespread acceptance of IFNa for the treatment of metastatic pancreatic neuroendocrine tumors has been limited by studies challenging its efficacy, as well as the potential for side effects that may include disabling fatigue, depression, alteration of thyroid function, and myelosuppression.",
"   </p>",
"   <p>",
"    The addition of IFNa to",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?42/7/43128?source=see_link\">",
"     octreotide",
"    </a>",
"    may control symptoms in patients who are resistant or refractory to octreotide alone (",
"    <a class=\"graphic graphic_table graphicRef78817 \" href=\"mobipreview.htm?34/9/34973\">",
"     table 3",
"    </a>",
"    ). However, it is not clear that combined therapy is superior to either agent alone for initial therapy in terms of symptom control, objective antitumor response, or survival. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190948949#H190948949\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Interferon'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Surgical resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hepatic resection is indicated for the treatment of metastatic liver disease in the absence of diffuse bilobar involvement, compromised liver function, or extensive extrahepatic metastases (eg, pulmonary, peritoneal). Although the majority of cases will not be cured by surgery, prolonged survival is often possible, given the slow-growing nature of these tumors. Furthermore, resection leads to significant reductions in serum glucagon concentration, and in the severity of NME, which may resolve completely in some patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3,26\">",
"     3,26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, resection should be considered only for patients with a limited number of hepatic metastases and is most successful when undertaken with curative intent. Concomitant resection of the primary is indicated if the primary site is causing symptoms, or if both the primary site and liver metastases are amenable to potentially curative resection. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/30/43496?source=see_link&amp;anchor=H691406#H691406\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth\", section on 'Resection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Embolization and chemoembolization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Liver metastases derive most of their blood supply from the hepatic artery, whereas healthy hepatocytes derive most of their blood supply from the portal vein. This provides the rationale for therapeutic embolization of the hepatic artery, with the goal of inducing necrosis of the metastases with minimal damage to normal liver parenchyma.",
"   </p>",
"   <p>",
"    Hepatic arterial embolization with or without selective hepatic artery infusion of chemotherapy is frequently applied as a palliative technique in patients with symptomatic hepatic metastases who are not candidates for surgical resection. The response rates associated with embolization or chemoembolization, as measured either by decrease in hormonal secretion or by radiographic regression, are generally greater than 50 percent. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/30/43496?source=see_link&amp;anchor=H691449#H691449\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth\", section on 'Hepatic artery embolization'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     RFA and cryoablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other approaches to the treatment of hepatic-predominant disease include radiofrequency ablation (RFA) and cryoablation, either alone or in conjunction with surgical debulking. These procedures, which can be performed using percutaneous or laparoscopic approaches, appear to be less morbid than either hepatic resection or hepatic artery embolization. However, both techniques are applicable only to smaller lesions, and their long-term efficacy is uncertain. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/30/43496?source=see_link&amp;anchor=H691456#H691456\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth\", section on 'RFA and cryoablation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Liver transplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single case of complete remission for six years after orthotopic liver transplantation (OLT) for glucagonoma has been reported [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/27\">",
"     27",
"    </a>",
"    ]. However, the total number of patients with liver-isolated metastatic glucagonoma or other pancreatic neuroendocrine tumors in whom OLT has been attempted is small, and follow-up data are insufficient to judge whether complete cure has truly been achieved.",
"   </p>",
"   <p>",
"    The limited availability of donor organs in many regions has restricted widespread investigation of this procedure. Until more data become available, most clinicians consider liver transplantation an investigational approach for metastatic pancreatic neuroendocrine tumors, including glucagonoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/30/43496?source=see_link&amp;anchor=H691420#H691420\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth\", section on 'Liver transplantation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Chemotherapy and novel treatment approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Experience with systemic chemotherapy is limited. The traditional regimen of choice has been",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/30/9702?source=see_link\">",
"     streptozocin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    . Although objective response rates as high as 69 percent were initially reported, with decreases in endocrine hyperfunction, the true radiologic response rate is probably between 10 and 40 percent. Uncertainty as to efficacy, as well as the toxicity of this regimen, which can include nausea, prolonged myelosuppression, and renal failure, has prevented its widespread acceptance as a standard first-line therapy for patients with metastatic pancreatic neuroendocrine tumors.",
"   </p>",
"   <p>",
"    More recently, antitumor activity has also been shown for regimens containing the orally active alkylating agent",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?10/47/11000?source=see_link\">",
"     temozolomide",
"    </a>",
"    . In the absence of comparative trials, the choice of first-line",
"    <span class=\"nowrap\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/30/9702?source=see_link\">",
"      streptozocin",
"     </a>",
"     /",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"      doxorubicin",
"     </a>",
"    </span>",
"    or a temozolomide-based regimen must be individualized, taking into account the convenience of oral rather than intravenous treatment, performance status, and the anticipated side effect profile of both combinations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190948956#H190948956\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Cytotoxic chemotherapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The modest efficacy of conventional cytotoxic chemotherapy has prompted the development of novel therapeutic approaches for patients with advanced pancreatic neuroendocrine tumors. In the United States, two molecularly targeted agents were approved for treatment of advanced pancreatic neuroendocrine tumors in 2011:",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?43/10/44200?source=see_link\">",
"     sunitinib",
"    </a>",
"    , a small molecule tyrosine kinase inhibitor, and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?6/4/6218?source=see_link\">",
"     everolimus",
"    </a>",
"    , an inhibitor of the mammalian target of rapamycin. These and other forms of novel therapy, including peptide receptor radioligand therapy, are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=see_link&amp;anchor=H190949026#H190949026\">",
"     \"Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion\", section on 'Molecularly targeted therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h1\">",
"     PROGNOSIS AND CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucagonomas are generally slow-growing, but usually advanced by the time of diagnosis. Once the tumor is metastatic, cure is rarely, if ever, achieved. However, despite the presence of metastases, many patients are able to experience prolonged survival with a combination of the above therapeutic modalities. In the most recent series, only 9 of 21 patients died of tumor-related causes, an average of 4.9 years after the diagnosis of metastatic disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"     3",
"    </a>",
"    ]. The remaining patients were still alive, with a mean follow-up of 3.7 years.",
"   </p>",
"   <p>",
"    A postresection prognostic scoring system has been proposed based upon a series of 3851 patients with pancreatic neuroendocrine tumors (n=75 glucagonomas) reported to the National Cancer Database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/28\">",
"     28",
"    </a>",
"    ]. In multivariate analysis, age, tumor grade, and metastases were the most significant predictors of survival. Strata for these factors were assigned a relative point value (age &lt;55 [0 points], 55 to 75 [1 point], &gt;75 [2 points], tumor grade",
"    <span class=\"nowrap\">",
"     well/moderately",
"    </span>",
"    differentiated [0 points] versus poorly differentiated [1 point], and distant metastases none [0 points] versus liver [1 point] versus other distant sites [2 points]) and incorporated into a scoring system which permitted stratification of the patients into the following prognostically distinct groups:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prognostic score 1 (raw score of 0) &ndash; five-year survival 77 percent",
"     </li>",
"     <li>",
"      Prognostic score 2 (raw score 1-2) &ndash; five-year survival 51 percent",
"     </li>",
"     <li>",
"      Prognostic score 3 (raw score &ge;3) &ndash; five-year survival 36 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     POSTTREATMENT SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is limited evidence from which to make recommendations for follow-up after resection of a glucagonoma. Guidelines from the National Comprehensive Cancer Network based upon expert consensus include the following recommendations for follow-up after treatment of a pancreatic neuroendocrine tumor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31640/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Three and six months postresection &ndash; History and physical examination, serum glucagon, and",
"      <span class=\"nowrap\">",
"       CT/MRI.",
"      </span>",
"     </li>",
"     <li>",
"      Long-term &ndash; History and physical examination with tumor markers every six to 12 months for years 1 to 3, and as clinically indicated thereafter. Imaging studies are recommended only as clinically indicated.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H68311489\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Nearly all reported cases of the glucagonoma syndrome have been associated with tumors originating in the alpha cells of the pancreas. Glucagonomas are generally slow-growing, but usually advanced by the time of diagnosis. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The clinical syndrome classically associated with glucagonoma includes necrolytic migratory erythema (NME), cheilitis, diabetes mellitus, anemia, weight loss, diarrhea, venous thrombosis, and neuropsychiatric symptoms. Weight loss and NME are the most prevalent symptoms, occurring in approximately 65 to 70 percent of patients by the time of diagnosis. While not pathognomonic for glucagonoma, the presence of NME should prompt further work-up for a pancreatic neuroendocrine tumor. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Glucagonoma is associated with markedly elevated serum concentrations of glucagon (&gt;500",
"      <span class=\"nowrap\">",
"       pg/mL).",
"      </span>",
"      Many conditions other than glucagonoma can induce \"physiologic\" elevations in the serum glucagon concentration. These include hypoglycemia, fasting, trauma, sepsis, acute pancreatitis, abdominal surgery, Cushing's syndrome, and renal and hepatic failure. However, these conditions are associated with only moderate elevations of glucagon, usually less than 500",
"      <span class=\"nowrap\">",
"       pg/mL",
"      </span>",
"      (upper limit of normal &lt;100",
"      <span class=\"nowrap\">",
"       pg/mL).",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Serum glucagon'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In patients suspected of having a glucagonoma, cross sectional imaging with helical, triple-phase abdominal computed tomography (CT) is the initial imaging procedure of choice. Since the primary tumor is usually large by the time of diagnosis, it is localizable by CT in the majority of cases. As a result of its greater sensitivity for liver metastases, some physicians prefer MRI over CT for assessing the status of the liver. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cross sectional imaging'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Endoscopic ultrasound (EUS) is also used in the evaluation of patients with suspected glucagonoma. It is most useful after CT has revealed an apparently localized pancreatic tumor to examine the regional extent of disease and to obtain biopsy material. It is also used when cross sectional imaging is unrevealing in a patient with clinical evidence of glucagonoma. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Endoscopic ultrasonography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once the primary tumor",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      metastases have been localized by CT or EUS, we proceed with needle biopsy to confirm the diagnosis. EUS-guided biopsy is the preferred method for localized disease. In comparison, a CT-guided liver biopsy is performed if liver metastases are present. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Biopsy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For the minority of cases in which the tumor is localized at the time of diagnosis, resection of the primary pancreatic tumor is indicated since it offers the chance of complete cure. Treatment of patients with metastatic disease may include resection of the primary tumor and metastases, treatment with a somatostatin analog, embolization, radiofrequency or cryoablation, and chemotherapy (",
"      <a class=\"graphic graphic_algorithm graphicRef79461 \" href=\"mobipreview.htm?31/57/32671\">",
"       algorithm 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The prevalence of metastatic disease at the time of diagnosis varies from series to series, ranging from 50 to 100 percent. The most common site of metastasis is the liver, followed by regional lymph nodes, bone, adrenal gland, kidney, and lung. Once the tumor is metastatic, cure is rarely, if ever, achieved. However, despite the presence of metastases, many patients are able to experience prolonged survival with a combination of therapeutic modalities. (See",
"      <a class=\"local\" href=\"#H28\">",
"       'Prognosis and clinical course'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/1\">",
"      Becker SW, Kahn D, Rothman S. Cutaneous manifestations of internal malignant tumors. Arch Dermatol Syph 1942; 45:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/2\">",
"      McGavran MH, Unger RH, Recant L, et al. A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med 1966; 274:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/3\">",
"      Wermers RA, Fatourechi V, Wynne AG, et al. The glucagonoma syndrome. Clinical and pathologic features in 21 patients. Medicine (Baltimore) 1996; 75:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/4\">",
"      Boden G. Glucagonomas and insulinomas. Gastroenterol Clin North Am 1989; 18:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/5\">",
"      Kindmark H, Sundin A, Granberg D, et al. Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years. Med Oncol 2007; 24:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/6\">",
"      Stacpoole PW. The glucagonoma syndrome: clinical features, diagnosis, and treatment. Endocr Rev 1981; 2:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/7\">",
"      Wilkinson DS. Necrolytic migratory erythema with carcinoma of the pancreas. Trans St Johns Hosp Dermatol Soc 1973; 59:244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/8\">",
"      Chang-Chretien K, Chew JT, Judge DP. Reversible dilated cardiomyopathy associated with glucagonoma. Heart 2004; 90:e44.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/9\">",
"      Klein S, Jahoor F, Baba H, et al. In vivo assessment of the metabolic alterations in glucagonoma syndrome. Metabolism 1992; 41:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/10\">",
"      Norton JA, Kahn CR, Schiebinger R, et al. Amino acid deficiency and the skin rash associated with glucagonoma. Ann Intern Med 1979; 91:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/11\">",
"      Pujol RM, Wang CY, el-Azhary RA, et al. Necrolytic migratory erythema: clinicopathologic study of 13 cases. Int J Dermatol 2004; 43:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/12\">",
"      Wermers RA, Fatourechi V, Kvols LK. Clinical spectrum of hyperglucagonemia associated with malignant neuroendocrine tumors. Mayo Clin Proc 1996; 71:1030.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/13\">",
"      R&ouml;sch T, Lightdale CJ, Botet JF, et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992; 326:1721.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/14\">",
"      Okauchi Y, Nammo T, Iwahashi H, et al. Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS). Intern Med 2009; 48:1025.",
"     </a>",
"    </li>",
"    <li>",
"     AJCC (American Joint Committee on Cancer) Cancer Staging Manual, 7th ed, Edge SB, Byrd DR, Compton CC, et al (Eds), Springer, New York  Vol 2010, p.241.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/16\">",
"      Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg 2007; 205:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/17\">",
"      Smith AP, Doolas A, Staren ED. Rapid resolution of necrolytic migratory erythema after glucagonoma resection. J Surg Oncol 1996; 61:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/18\">",
"      Fraker DL, Norton JA. The role of surgery in the management of islet cell tumors. Gastroenterol Clin North Am 1989; 18:805.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/19\">",
"      Alexander EK, Robinson M, Staniec M, Dluhy RG. Peripheral amino acid and fatty acid infusion for the treatment of necrolytic migratory erythema in the glucagonoma syndrome. Clin Endocrinol (Oxf) 2002; 57:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/20\">",
"      Contessa JN, Griffith KA, Wolff E, et al. Radiotherapy for pancreatic neuroendocrine tumors. Int J Radiat Oncol Biol Phys 2009; 75:1196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/21\">",
"      Strosberg J, Hoffe S, Gardner N, et al. Effective treatment of locally advanced endocrine tumors of the pancreas with chemoradiotherapy. Neuroendocrinology 2007; 85:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/22\">",
"      Tennvall J, Ljungberg O, Ahr&eacute;n B, et al. Radiotherapy for unresectable endocrine pancreatic carcinomas. Eur J Surg Oncol 1992; 18:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/23\">",
"      Torrisi JR, Treat J, Zeman R, Dritschilo A. Radiotherapy in the management of pancreatic islet cell tumors. Cancer 1987; 60:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/24\">",
"      Boden G, Ryan IG, Eisenschmid BL, et al. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995. N Engl J Med 1986; 314:1686.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/25\">",
"      Rosenbaum A, Flourie B, Chagnon S, et al. Octreotide (SMS 201-995) in the treatment of metastatic glucagonoma: report of one case and review of the literature. Digestion 1989; 42:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/26\">",
"      McEntee GP, Nagorney DM, Kvols LK, et al. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108:1091.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/27\">",
"      Radny P, Eigentler TK, Soennichsen K, et al. Metastatic glucagonoma: treatment with liver transplantation. J Am Acad Dermatol 2006; 54:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31640/abstract/28\">",
"      Bilimoria KY, Talamonti MS, Tomlinson JS, et al. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients. Ann Surg 2008; 247:490.",
"     </a>",
"    </li>",
"    <li>",
"     National Comprehensive Cancer Network (NCCN) guidelines. Available at: www.nccn.org (Accessed on May 15, 2012).",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2611 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-211.167.112.14-E421669322-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31640=[""].join("\n");
var outline_f30_57_31640=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H68311489\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Necrolytic migratory erythema",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Other symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Laboratory abnormalities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS, LOCALIZATION, AND STAGING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Serum glucagon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H390545\">",
"      Tumor localization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Cross sectional imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Endoscopic ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Other imaging modalities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Staging system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nutritional support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Radiation therapy for nonsurgical candidates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Treatment for metastatic disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Octreotide and interferon alfa",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Surgical resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Embolization and chemoembolization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - RFA and cryoablation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Liver transplantation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Chemotherapy and novel treatment approaches",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      PROGNOSIS AND CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      POSTTREATMENT SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H68311489\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"GAST/2611\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2611|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?31/57/32671\" title=\"algorithm 1\">",
"      Algorithm for treatment of metastatic neuroendocrine tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2611|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?17/32/17925\" title=\"picture 1\">",
"      Necrolytic migratory erythema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"GAST/2611|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/32/43532\" title=\"table 1\">",
"      TNM panc endo exo CA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/42/4780\" title=\"table 2\">",
"      Survival rates following resection of a pancreatic neuroendocrine tumor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/9/34973\" title=\"table 3\">",
"      Octreotide IFN met neuroend tum",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/57/18330?source=related_link\">",
"      Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine tumors (islet-cell tumors)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/63/9206?source=related_link\">",
"      Clinical features of the carcinoid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/10/14504?source=related_link\">",
"      Clinical manifestations and diagnosis of Zollinger-Ellison syndrome (gastrinoma)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/30/12777?source=related_link\">",
"      Insulinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/30/43496?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Local options to control tumor growth",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/46/39658?source=related_link\">",
"      Metastatic gastroenteropancreatic neuroendocrine tumors: Systemic therapy options to control tumor growth and symptoms of hormone hypersecretion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43240?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/34/3623?source=related_link\">",
"      Somatostatinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/59/16311?source=related_link\">",
"      The VIPoma syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31641="Healthy diet in adults";
var content_f30_57_31641=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Healthy diet in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Graham A Colditz, MD, DrPh",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Timothy O Lipman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31641/contributors\">",
"     Fenny H Lin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/57/31641/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large, prospective epidemiologic studies of diet and chronic diseases have facilitated major advances in our understanding of the contribution of diet to the pathogenesis of disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/1\">",
"     1",
"    </a>",
"    ]. These studies are complemented by randomized trials and studies of nutrient action in animal models which have led to changing dietary guidelines around the world [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/2\">",
"     2",
"    </a>",
"    ]. Although guidelines vary from country to country, recommendations from different parts of the world share similarities in terms of the emphasis on certain types of foods and nutrients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/2-6\">",
"     2-6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will review important components of a healthy diet. Dietary assessment and diets for specific populations are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23175?source=see_link\">",
"     \"Dietary and nutritional assessment in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18441?source=see_link\">",
"     \"Dietary recommendations for toddlers, preschool, and school-age children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/12/31946?source=see_link\">",
"     \"Geriatric nutrition: Nutritional issues in older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355136369\">",
"    <span class=\"h1\">",
"     CALORIC BALANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maintaining caloric balance over time is important to maintaining healthy weight. Overnutrition leading to overweight and obesity is an important dietary problem, as it is associated with premature mortality as well as increased incidence of cardiovascular disease, diabetes, hypertension, cancer, and other important conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=see_link\">",
"     \"Health hazards associated with obesity in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients with normal weight, caloric intake should equal energy expenditure. Balancing caloric intake requires that many individuals limit their typical calorie consumption while also engaging in physical activity. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/46/28394?source=see_link\">",
"     \"Overview of the benefits and risks of exercise\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Calculating total energy expenditure for recommended daily caloric intake is based on age, sex, weight, and activity level (",
"    <a class=\"graphic graphic_table graphicRef63308 \" href=\"mobipreview.htm?34/37/35419\">",
"     table 1",
"    </a>",
"    ). Calculating one&rsquo;s actual daily caloric intake can be aided by using 24-hour dietary recall, a food diary, or other assessment tools to determine caloric intake of different foods and beverages. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23175?source=see_link\">",
"     \"Dietary and nutritional assessment in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H948339\">",
"    <span class=\"h1\">",
"     MACRONUTRIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Macronutrients are the chemical compounds consumed in the largest quantities and provide bulk energy. The three primary macronutrients include carbohydrates, proteins, and fats. Fiber can also be considered a macronutrient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The total caloric intake should be broken down by percentage of macronutrient intake, as recommended by the United States (US) Dietary Guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      45 to 65 percent from carbohydrates",
"     </li>",
"     <li>",
"      10 to 35 percent from protein",
"     </li>",
"     <li>",
"      20 to 35 percent from fat",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H948347\">",
"    <span class=\"h2\">",
"     Carbohydrate",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both the quantity and type of carbohydrate (eg, simple versus complex, whole grain versus refined grain) have differential effects on postprandial glucose levels and glycemic index. Several prospective studies have associated diets high in glycemic index with risk of developing type 2 diabetes mellitus, coronary heart disease, and some cancers. Glycemic index for common foods are available in a table (",
"    <a class=\"graphic graphic_table graphicRef71978 \" href=\"mobipreview.htm?8/40/8845\">",
"     table 2",
"    </a>",
"    ). One important way of achieving a healthy diet is to replace carbohydrates having a high glycemic index (eg, pizza, rice, pancakes) with a low glycemic index (eg, fruits, vegetables). Added sugars should comprise no more than 25 percent of total calories consumed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38649?source=see_link\">",
"     \"Dietary carbohydrates\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950468\">",
"    <span class=\"h2\">",
"     Protein",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals should be counseled to eat a variety of protein-rich foods, including fish, lean meat such as poultry, eggs, beans, peas, soy products, and unsalted nuts and seeds. Patients should be advised to avoid protein sources with trans and saturated fats, including red and processed meats.",
"   </p>",
"   <p>",
"    Common sources of dietary protein include whole protein foods (eg, meat, fish, egg, vegetables, milk) and protein powders (eg, casein, whey, soy). The source of protein has a differential effect on health (eg, red meats are associated with increased mortality, compared to white meats). (See",
"    <a class=\"local\" href=\"#H950600\">",
"     'Meat and other protein-rich foods'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H948361\">",
"    <span class=\"h2\">",
"     Fat",
"    </span>",
"    &nbsp;&mdash;&nbsp;The type of fat consumed in a given diet appears to be more important than the amount of total fat (",
"    <a class=\"graphic graphic_table graphicRef75539 \" href=\"mobipreview.htm?33/62/34796\">",
"     table 3",
"    </a>",
"    ). Saturated fat and trans fat contribute to coronary heart disease (CHD), while monounsaturated and polyunsaturated fats are protective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/10,11\">",
"     10,11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Individuals should consume less than 10 percent of calories from saturated fatty acids. Saturated fats (eg, in meats, cheese, ice cream) can be replaced with monounsaturated and polyunsaturated fatty acids (eg, in fish, olive oil, nuts). Patients should be advised to replace fat-full milk products (eg, whole milk, ice cream) with fat-free or low-fat milk products (eg, skim milk, yogurt, fortified soy beverages).",
"     </li>",
"     <li>",
"      Trans fatty acid consumption should be kept as low as possible. The major sources of trans fats include margarines and partially hydrogenated vegetable fats. These fats are also present in many processed and fast foods.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The impact of saturated fatty acids and trans fat on health outcomes along with strategies for reducing their consumption are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2601?source=see_link\">",
"     \"Dietary fat\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is some evidence that long-term consumption of fish oil and omega-3 fatty acids reduces the risk of cardiovascular disease. One to two servings of oily fish in the weekly diet is suggested for most adult patients. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36330?source=see_link\">",
"     \"Fish oil and marine omega-3 fatty acids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Consumption of dietary cholesterol should be less than 300 mg per day, as recommended by the US Dietary Guidelines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Consumption of trans fat, saturated fat, and dietary cholesterol each affect plasma cholesterol levels. Elevated plasma cholesterol concentrations, particularly LDL-cholesterol, show a strong and consistent association with the incidence of CHD [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. However, there are limited data showing that dietary interventions to lower cholesterol intake improve patient outcomes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/51/28474?source=see_link\">",
"     \"Lipid lowering with diet or dietary supplements\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/19/40248?source=see_link\">",
"     \"Lipoprotein(a) and cardiovascular disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H949890\">",
"    <span class=\"h2\">",
"     Fiber",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended amount of dietary fiber is 14 g per 1000 calories, or 25 g per day for women and 38 g per day for men [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3,14\">",
"     3,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Fiber is the portion of plants that cannot be digested by enzymes in the gastrointestinal tract. Fiber is available in a large variety of natural foods and supplements (",
"    <a class=\"graphic graphic_table graphicRef82094 \" href=\"mobipreview.htm?17/1/17438\">",
"     table 4",
"    </a>",
"    ). Patients should be advised to replace refined grains (eg, white rice, white bread) with whole grains (eg, brown rice, whole wheat bread), which have higher fiber content. (See",
"    <a class=\"local\" href=\"#H950615\">",
"     'Grains'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Increased fiber intake is associated with decreased risk in cardiovascular events, incidence of diabetes, and all-cause mortality:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cardiovascular disease &mdash; High fiber intake is associated with a 40 to 50 percent reduction in the risk of CHD and stroke compared with low fiber intake [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/15-19\">",
"       15-19",
"      </a>",
"      ]. A pooled analysis of cohort studies found that each 10 g increase in energy-adjusted intake of fiber per day was associated with a 14 percent relative reduction in the risk for all coronary events and a 27 percent reduction in CHD death [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/20\">",
"       20",
"      </a>",
"      ]. High fiber diets may in part protect against CHD by controlling cardiovascular risk factors, including lowering insulin levels, improving lipid profiles, and lowering blood pressure [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diabetes mellitus &mdash; Fiber consumption from grains has a protective effect against diabetes mellitus. Increased fiber intake may also be beneficial in controlling blood glucose in patients with established diabetes. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/2/25641?source=see_link\">",
"       \"Nutritional considerations in type 1 diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/18/14634?source=see_link\">",
"       \"Nutritional considerations in type 2 diabetes mellitus\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/30/29162?source=see_link&amp;anchor=H10#H10\">",
"       \"Prediction and prevention of type 2 diabetes mellitus\", section on 'Diet'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/24/9610?source=see_link&amp;anchor=H11#H11\">",
"       \"Risk factors for type 2 diabetes mellitus\", section on 'Dietary patterns'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cancer &mdash; A number of laboratory, nutritional, and epidemiologic studies have identified low levels of dietary fiber in the pathogenesis of colorectal cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/22\">",
"       22",
"      </a>",
"      ]. However, the degree to which dietary fiber protects against the development of adenomas or colorectal cancer is uncertain, since the results of several epidemiologic studies and randomized trials are discordant. Dietary fiber and risk of colorectal and other cancers is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=see_link&amp;anchor=H17#H17\">",
"       \"Colorectal cancer: Epidemiology, risk factors, and protective factors\", section on 'Fiber'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42378?source=see_link&amp;anchor=H9#H9\">",
"       \"Cancer prevention\", section on 'Fruits and vegetables'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Mortality &mdash; Observational studies suggest that increased dietary fiber intake is associated with decreased all-cause and CHD mortality [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/20,23\">",
"       20,23",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the NIH-AARP cohort, with more than 20,000 male deaths and 10,000 female deaths during nine years of follow-up, higher dietary fiber intake was associated with a 22 percent lower risk of all-cause mortality in both men and women (comparing highest to lowest quintiles of fiber intake) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/23\">",
"       23",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a large European prospective cohort study of 452,717 healthy individuals (mean follow-up 12.7 years), there was an inverse association between fiber intake and total mortality (HR 0.90, 95% CI 0.88-0.92) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/24\">",
"       24",
"      </a>",
"      ]. Fiber intake was also inversely associated with mortality from circulatory, respiratory, digestive, and non-cardiovascular, noncancer inflammatory diseases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/24\">",
"       24",
"      </a>",
"      ]. The associations were stronger in smokers and heavy drinkers (&gt;18 grams",
"      <span class=\"nowrap\">",
"       alcohol/day).",
"      </span>",
"      Fiber from vegetables and cereals had higher impact than fiber from fruit.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H948428\">",
"    <span class=\"h1\">",
"     MICRONUTRIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutrients needed in very small amounts are called micronutrients and include several minerals (eg, sodium, calcium) and vitamins. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=see_link\">",
"     \"Overview of dietary trace minerals\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"     \"Vitamin supplementation in disease prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H948435\">",
"    <span class=\"h2\">",
"     Sodium",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommended dietary sodium intake for the general population is less than 100",
"    <span class=\"nowrap\">",
"     meq/day",
"    </span>",
"    (2.3 g of sodium or 6 g of sodium chloride).",
"   </p>",
"   <p>",
"    A high dietary intake of sodium is associated with the development of hypertension and cardiovascular disease. Reduction in sodium intake is associated with decreased risk of cardiovascular events, including death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/25\">",
"     25",
"    </a>",
"    ]. Some individuals are particularly sensitive to sodium in the diet (eg, older individuals, African-Americans, patients with chronic kidney disease) and are referred to as being sodium-sensitive.",
"   </p>",
"   <p>",
"    Sodium restriction is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"     \"Salt intake, salt restriction, and essential hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H248829338\">",
"    <span class=\"h2\">",
"     Calcium and vitamin D",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommended calcium intake for postmenopausal women is &ge;1200 mg daily, while recommended vitamin D intake is &ge;400 International units (units) daily in younger individuals and at least 800 units daily in older adults.",
"   </p>",
"   <p>",
"    Calcium and vitamin D&nbsp;are necessary for normal skeletal homeostasis. Given the benefits of calcium and vitamin D in preventing osteoporosis, patients should be encouraged to consume foods with calcium",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vitamin D, such as fortified milk products. Supplements should be offered to patients with inadequate calcium or vitamin D intake (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/21/33113?source=see_link&amp;anchor=H14#H14\">",
"     \"Prevention of osteoporosis\", section on 'Calcium and vitamin D'",
"    </a>",
"    ). Recommendations for calcium and vitamin D supplementation in the treatment of osteoporosis are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=see_link\">",
"     \"Calcium and vitamin D supplementation in osteoporosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The effect of calcium and vitamin D intake on most extraskeletal health outcomes remains unclear. This is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31193?source=see_link\">",
"     \"Vitamin D and extraskeletal health\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/52/31562?source=see_link&amp;anchor=H20#H20\">",
"     \"Risk factors for prostate cancer\", section on 'Calcium and vitamin D'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=see_link&amp;anchor=H21#H21\">",
"     \"Colorectal cancer: Epidemiology, risk factors, and protective factors\", section on 'Calcium and dairy products'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=see_link\">",
"     \"Risk factors for calcium stones in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/51/28474?source=see_link&amp;anchor=H17#H17\">",
"     \"Lipid lowering with diet or dietary supplements\", section on 'Calcium'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7505602\">",
"    <span class=\"h2\">",
"     Folate",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to its importance for erythropoiesis, folate has an important role in the prevention of neural tube defects. It is not clear if folate prevents other diseases (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link&amp;anchor=H3#H3\">",
"     \"Vitamin supplementation in disease prevention\", section on 'Folic acid'",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Low folate intake is associated with an increased risk of neural tube defects; supplementation with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      reduces this risk in women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/26\">",
"       26",
"      </a>",
"      ]. Women of reproductive potential should take a daily multivitamin containing at least 0.4 mg of folic acid. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?4/61/5081?source=see_link\">",
"       \"Folic acid for prevention of neural tube defects\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In observational studies, higher dietary folate intake is associated with a decreased risk of developing colon cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/27-29\">",
"       27-29",
"      </a>",
"      ]. However, in randomized trials,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/61/9174?source=see_link\">",
"       folic acid",
"      </a>",
"      supplementation does not seem to protect against cancer and may increase risk of colorectal and other cancers [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/30,31\">",
"       30,31",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=see_link\">",
"       \"Colorectal cancer: Epidemiology, risk factors, and protective factors\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"       \"Vitamin supplementation in disease prevention\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H87358612\">",
"    <span class=\"h2\">",
"     Other vitamins",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recommended dietary allowances for the major vitamins are presented in a table (",
"    <a class=\"graphic graphic_table graphicRef72514 \" href=\"mobipreview.htm?29/45/30416\">",
"     table 5",
"    </a>",
"    ). Vitamin supplementation is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"     \"Vitamin supplementation in disease prevention\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H949615\">",
"    <span class=\"h1\">",
"     TYPES OF FOOD",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to macronutrients and micronutrients, specific types of food intake play an important role in nutrition and health outcomes. As an example, in large prospective cohort studies of healthy men and women, fruits, vegetables, and nuts were associated with weight loss whereas processed meats, unprocessed red meats, potato chips, fried foods, and desserts were associated with weight gain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite variability in how types of food are classified, many countries categorize food into the following groups: fruits, vegetables, grains, dairy products, and",
"    <span class=\"nowrap\">",
"     meat/protein-rich",
"    </span>",
"    foods (",
"    <a class=\"graphic graphic_table graphicRef80497 \" href=\"mobipreview.htm?37/9/38047\">",
"     table 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/4-6,33\">",
"     4-6,33",
"    </a>",
"    ]. The US Dietary Guidelines provide a guide to recommended average daily intake of food groups based on caloric intake (",
"    <a class=\"graphic graphic_table graphicRef68730 \" href=\"mobipreview.htm?20/11/20671\">",
"     table 7",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h2\">",
"     Fruits and vegetables",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients should be counseled to consume five or more servings of fruits",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    vegetables daily (",
"    <a class=\"graphic graphic_table graphicRef68730 \" href=\"mobipreview.htm?20/11/20671\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ]. Fruits and vegetables are a rich source of fiber, essential vitamin and minerals, as well as carbohydrates with a low glycemic index. (See",
"    <a class=\"local\" href=\"#H949890\">",
"     'Fiber'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"     \"Vitamin supplementation in disease prevention\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38649?source=see_link&amp;anchor=H3#H3\">",
"     \"Dietary carbohydrates\", section on 'Glycemic index'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Increased fruit and vegetable intake is associated with decreased risk in cardiovascular disease, cancer, and mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h3\">",
"     Cardiovascular disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies suggest that fruit and vegetable consumption is associated with a lower risk of CHD and stroke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. A meta-analysis of cohort studies also found higher intake of fruits and vegetables was associated with a lower risk of stroke; compared with intake below three servings per day, risk was reduced with three to five servings and with more than five servings daily (RR 0.89 and 0.74, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/36\">",
"     36",
"    </a>",
"    ]. One study found that the lowest risks were associated with high consumption of cruciferous vegetables (eg, broccoli, cabbage, cauliflower, Brussels sprouts), green leafy vegetables, citrus fruits, and vitamin C-rich fruits and vegetables [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/37\">",
"     37",
"    </a>",
"    ]. Intake beyond six servings per day provided little further reduction in ischemic stroke risk compared with intake of five to six servings per day.",
"   </p>",
"   <p>",
"    A possible explanation for this association is the high content of fiber in these foods, which may offer substantial protection against heart disease and stroke. (See",
"    <a class=\"local\" href=\"#H949890\">",
"     'Fiber'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several laboratory and small observational studies have found some anticarcinogenic properties of fruits and vegetables, but large prospective cohort studies have not found a substantial effect on cancer incidence in the general population. Some observational studies support a association between an increased intake of tomatoes and tomato-based products with a lower risk of prostate cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42378?source=see_link&amp;anchor=H9#H9\">",
"     \"Cancer prevention\", section on 'Fruits and vegetables'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355137805\">",
"    <span class=\"h3\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;Large prospective cohort studies have found that increased consumption of fruits and vegetables is associated with decreased all-cause and CHD mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/40-42\">",
"     40-42",
"    </a>",
"    ]. In the European Prospective Investigation into Cancer and Nutrition (EPIC) study, participants consuming eight or more portions of fruits and vegetables daily had a lower risk of CHD mortality, compared with those consuming less than three portions daily (RR 0.78, 95% CI 0.65-0.95) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/42\">",
"     42",
"    </a>",
"    ]. Each portion increment (80 g) was associated with an approximate 4 percent lower risk of CHD mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950615\">",
"    <span class=\"h2\">",
"     Grains",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals should be advised to consume at least half of all grains as whole grains (ie, three or more ounces of whole grain) for a 2000 calorie diet, as recommended by the US Dietary Guidelines (",
"    <a class=\"graphic graphic_table graphicRef68730 \" href=\"mobipreview.htm?20/11/20671\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Foods made from wheat, oats, rice, cornmeal, or barley are considered grain products. Common types of food made from grain include bread, breakfast cereal, oatmeal, tortillas, and pasta.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Refined grains (eg, white rice, white bread, refined and sweetened cereals) are milled, which removes fiber, iron, and B vitamins, in order to give a finer texture and improve shelf life.",
"     </li>",
"     <li>",
"      Enriched grains are refined grains that have iron and B vitamins added back, but not fiber in most cases.",
"     </li>",
"     <li>",
"      Whole grain foods include brown rice, whole wheat bread, whole grain cereal, and oatmeal. These are a good source of fiber and carbohydrates with a lower glycemic index.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In large prospective studies of healthy individuals, refined grains are associated with long-term weight gain, whereas whole grains are associated with weight loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/32\">",
"     32",
"    </a>",
"    ]. Patients should be advised to replace refined grains with whole grains (",
"    <a class=\"graphic graphic_table graphicRef80497 \" href=\"mobipreview.htm?37/9/38047\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950607\">",
"    <span class=\"h2\">",
"     Dairy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The US Dietary Guidelines recommend that individuals include three cups of dairy products daily for a 2000 calorie diet (",
"    <a class=\"graphic graphic_table graphicRef68730 \" href=\"mobipreview.htm?20/11/20671\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ]. The dairy food group is composed of milk and foods made from milk. Examples include milk, cheese, yogurt, and milk-based desserts (eg, pudding, frozen yogurt, ice cream) (",
"    <a class=\"graphic graphic_table graphicRef80497 \" href=\"mobipreview.htm?37/9/38047\">",
"     table 6",
"    </a>",
"    ). Dairy products are a good source of protein, calcium, vitamin D, and potassium. Diets that include lower amounts of dairy products should ensure adequate intake of these nutrients from other sources.",
"   </p>",
"   <p>",
"    While whole milk has been considered a risk factor for cardiovascular disease given its saturated fat content, there is not clear evidence that milk drinking or dairy intake is associated with an increased risk of cardiovascular disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/43,44\">",
"     43,44",
"    </a>",
"    ]. One meta-analysis of ten cohort studies found that milk drinking may be associated with a small reduction in heart disease (RR 0.87, 95% CI 0.74-1.03)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    ischemic stroke (RR 0.84, 95%CI 0.78-0.90) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Individuals should be advised to replace fat-full milk products (eg, whole milk, ice cream) with fat-free or low-fat milk products (eg, skim milk, yogurt). (See",
"    <a class=\"local\" href=\"#H948361\">",
"     'Fat'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950600\">",
"    <span class=\"h2\">",
"     Meat and other protein-rich foods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals should be advised to take 5.5 ounces of lean meat and beans daily (approximately two to three servings) for a 2000 calorie diet, as recommended by the US Dietary Guidelines (",
"    <a class=\"graphic graphic_table graphicRef68730 \" href=\"mobipreview.htm?20/11/20671\">",
"     table 7",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ]. Protein-rich foods include meat, seafood, eggs, beans, peas, nuts, and seeds (",
"    <a class=\"graphic graphic_table graphicRef80497 \" href=\"mobipreview.htm?37/9/38047\">",
"     table 6",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Protein sources with higher trans and saturated fats, including red and processed meats (eg, cold cuts, hot dogs), have a negative impact on health compared to lean protein (see",
"    <a class=\"local\" href=\"#H950468\">",
"     'Protein'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H948361\">",
"     'Fat'",
"    </a>",
"    above). In the NIH-AARP cohort, consumption of red meats and processed meats was associated with increased all-cause, cardiovascular, and cancer mortality, while consumption of white meat was associated with a lower risk of all-cause and cancer mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/45\">",
"     45",
"    </a>",
"    ]. Similarly, in an analysis that combined results from women in the Nurses&rsquo; Health Study (N = 83,644) and men in the Health Professionals Follow-up Study (N = 37,698), higher intake of red meat was associated with elevated risks of total, cardiovascular, and cancer mortality, whereas substituting other foods (eg, poultry, fish, legumes, nuts, low-fat dairy, whole grains) was associated with lower risks; risks were higher for processed red meat than for unprocessed red meat [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One to two servings of oily fish in the weekly diet is suggested for most adult patients as there is some evidence that long-term consumption of fish oil and omega-3 fatty acids reduces the risk of cardiovascular disease. This is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36330?source=see_link\">",
"     \"Fish oil and marine omega-3 fatty acids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26714230\">",
"    <span class=\"h1\">",
"     BEVERAGES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26714238\">",
"    <span class=\"h2\">",
"     Alcohol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alcohol should only be consumed in moderation with no more than one drink per day for women and two drinks per day for men. The specific risks and benefits of alcohol consumption vary based on age, sex, and comorbid conditions. For the general population, moderate alcohol consumption typically lowers the risk of cardiovascular disease, while also raising the risk of colon cancer and, in women, breast cancer. Those that drink moderately likely do not need to be counseled to stop. At the same time, those who do not drink alcohol do not need to start. Alcohol is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=see_link\">",
"     \"Overview of the risks and benefits of alcohol consumption\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/33/31258?source=see_link\">",
"     \"Cardiovascular benefits and risks of moderate alcohol consumption\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26714245\">",
"    <span class=\"h2\">",
"     Sweetened beverages",
"    </span>",
"    &nbsp;&mdash;&nbsp;The consumption of soft drinks and other sweetened beverages (eg, fruit drinks) should be discouraged [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ]. These beverages are a major source of added refined sugar in the diet. Sugar-sweetened beverages and fruit juices are associated with an increased risk of weight gain in healthy adult men and women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/32\">",
"     32",
"    </a>",
"    ]. Their consumption is also associated with lower intake of key nutrients because they are consumed instead of nutrient dense foods. One cohort study found an association between naturally or artificially-sweetened beverages and an increased risk of hypertension [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/47\">",
"     47",
"    </a>",
"    ]. Individuals should be encouraged to drink plain water rather than sweetened beverages.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H355136837\">",
"    <span class=\"h1\">",
"     TYPES OF DIET",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several types of diets, many of which have been studied for weight loss reduction, rather than maintenance of normal weight. These include low calorie, low fat, low carbohydrate (eg, Atkins diet), high protein, and portion-controlled diets. These diets are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8345?source=see_link&amp;anchor=H6#H6\">",
"     \"Dietary therapy for obesity\", section on 'Types of diets'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Outside of overweight and obese populations, there are few well-designed prospective cohort studies or randomized trials comparing different diets. This is partly due to the wide variability in cultural influences on dietary patterns. Thus, it is not known which type of diet is optimal for the general population.",
"   </p>",
"   <p>",
"    Low-fat diet, vegetarian diet, Dietary Approaches to Stop Hypertension (DASH) diet, and the Mediterranean diet are among the most commonly-used diets to maintain good health, where weight loss is not necessarily the primary goal. All of these diets are associated with health benefits. The decision to choose one of these diets is generally based on patient preference and the ability to adhere to a given diet.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950704\">",
"    <span class=\"h2\">",
"     Low-fat diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Low-fat diets are a standard strategy to help patients lose or maintain weight, and almost all dietary guidelines recommend a reduction in the daily intake of fat to 30 percent of energy intake or less [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite concern that low fat diets may promote an unhealthy increase in carbohydrate consumption and consequent weight gain, this does not appear to be the case. This was illustrated by the Women's Health Initiative Dietary Modification Trial of 48,835 postmenopausal women over age 50 years who were randomly assigned to a dietary intervention of group and individual sessions to promote a decrease in fat intake and increases in fruit, vegetable, and grain consumption versus a control group who received only dietary educational materials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/48\">",
"     48",
"    </a>",
"    ]. There were no weight loss or caloric restriction goals. After an average of 7.5 years of follow-up, the following results were seen:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women in the intervention group lost weight and maintained lower weight than the control women at 1 year (difference of 1.9 kg) and at 7.5 years (difference of 0.4 kg).",
"     </li>",
"     <li>",
"      No tendency toward weight gain was seen in the intervention group, whereas some weight gain was observed in the control group.",
"     </li>",
"     <li>",
"      Weight loss was related to the level of fat intake and was greatest in women who were most able to decrease their percentage of energy from fat. A similar but lesser trend was seen with increased vegetable and fruit intake.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H81663199\">",
"    <span class=\"h2\">",
"     Vegetarian diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vegetarian diets vary considerably depending on the degree of dietary restrictions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/49\">",
"     49",
"    </a>",
"    ]. According to the strictest definition, a vegetarian diet consists primarily of cereals, fruits, vegetables, legumes, and nuts; animal foods, including milk, dairy products, and eggs generally are excluded [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Several less restrictive vegetarian diets may include eggs and dairy products. Some vegetarian diets may be grouped as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Macrobiotic &mdash; Vegetables, fruits, legumes, and seaweeds are included in the diet, while whole grains, especially brown rice, are also emphasized. Locally-grown fruits are recommended. Animal foods limited to white meat or white-meat fish may be included in the diet once or twice a week.",
"     </li>",
"     <li>",
"      Semi-vegetarian &mdash; Meat occasionally is included in the diet. Some people who follow such a diet may not eat red meat but may eat fish and perhaps chicken.",
"     </li>",
"     <li>",
"      Lacto-ovovegetarian &mdash; Eggs, milk, and milk products (lacto = dairy; ovo = eggs) are included, but no meat is consumed.",
"     </li>",
"     <li>",
"      Lactovegetarian &mdash; Milk and milk products are included in the diet, but no eggs or meat are consumed.",
"     </li>",
"     <li>",
"      Vegan &mdash; All animal products, including eggs, milk, and milk products, are excluded from the diet. Some vegans do not use honey and may refrain from using animal products such as leather or wool. They also may avoid foods that are processed or not organically grown [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The long-term effects of a vegetarian diet on health outcomes are difficult to separate from those of the vegetarian lifestyle (eg, regular exercise, avoidance of tobacco and alcohol products). However, observational studies suggest that consumption of a vegetarian diet is associated with lower incidence of obesity, coronary heart disease, hypertension, and type 2 diabetes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/53-55\">",
"     53-55",
"    </a>",
"    ]. In addition, observational evidence suggests that being a lactovegetarian has greater health benefits and reduced health risks than being a vegan [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The nutritional adequacy of a vegetarian diet should be judged individually, not on the basis of what it is called but on the type, amount, and variety of nutrients that are consumed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/57\">",
"     57",
"    </a>",
"    ]. Vegans, who typically exclude dairy products in their diet, may have low bone mineral density and higher risk of fractures due to inadequate intake of vitamin D [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/58\">",
"     58",
"    </a>",
"    ]. Patients on a vegetarian diet who completely exclude animal products may also have inadequate vitamin B12 intake and may need to take vitamin B12 supplements. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link&amp;anchor=H54#H54\">",
"     \"Vitamin supplementation in disease prevention\", section on 'Special diets'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H950732\">",
"    <span class=\"h2\">",
"     DASH diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Dietary Approaches to Stop Hypertension (DASH) diet is comprised of four to five servings of fruit, four to five servings of vegetables, two to three servings of low-fat dairy per day, and &lt;25 percent dietary intake from fat.",
"   </p>",
"   <p>",
"    The DASH diet has been studied in both normotensive and hypertensive populations and found to lower systolic and diastolic pressure more than a diet rich in fruits and vegetables alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/59\">",
"     59",
"    </a>",
"    ]. The combination of low sodium and DASH diet resulted in further decreases in blood pressure, comparable to those observed with antihypertensive agents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/60\">",
"     60",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"     \"Salt intake, salt restriction, and essential hypertension\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42679?source=see_link\">",
"     \"Diet in the treatment and prevention of hypertension\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Mediterranean diet",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no single definition of a Mediterranean diet, but such diets are typically high in fruits, vegetables, whole grains, beans, nuts, and seeds and include olive oil as an important source of fat. There are typically low to moderate amounts of fish, poultry, and dairy products, with little red meat. The Mediterranean diet is associated with several health benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 12 studies involving 8 cohorts found that a Mediterranean diet was associated with improved health status and reductions in overall mortality, cardiovascular mortality, cancer mortality, and incidence of Parkinson's disease and Alzheimer's disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The largest of the included studies prospectively evaluated conformity to the Mediterranean diet in the NIH-AARP cohort [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31641/abstract/62\">",
"       62",
"      </a>",
"      ]. In men, there was an approximately 20 percent reduction in all-cause, cardiovascular, and cancer mortality, while in women, a similar reduction was found in all-cause and cardiovascular mortality but a smaller benefit for cancer mortality.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=see_link\">",
"       \"Patient information: Diet and health (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/38/40546?source=see_link\">",
"       \"Patient information: Vitamin supplements (The Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/56/24450?source=see_link\">",
"       \"Patient information: Can foods or supplements lower cholesterol? (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=see_link\">",
"       \"Patient information: Diet and health (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"       \"Patient information: High-fiber diet (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Maintaining caloric balance over time is important to maintaining healthy weight. Balancing caloric intake requires that many individuals decrease their typical calorie consumption while also engaging in physical activity. Calculating total energy expenditure for recommended daily caloric intake is based on age, sex, weight, and activity level (",
"      <a class=\"graphic graphic_table graphicRef63308 \" href=\"mobipreview.htm?34/37/35419\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H355136369\">",
"       'Caloric balance'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/46/28394?source=see_link\">",
"       \"Overview of the benefits and risks of exercise\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Caloric intake should be proportioned among the three macronutrients: carbohydrates, proteins, and fats. Macronutrients are the chemical compounds consumed in the largest quantities and provide bulk energy. (See",
"      <a class=\"local\" href=\"#H948339\">",
"       'Macronutrients'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2601?source=see_link\">",
"       \"Dietary fat\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Micronutrients are nutrients required in small amounts and include several minerals and vitamins. (See",
"      <a class=\"local\" href=\"#H948428\">",
"       'Micronutrients'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=see_link\">",
"       \"Vitamin supplementation in disease prevention\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=see_link\">",
"       \"Salt intake, salt restriction, and essential hypertension\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The recommended dietary sodium intake for the general population is less than 100",
"      <span class=\"nowrap\">",
"       meq/day",
"      </span>",
"      (2.3 g of sodium or 6 g of sodium chloride). Low sodium intake is associated with decreased risk of cardiovascular events, including death.",
"     </li>",
"     <li>",
"      Most individuals who consume a balanced diet do not need to take vitamin supplements.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The main food groups generally consist of",
"      <span class=\"nowrap\">",
"       fruits/vegetables,",
"      </span>",
"      grains, dairy products, and",
"      <span class=\"nowrap\">",
"       meat/protein-rich",
"      </span>",
"      foods (",
"      <a class=\"graphic graphic_table graphicRef80497 \" href=\"mobipreview.htm?37/9/38047\">",
"       table 6",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Individuals should be counseled to consume five or more servings of fruits",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vegetables daily. Fruits and vegetables are a rich source of fiber, and",
"      <span class=\"nowrap\">",
"       fruit/vegetable",
"      </span>",
"      consumption is inversely associated with risk of coronary heart disease, stroke, and mortality. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Fruits and vegetables'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals should be advised to replace refined grains (eg, white bread, white rice, refined and sweetened cereals) with whole grains (eg, whole wheat bread, brown rice, whole grain cereals or oatmeal), which have higher fiber content. Refined grains are associated with long-term weight gain. (See",
"      <a class=\"local\" href=\"#H950615\">",
"       'Grains'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Individuals should be advised to replace fat-full milk products (eg, whole milk, ice cream) with fat-free or low-fat milk products (eg, skim milk, yogurt). Saturated and trans fatty acid consumption should be kept as low as possible by limiting foods such as partially hydrogenated oils (eg, stick margarine). (See",
"      <a class=\"local\" href=\"#H950607\">",
"       'Dairy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2601?source=see_link\">",
"       \"Dietary fat\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Individuals should be advised to avoid red and processed meats and counseled to eat a variety of protein-rich foods, including seafood, lean meat such as poultry, eggs, beans, peas, soy products, and unsalted nuts and seeds. Consumption of red meats and processed meats is associated with increased mortality, while consumption of white meat is associated with decreased mortality. (See",
"      <a class=\"local\" href=\"#H950468\">",
"       'Protein'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H950600\">",
"       'Meat and other protein-rich foods'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The consumption of soft drinks and other sweetened beverages (eg, fruit drinks) is a major source of added refined sugar in the diet and should be discouraged. (See",
"      <a class=\"local\" href=\"#H26714245\">",
"       'Sweetened beverages'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Low-fat diet, vegetarian diets, Dietary Approaches to Stop Hypertension (DASH) diet, and the Mediterranean diet are among the most commonly-used diets to maintain good health, where weight loss is not necessarily the primary goal. These diets are associated with health benefits. However, it is not known which type of diet is optimal for the general population. The decision to choose one of these diets is generally based on individual preference and the ability to adhere to a given diet. (See",
"      <a class=\"local\" href=\"#H949615\">",
"       'Types of food'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8345?source=see_link\">",
"       \"Dietary therapy for obesity\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Willett WC. Nutritional Epidemiology, 2nd ed, Oxford University Press, New York 1998.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/2\">",
"      Diet, nutrition and the prevention of chronic diseases. World Health Organ Tech Rep Ser 2003; 916:i.",
"     </a>",
"    </li>",
"    <li>",
"     U.S. Department of Agriculture and U.S. Department of Health and Human Services. Dietary Guidelines for Americans 2010. 7th Edition, Washington, DC: U.S. Government Printing Office, December 2010. file://www.dietaryguidelines.gov.",
"    </li>",
"    <li>",
"     Department of Health, National Health Service, Choosing a Better Diet: a food and health action plan. file://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/documents/digitalasset/dh_4105709.pdf (Accessed on April 05, 2011).",
"    </li>",
"    <li>",
"     The Traditional Healthy Asian Diet Pyramid file://www.oldwayspt.org/asian-diet-pyramid (Accessed on April 05, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/6\">",
"      Keller I, Lang T. Food-based dietary guidelines and implementation: lessons from four countries--Chile, Germany, New Zealand and South Africa. Public Health Nutr 2008; 11:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/7\">",
"      Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/8\">",
"      Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/9\">",
"      Willett WC, Dietz WH, Colditz GA. Guidelines for healthy weight. N Engl J Med 1999; 341:427.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/10\">",
"      Hu FB, Stampfer MJ, Manson JE, et al. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med 1997; 337:1491.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/11\">",
"      Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010; 7:e1000252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/12\">",
"      Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308:367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/13\">",
"      Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005; 353:46.",
"     </a>",
"    </li>",
"    <li>",
"     Institute of Medicine. Dietary reference intakes. file://www.nap.edu/openbook.php?isbn=0309071836 (Accessed on April 01, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/15\">",
"      Pietinen P, Rimm EB, Korhonen P, et al. Intake of dietary fiber and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Circulation 1996; 94:2720.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/16\">",
"      Key TJ, Thorogood M, Appleby PN, Burr ML. Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up. BMJ 1996; 313:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/17\">",
"      Ascherio A, Rimm EB, Hern&aacute;n MA, et al. Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation 1998; 98:1198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/18\">",
"      Wolk A, Manson JE, Stampfer MJ, et al. Long-term intake of dietary fiber and decreased risk of coronary heart disease among women. JAMA 1999; 281:1998.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/19\">",
"      Jensen MK, Koh-Banerjee P, Hu FB, et al. Intakes of whole grains, bran, and germ and the risk of coronary heart disease in men. Am J Clin Nutr 2004; 80:1492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/20\">",
"      Pereira MA, O'Reilly E, Augustsson K, et al. Dietary fiber and risk of coronary heart disease: a pooled analysis of cohort studies. Arch Intern Med 2004; 164:370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/21\">",
"      Ludwig DS, Pereira MA, Kroenke CH, et al. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults. JAMA 1999; 282:1539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/22\">",
"      Negri E, Franceschi S, Parpinel M, La Vecchia C. Fiber intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1998; 7:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/23\">",
"      Park Y, Subar AF, Hollenbeck A, Schatzkin A. Dietary fiber intake and mortality in the NIH-AARP diet and health study. Arch Intern Med 2011; 171:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/24\">",
"      Chuang SC, Norat T, Murphy N, et al. Fiber intake and total and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition cohort. Am J Clin Nutr 2012; 96:164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/25\">",
"      Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/26\">",
"      U.S. Preventive Services Task Force. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150:626.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/27\">",
"      Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/28\">",
"      Freudenheim JL, Graham S, Marshall JR, et al. Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 1991; 20:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/29\">",
"      Mason JB, Levesque T. Folate: effects on carcinogenesis and the potential for cancer chemoprevention. Oncology (Williston Park) 1996; 10:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/30\">",
"      Ebbing M, B&oslash;naa KH, Nyg&aring;rd O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302:2119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/31\">",
"      Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297:2351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/32\">",
"      Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364:2392.",
"     </a>",
"    </li>",
"    <li>",
"     United States Department of Agriculture. file://www.mypyramid.gov/pyramid/index.html (Accessed on April 04, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/34\">",
"      Joshipura KJ, Hu FB, Manson JE, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001; 134:1106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/35\">",
"      Bazzano LA, He J, Ogden LG, et al. Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. Arch Intern Med 2001; 161:2573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/36\">",
"      He FJ, Nowson CA, MacGregor GA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet 2006; 367:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/37\">",
"      Joshipura KJ, Ascherio A, Manson JE, et al. Fruit and vegetable intake in relation to risk of ischemic stroke. JAMA 1999; 282:1233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/38\">",
"      Dagnelie PC, Schuurman AG, Goldbohm RA, Van den Brandt PA. Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies. BJU Int 2004; 93:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/39\">",
"      Giovannucci E. A review of epidemiologic studies of tomatoes, lycopene, and prostate cancer. Exp Biol Med (Maywood) 2002; 227:852.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/40\">",
"      Nagura J, Iso H, Watanabe Y, et al. Fruit, vegetable and bean intake and mortality from cardiovascular disease among Japanese men and women: the JACC Study. Br J Nutr 2009; 102:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/41\">",
"      Sauvaget C, Nagano J, Allen N, Kodama K. Vegetable and fruit intake and stroke mortality in the Hiroshima/Nagasaki Life Span Study. Stroke 2003; 34:2355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/42\">",
"      Crowe FL, Roddam AW, Key TJ, et al. Fruit and vegetable intake and mortality from ischaemic heart disease: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Heart study. Eur Heart J 2011; 32:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/43\">",
"      Elwood PC, Pickering JE, Hughes J, et al. Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. Eur J Clin Nutr 2004; 58:718.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/44\">",
"      German JB, Gibson RA, Krauss RM, et al. A reappraisal of the impact of dairy foods and milk fat on cardiovascular disease risk. Eur J Nutr 2009; 48:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/45\">",
"      Sinha R, Cross AJ, Graubard BI, et al. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med 2009; 169:562.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/46\">",
"      Pan A, Sun Q, Bernstein AM, et al. Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med 2012; 172:555.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/47\">",
"      Cohen L, Curhan G, Forman J. Association of sweetened beverage intake with incident hypertension. J Gen Intern Med 2012; 27:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/48\">",
"      Howard BV, Manson JE, Stefanick ML, et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA 2006; 295:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/49\">",
"      Leitzmann C. Vegetarian diets: what are the advantages? Forum Nutr 2005; :147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/50\">",
"      American Dietetic Association, Dietitians of Canada. Position of the American Dietetic Association and Dietitians of Canada: Vegetarian diets. J Am Diet Assoc 2003; 103:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/51\">",
"      Haddad EH, Sabat&eacute; J, Whitten CG. Vegetarian food guide pyramid: a conceptual framework. Am J Clin Nutr 1999; 70:615S.",
"     </a>",
"    </li>",
"    <li>",
"     Johnston PK, Sabate J. Nutritional implications of vegetarian diets. In: Modern nutrition in health and disease, 10, Shils ME, Shike M, Ross AC, et al (Eds), Lippincott Williams &amp; Wilkins, Baltimore 2006. p.1638.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/53\">",
"      Craig WJ. Health effects of vegan diets. Am J Clin Nutr 2009; 89:1627S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/54\">",
"      Rao V, Al-Weshahy A. Plant-based diets and control of lipids and coronary heart disease risk. Curr Atheroscler Rep 2008; 10:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/55\">",
"      Barnard ND, Katcher HI, Jenkins DJ, et al. Vegetarian and vegan diets in type 2 diabetes management. Nutr Rev 2009; 67:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/56\">",
"      Weaver CM. Should dairy be recommended as part of a healthy vegetarian diet? Point. Am J Clin Nutr 2009; 89:1634S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/57\">",
"      Haddad EH, Tanzman JS. What do vegetarians in the United States eat? Am J Clin Nutr 2003; 78:626S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/58\">",
"      Appleby P, Roddam A, Allen N, Key T. Comparative fracture risk in vegetarians and nonvegetarians in EPIC-Oxford. Eur J Clin Nutr 2007; 61:1400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/59\">",
"      Appel LJ, Moore TJ, Obarzanek E, et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/60\">",
"      Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/61\">",
"      Sofi F, Cesari F, Abbate R, et al. Adherence to Mediterranean diet and health status: meta-analysis. BMJ 2008; 337:a1344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31641/abstract/62\">",
"      Mitrou PN, Kipnis V, Thi&eacute;baut AC, et al. Mediterranean dietary pattern and prediction of all-cause mortality in a US population: results from the NIH-AARP Diet and Health Study. Arch Intern Med 2007; 167:2461.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5364 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-6FA69E1D15-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31641=[""].join("\n");
var outline_f30_57_31641=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H355136369\">",
"      CALORIC BALANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H948339\">",
"      MACRONUTRIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H948347\">",
"      Carbohydrate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950468\">",
"      Protein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H948361\">",
"      Fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H949890\">",
"      Fiber",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H948428\">",
"      MICRONUTRIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H948435\">",
"      Sodium",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H248829338\">",
"      Calcium and vitamin D",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7505602\">",
"      Folate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H87358612\">",
"      Other vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H949615\">",
"      TYPES OF FOOD",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      Fruits and vegetables",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      - Cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Cancer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H355137805\">",
"      - Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950615\">",
"      Grains",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950607\">",
"      Dairy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950600\">",
"      Meat and other protein-rich foods",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26714230\">",
"      BEVERAGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26714238\">",
"      Alcohol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26714245\">",
"      Sweetened beverages",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H355136837\">",
"      TYPES OF DIET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950704\">",
"      Low-fat diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H81663199\">",
"      Vegetarian diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H950732\">",
"      DASH diet",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Mediterranean diet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/5364\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/5364|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/37/35419\" title=\"table 1\">",
"      Estimating energy expenditure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/40/8845\" title=\"table 2\">",
"      Glycemic index and load values",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?33/62/34796\" title=\"table 3\">",
"      Sources and effects of fat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/1/17438\" title=\"table 4\">",
"      Dietary fiber content of frequently consumed foods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/45/30416\" title=\"table 5\">",
"      Dietary Reference Intakes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/9/38047\" title=\"table 6\">",
"      Major food groups",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?20/11/20671\" title=\"table 7\">",
"      USDA recommended average daily food intake",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/56/12170?source=related_link\">",
"      Calcium and vitamin D supplementation in osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/24/42378?source=related_link\">",
"      Cancer prevention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/33/31258?source=related_link\">",
"      Cardiovascular benefits and risks of moderate alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/25/42394?source=related_link\">",
"      Colorectal cancer: Epidemiology, risk factors, and protective factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42679?source=related_link\">",
"      Diet in the treatment and prevention of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/40/23175?source=related_link\">",
"      Dietary and nutritional assessment in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/47/38649?source=related_link\">",
"      Dietary carbohydrates",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/34/2601?source=related_link\">",
"      Dietary fat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/0/18441?source=related_link\">",
"      Dietary recommendations for toddlers, preschool, and school-age children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/9/8345?source=related_link\">",
"      Dietary therapy for obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/30/36330?source=related_link\">",
"      Fish oil and marine omega-3 fatty acids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/61/5081?source=related_link\">",
"      Folic acid for prevention of neural tube defects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/12/31946?source=related_link\">",
"      Geriatric nutrition: Nutritional issues in older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/35/30266?source=related_link\">",
"      Health hazards associated with obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/51/28474?source=related_link\">",
"      Lipid lowering with diet or dietary supplements",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/19/40248?source=related_link\">",
"      Lipoprotein(a) and cardiovascular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/2/25641?source=related_link\">",
"      Nutritional considerations in type 1 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/18/14634?source=related_link\">",
"      Nutritional considerations in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/19/39226?source=related_link\">",
"      Overview of dietary trace minerals",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/46/28394?source=related_link\">",
"      Overview of the benefits and risks of exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38874?source=related_link\">",
"      Overview of the risks and benefits of alcohol consumption",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?23/56/24450?source=related_link\">",
"      Patient information: Can foods or supplements lower cholesterol? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/62/28642?source=related_link\">",
"      Patient information: Diet and health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?11/35/11827?source=related_link\">",
"      Patient information: Diet and health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=related_link\">",
"      Patient information: High-fiber diet (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/38/40546?source=related_link\">",
"      Patient information: Vitamin supplements (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/21/33113?source=related_link\">",
"      Prevention of osteoporosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/53/33626?source=related_link\">",
"      Risk factors for calcium stones in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/52/31562?source=related_link\">",
"      Risk factors for prostate cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/24/9610?source=related_link\">",
"      Risk factors for type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/35/24120?source=related_link\">",
"      Salt intake, salt restriction, and essential hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/29/31193?source=related_link\">",
"      Vitamin D and extraskeletal health",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/46/36586?source=related_link\">",
"      Vitamin supplementation in disease prevention",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31642="Initial and reoperative thyroidectomy";
var content_f30_57_31642=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Initial and reoperative thyroidectomy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Tracy S Wang, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Melanie L Richards, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Julie Ann Sosa, MD, MA",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Sally E Carty, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?30/57/31642/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?30/57/31642/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 21, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid surgery has evolved greatly, from a dangerous and bloody undertaking 100 years ago to a safe operation with few major risks, small incisions, and favorable outcomes in expert hands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/1\">",
"     1",
"    </a>",
"    ]. Thyroidectomy is performed for a number of benign and malignant conditions.",
"   </p>",
"   <p>",
"    The technique of thyroidectomy will be reviewed here. The anatomy and physiology of the thyroid gland are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=see_link\">",
"     \"Surgical anatomy of the thyroid gland\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=see_link\">",
"     \"Thyroid hormone synthesis and physiology\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/61/10200?source=see_link\">",
"     \"Thyroid hormone action\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indications for thyroidectomy in benign and malignant disorders of the thyroid are discussed elsewhere in detail.",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Thyroid nodules (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=see_link\">",
"       \"Diagnostic approach to and treatment of thyroid nodules\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Hyperthyroidism (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link\">",
"       \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Differentiated thyroid cancer (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link\">",
"       \"Surgical treatment of differentiated thyroid cancer\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Medullary thyroid cancer (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=see_link\">",
"       \"Medullary thyroid cancer: Treatment and prognosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Anaplastic thyroid cancer (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/10/23721?source=see_link\">",
"       \"Anaplastic thyroid cancer\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Thyroid lymphoma (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/8/35974?source=see_link\">",
"       \"Thyroid lymphoma\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Obstructive or substernal goiter (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=see_link\">",
"       \"Treatment of obstructive or substernal goiter\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Metastases to the thyroid &ndash; Metastases to the thyroid gland from extrathyroidal primary cancers are rare; the most common are renal cell carcinoma and melanoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/2,3\">",
"       2,3",
"      </a>",
"      ]. Local control can usually be achieved with surgical resection.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;With few exceptions, thyroidectomy is elective surgery and any major medical conditions should be addressed before proceeding to the operating room. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=see_link\">",
"     \"Estimation of cardiac risk prior to noncardiac surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=see_link\">",
"     \"Evaluation of preoperative pulmonary risk\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Medical management of hyperthyroidism &ndash; Patients undergoing surgery for hyperthyroidism should be optimized medically. Antithyroid medications",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      beta-blockade may be prescribed if indicated to avoid the risk of thyroid storm. Preoperative iodine administration with oral Lugol's solution (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/27/30134?source=see_link\">",
"       potassium iodide",
"      </a>",
"      , SSKI) helps to block iodine uptake and the secretion of thyroid hormones [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/4\">",
"       4",
"      </a>",
"      ]. Lugol's solution may also decrease vascularity and reduce intraoperative bleeding. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link&amp;anchor=H6#H6\">",
"       \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\", section on 'Preoperative preparation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Thyroid imaging &ndash; Diagnostic thyroid ultrasound should be performed in all patients with a suspected thyroid nodule, nodular goiter, or a thyroid abnormality detected by another imaging modality. Preoperative neck ultrasound to assess the contralateral lobe and cervical lymph nodes is also recommended for all patients undergoing thyroidectomy for malignant cytologic findings on biopsy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/5\">",
"       5",
"      </a>",
"      ]. Routine use of other imaging modalities, such as computed tomography (CT) or magnetic resonance imaging (MRI), is not recommended. In addition, the high iodine load in CT contrast may delay the subsequent administration of postoperative radioactive iodine in patients with thyroid cancer. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link\">",
"       \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link\">",
"       \"Surgical treatment of differentiated thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laboratory testing &ndash; The surgeon should confirm whether the patient is currently euthyroid, hyperthyroid, or hypothyroid with a serum TSH prior to proceeding with an operation. A serum calcium level is useful for identifying patients who may have parathyroid disease in conjunction with thyroid disease. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=see_link\">",
"       \"Laboratory assessment of thyroid function\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5545?source=see_link\">",
"       \"Diagnosis and differential diagnosis of primary hyperparathyroidism\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The diagnosis of multiple endocrine neoplasia type 2 (MEN2A or MEN2B) or familial medullary thyroid cancer (FMTC) should be considered in patients with medullary carcinoma of the thyroid. Preoperative serum calcitonin and carcinoembryonic antigen levels should be obtained for patients with medullary carcinoma of the thyroid. Patients also should be tested for primary hyperparathyroidism and pheochromocytoma. Genetic counseling and analysis for a RET proto-oncogene mutation is also recommended [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/6-8\">",
"       6-8",
"      </a>",
"      ] . The evaluation of patients with medullary thyroid cancer is discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H1589190#H1589190\">",
"       \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Genetic screening in sporadic MTC'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Laryngoscopy &ndash; Injury to the recurrent laryngeal nerve, either transient or permanent, is of concern in thyroidectomy, particularly in reoperative surgery. Preoperative laryngoscopy is recommended for all patients with preoperative hoarseness or voice changes and for all patients undergoing reoperative surgery, even in those who have had previous neck or mediastinal surgery unrelated to the thyroid [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/14/28906?source=see_link\">",
"       \"Direct laryngoscopy and tracheal intubation in adults\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Some have recommended routine preoperative laryngoscopy and even videostroboscopy in patients undergoing initial thyroidectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. Videostroboscopy adds to health care costs but can provide a magnified, slow-motion view of the vocal cords. Advantages to this approach may include the preoperative diagnosis of occult nerve paresis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]. In a nonrandomized study of 365 thyroidectomy patients, preoperative recurrent laryngeal nerve paresis was present in 70 percent of patients with invasive disease as compared with 0.3 percent of patients with noninvasive disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/11\">",
"       11",
"      </a>",
"      ]. Vocal cord paralysis was associated with voice change in only one third of patients. Preoperative confirmation of invasive disease can facilitate preoperative recognition of disease extent, appropriate operative planning, and patient counseling.",
"     </li>",
"     <li>",
"      Reoperative thyroidectomy &ndash; Reoperative thyroidectomy is performed for recurrent thyroid disease or recurrent cancer. The term also refers to thyroid surgery in the setting of previous anterior neck surgery from the anterior approach, including previous parathyroidectomy, anterior cervical spine surgery, tracheostomy, or carotid endarterectomy. Reoperative thyroid surgery is technically challenging due to the formation of adhesions and scar tissue, and is associated with increased rates of recurrent laryngeal nerve injury and hypoparathyroidism [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/9,12,13\">",
"       9,12,13",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      The risks of reoperative surgery should be carefully considered and balanced with the options of medical management",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      observation, particularly in patients with benign disease [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/9,12,13\">",
"       9,12,13",
"      </a>",
"      ]. Once the decision to proceed with surgery has been made, a careful review of operative notes and pathology reports from the previous surgical procedures is crucial for determining prior extent of disease and the visualization, location, and possible excision of parathyroid glands. In many cases, formal review of the prior histology slides is also informative.",
"      <br/>",
"      <br/>",
"      In situations where a partial thyroidectomy has been performed and subsequent pathology suggests need for a completion thyroidectomy, the optimal timing of the repeat procedure is unclear. Early surgical intervention can be considered within five to seven days of the initial surgery and prior to the period of intense inflammatory healing, or surgery may be delayed six weeks or more to allow the inflammation to subside. However, the timing of completion thyroidectomy has not been shown to have an impact on the incidence of surgical complications [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antibiotics &ndash; Thyroid surgery is a clean procedure in a well-vascularized area and postoperative infection rates are very low [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/15\">",
"       15",
"      </a>",
"      ]. A perioperative antibiotic, such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?4/2/4136?source=see_link\">",
"       cefazolin",
"      </a>",
"      , can be given selectively for patients who are immunocompromised or with other medical comorbidities that could increase the risk of infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/16,17\">",
"       16,17",
"      </a>",
"      ]. When employed, antibiotics should be administered after arriving in the operating room and before the incision is made. The efficacy of antibiotic prophylaxis decreases if administered more than one hour before surgery [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/18-20\">",
"       18-20",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"       \"Overview of control measures to prevent surgical site infection\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Antiemetics &ndash; Postoperative nausea and vomiting occur frequently after thyroidectomy. Prophylactic antiemetics should be considered. A randomized trial of 72 patients undergoing thyroidectomy showed a significant decrease in postoperative nausea and vomiting with a single dose of steroid (",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?33/4/33856?source=see_link\">",
"       dexamethasone",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/21\">",
"       21",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/2/33834?source=see_link&amp;anchor=H1324456782#H1324456782\">",
"       \"Overview of complications occurring in the post-anesthesia care unit\", section on 'Postoperative nausea/vomiting'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Deep venous thrombosis prophylaxis &ndash; For patients undergoing general anesthesia, primary prophylaxis for prevention of deep venous thrombosis such as sequential compression devices should be employed. Patients should also be encouraged to ambulate the night of surgery. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link\">",
"       \"Prevention of venous thromboembolic disease in surgical patients\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     INTRAOPERATIVE NEUROMONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Iatrogenic injury to the recurrent laryngeal nerve (RLN) remains one of the most concerning complications of thyroid surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/22\">",
"     22",
"    </a>",
"    ]. Rates of RLN injury range from 0 to 7.1 percent for transient injury to 0 to 11 percent for permanent injury. Rates of injury appear to be related to surgeon volume [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/23-26\">",
"     23-26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Routine visual identification of the RLN decreases the incidence of injury and is standard of care in thyroid surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/27\">",
"     27",
"    </a>",
"    ]. Intraoperative neuromonitoring (IONM) has been introduced with the goal of reducing the rate of RLN injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6320596\">",
"    <span class=\"h2\">",
"     Technique of nerve monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two main components of IONM are stimulation of the RLN and assessment of the vocal fold response to stimulation.",
"   </p>",
"   <p>",
"    Several techniques of IONM have been described. The endotracheal tube surface electrode system is the most widely used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]. For this method, a laryngeal surface electrode is applied to the concave surface of the endotracheal tube just proximal to the vocal cord [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/31\">",
"     31",
"    </a>",
"    ]. The endotracheal tube is positioned and secured so that the electrodes on the surface of the endotracheal tube are aligned with the vocal cords. A specially designed probe is used to deliver the low voltage electric current.",
"   </p>",
"   <p>",
"    During a surgical procedure, the nerve monitor's auditory signal or visual EMG signal can be used to provide intraoperative information about the course of the RLN. The monitor can also confirm RLN function after visual identification. Additionally, an unexpected signal with gland retraction, tissue dissection, or nerve dissection may provide an early warning of nerve irritation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Only short-acting muscle relaxants, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/46/33510?source=see_link\">",
"     succinylcholine",
"    </a>",
"    , should be utilized to prevent interference with obtaining an electromyographic signal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Efficacy of nerve monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;The benefits of IONM are primarily for high risk cases such as malignancy, reoperation, retrosternal or toxic goiter, and for low volume surgeons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. No randomized trials of IONM have been performed. Available studies regarding the use of IONM do not show a significant decrease in the incidence of either transient or permanent RLN injury in low risk surgical procedures for high volume surgeons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/30\">",
"     30",
"    </a>",
"    ]. However, there is benefit for the use of IONM in high risk surgical procedures and for low volume surgeons [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/30-32\">",
"     30-32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a nonrandomized series of 639 patients, a significant reduction in the rate of RLN injury in high risk thyroidectomies (recurrent disease, malignancy, or retrosternal or toxic goiter) was associated with the use of IONM compared to those done with visual RLN identification alone (4.6 versus 19 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/31\">",
"       31",
"      </a>",
"      ]. The rates of transient and permanent RLN injury during low risk surgical procedures were not significantly different between the monitored and unmonitored groups.",
"     </li>",
"     <li>",
"      A multi-institutional observational study of 16,448 patients with 29,998 nerves at risk found that IONM was associated with a reduction in the rate of permanent injury from 1.4 to 0.9 percent as compared with visual nerve identification for low volume surgeons (&lt;45 nerves at risk per year) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/30\">",
"       30",
"      </a>",
"      ]. No significant difference was found between visual RLN identification and intraoperative RLN monitoring overall.",
"     </li>",
"     <li>",
"      An observational study of 4382 patients undergoing surgery for benign goiter in 45 hospitals demonstrated a significantly decreased rate of transient and permanent RLN palsy associated with the use of IONM as compared with visual RLN identification [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A retrospective study compared the incidence of postoperative paresis or paralysis in 427 patients who underwent thyroidectomy with monitoring with 257 patients who did not have nerve monitoring [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/33\">",
"       33",
"      </a>",
"      ]. There was a modest reduction in postoperative RLN paresis in the monitored group, but this difference was not statistically significant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A recent survey of members of the American Association of Endocrine Surgeons found that 63 percent of respondents do not use IONM, while 14 percent used IONM routinely, and 23 percent were selective users. Nonusers were in practice longer, reported a lower case volume, were less familiar with the technology, and had limited access to the equipment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/34\">",
"     34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The use of IONM does not preclude the need for intraoperative nerve visualization and meticulous technique. Although the benefit of IONM appears to be the greatest in high risk procedures, some suggest that the routine use of IONM in low risk surgery will enable familiarity with the technique for maximum benefit of the technology in higher risk cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ANESTHESIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both general and local anesthetic techniques have been utilized for thyroid surgery. Local anesthetic technique requires clinician experience in performing cervical block anesthesia as well as favorable thyroid pathology and a patient who is able to communicate and is comfortable being conscious during the procedure. The vast majority of initial and reoperative thyroidectomies are performed under general endotracheal anesthesia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     General anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;General anesthesia is preferred for initial and reoperative thyroidectomy to avoid patient movement and discomfort during surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=see_link\">",
"     \"Overview of anesthesia and anesthetic choices\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Cervical block",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thyroid surgery can be performed with a cervical block. Several studies have shown that general anesthesia was associated with longer length of stay, longer operative room utilization time, and higher costs than a cervical block in combination with intravenous sedation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/35-37\">",
"     35-37",
"    </a>",
"    ]. With the cervical block technique, fewer patients experience nausea and require anti-emetic medication postoperatively. Rates of conversion to general anesthesia range from 0 to 12 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Technique of cervical block &ndash; Different techniques have been described for achieving a superficial or deep cervical plexus block. Adequate analgesia should desensitize the platysma, strap muscles, and thyroid capsule, and typically requires multiple injections of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      or marcaine along the posterior border of the sternocleidomastoid muscle (",
"      <a class=\"graphic graphic_figure graphicRef82712 \" href=\"mobipreview.htm?2/5/2131\">",
"       figure 1",
"      </a>",
"      ). Peripheral nerve blocks are discussed in detail elsewhere. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/39/18042?source=see_link\">",
"       \"Peripheral nerve block: Techniques\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5719?source=see_link\">",
"       \"Overview of peripheral nerve blocks\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Contraindications to cervical block &ndash; Potential contraindications for a cervical block include patient preference for general anesthesia, a language barrier or an inability to communicate verbally with the operating team, allergy to local anesthesia, a known retroesophageal or retrotracheal goiter, concomitant cervical lymphadenectomy, and known or suspected locally invasive cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/37,38\">",
"       37,38",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Other considerations which would favor general anesthesia include morbid obesity, previous cervical surgery, claustrophobia or anxiety disorder, and sleep apnea [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/38\">",
"       38",
"      </a>",
"      ]. An anticipated or known difficult intubation is also a contraindication to local anesthesia and sedation because conversion to a general anesthetic may be necessary if sedation is not adequate, presenting a serious and potentially dangerous intraoperative challenge.",
"     </li>",
"     <li>",
"      Complications of cervical block &ndash; Complications of a superficial cervical plexus block for thyroidectomy include injection into the thyroid gland causing a localized hematoma, intravascular injection of the local anesthetic, and infiltration of the vagus nerve leading to temporary paresis of the ipsilateral recurrent laryngeal nerve [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/37,38\">",
"       37,38",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     OPERATIVE MANAGEMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Positioning",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient is positioned supine in the semi-Fowler, or beach chair position, with the neck in extension. A roll can be placed transversely under the scapulae to facilitate exposure of the anterior neck and great care should be taken to assure there is no neck hyperextension to avoid injury (",
"    <a class=\"graphic graphic_figure graphicRef67508 \" href=\"mobipreview.htm?10/23/10608\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The safety of neck extension in patients with known cervical spine disease should be assessed preoperatively. This might require formal clearance by an orthopedic or neurosurgeon. Hyperextension of the neck during surgery can lead to vertigo, headache, and postoperative nausea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The skin preparation should extend from the lower",
"    <span class=\"nowrap\">",
"     lip/angle",
"    </span>",
"    of the mandible onto the anterior chest. Mediastinal surgery is never performed without preoperative discussion, but if it is contemplated, the entire chest is included in the operative field. Placement of an oral or nasogastric tube, an esophageal stethoscope, or a temperature probe facilitates identification of the tracheoesophageal groove and the recurrent laryngeal nerve.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Incision",
"    </span>",
"    &nbsp;&mdash;&nbsp;A Kocher (or collar) incision is made sharply on the anterior aspect of the mid neck. Efforts should be made to place this incision in a prior skin crease if possible. The incision length should be based on the size of the underlying thyroid as well as on patient habitus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/40\">",
"     40",
"    </a>",
"    ]. A longer incision may be needed if the patient is obese, the gland is large, or the neck is foreshortened as with kyphoscoliosis (",
"    <a class=\"graphic graphic_figure graphicRef82297 \" href=\"mobipreview.htm?7/46/7906\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Exposure",
"    </span>",
"    &nbsp;&mdash;&nbsp;After the incision is made, the dissection is carried to the platysma muscle. This muscle layer is only a few millimeters in thickness. The platysma is divided along the course of the incision, generally with cautery, and subplatysmal flaps are elevated above the level of the thyroid cartilage superiorly, over the sternocleidomastoid muscles laterally, and inferiorly to the level of the sternal notch (",
"    <a class=\"graphic graphic_figure graphicRef58295 \" href=\"mobipreview.htm?1/1/1046\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The raphe between the strap muscles is opened in the midline in the avascular plane. Enlarged Delphian lymph nodes can portend locally metastatic disease and should be excised if identified. The strap muscles are routinely preserved. However, if there is evidence of extension of tumor into the strap muscle based on adherence or frank invasion, any attached sternothyroid",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    sternohyoid muscle should be taken en bloc with the underlying thyroid to assure a negative resection margin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dissecting from the isthmus across the anterior lobar capsule, when the lateral border of the thyroid is reached, the middle thyroid vein(s) should be identified and divided (",
"    <a class=\"graphic graphic_figure graphicRef82298 \" href=\"mobipreview.htm?8/27/8628\">",
"     figure 5",
"    </a>",
"    ). The thyroid lobe is rolled from laterally to medially to display its posterior capsule and the tracheoesophageal groove, taking care not to enter the thyroid capsule during dissection (",
"    <a class=\"graphic graphic_figure graphicRef63713 \" href=\"mobipreview.htm?2/52/2887\">",
"     figure 6",
"    </a>",
"    ). The superior pole vessels are dissected out and ligated as close as possible to the thyroid capsule in order to avoid injury to the external branch of the superior laryngeal nerve (",
"    <a class=\"graphic graphic_figure graphicRef81126 \" href=\"mobipreview.htm?19/42/20134\">",
"     figure 7",
"    </a>",
"    ). Mobilization of the superior pole may aid in identification of the RLN as it enters the pharynx. All gross thyroid tissue from this area should be removed (",
"    <a class=\"graphic graphic_figure graphicRef72167 \" href=\"mobipreview.htm?25/1/25624\">",
"     figure 8",
"    </a>",
"    ). Dissection then continues down along the lateral aspect of the thyroid lobe. The recurrent laryngeal nerve should be identified and protected in the tracheoesophageal groove.",
"   </p>",
"   <p>",
"    Generally, to avoid injury to the parathyroid glands, the dissection should stay as close as possible to the thyroid capsule while still extirpating all gross thyroid tissue and disease. The inferior vascular pedicle and all remaining blood vessels going to and from the thyroid should be ligated, allowing the gland to be rolled up and onto the anterior aspect of the trachea (",
"    <a class=\"graphic graphic_figure graphicRef50925 \" href=\"mobipreview.htm?4/37/4694\">",
"     figure 9",
"    </a>",
"    ). The ligament of Berry should be divided as close as is safe on the trachea and near the insertion of the recurrent laryngeal nerve or its branches into the cricopharyngeus muscle (",
"    <a class=\"graphic graphic_figure graphicRef55871 \" href=\"mobipreview.htm?12/25/12692\">",
"     figure 10",
"    </a>",
"    ). This is the most common site of injury of the recurrent laryngeal nerve, so great care has to be taken here (",
"    <a class=\"graphic graphic_figure graphicRef74541 \" href=\"mobipreview.htm?23/37/24146\">",
"     figure 11",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The isthmus should be separated from the anterior aspect of the trachea, and the pyramidal lobe followed cephalad as far as possible and resected en bloc with the thyroid (",
"    <a class=\"graphic graphic_figure graphicRef55774 \" href=\"mobipreview.htm?10/13/10455\">",
"     figure 12",
"    </a>",
"    ). For thyroid lobectomy and isthmusectomy, the dissection is then complete. A heavy clamp can be applied across the junction of the isthmus and the contralateral thyroid lobe, the thyroid sharply divided and the stump oversewn with a hemostatic absorbable suture (",
"    <a class=\"graphic graphic_figure graphicRef67518 \" href=\"mobipreview.htm?29/6/29795\">",
"     figure 13",
"    </a>",
"    ). Alternatively, a harmonic scalpel can be employed to assure vascular control of the medial contralateral thyroid lobe. The specimen should be oriented and labeled for pathology. For total thyroidectomy, dissection continues onto the contralateral lobe using gentle traction of the mobilized isthmus to help expose that lobe. If any type of central neck dissection",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cervical thymectomy is to be performed, it can be done en bloc with the thyroidectomy specimen, or separately after the thyroid lobe or gland is removed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Identification of parathyroid glands",
"    </span>",
"    &nbsp;&mdash;&nbsp;The superior (posterior to the recurrent laryngeal nerve) and inferior (anterior to the nerve) parathyroid glands should be identified on their respective vascular pedicles, and preserved. The inferior thyroid artery supplies 80 percent of parathyroid glands; therefore, care has to be taken to avoid ligation of the artery too laterally prior to take-off of the arterial supply to the parathyroids. Knowledge of the normal anatomy of the parathyroid glands is important in identification during thyroid dissection, as well as preservation of the parathyroid glands on well-vascularized pedicles in situ (",
"    <a class=\"graphic graphic_figure graphicRef56752 \" href=\"mobipreview.htm?9/47/9972\">",
"     figure 14",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/23/29045?source=see_link\">",
"     \"Surgical anatomy of the parathyroid glands\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Normal parathyroid glands should not be removed during thyroid surgery unless the parathyroid gland appears to be grossly invaded by a thyroid malignancy, or it becomes severely ischemic during dissection. In the latter case, the parathyroid gland can be autotransplanted into well-vascularized muscle, such as a strap muscle or the sternocleidomastoid muscle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Parathyroid autotransplantation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A parathyroid gland of uncertain viability or an aberrant parathyroid gland identified in an intracapsular or intrathyroidal position such that it cannot be maintained intact on a vascular pedicle, should be immediately treated with a heterotopic transplantation into the ipsilateral strap muscle or sternocleidomastoid muscle. Parathyroid cells can stimulate neovascularization in healthy muscle by release of vascular endothelial growth factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/42\">",
"     42",
"    </a>",
"    ]. If the procedure is being performed for thyroid cancer, a frozen section should be performed to ensure that the specimen is indeed parathyroid and not a metastatic lymph node or a portion of thyroid tissues. If the parathyroid is involved with tumor, it should be sacrificed.",
"   </p>",
"   <p>",
"    While assembling the equipment necessary to perform an expedient autotransplant, the parathyroid gland should be placed in cold saline on ice to facilitate preservation. In a cancer case, a separate back table should be employed, along with a separate set of surgical equipment and a change in gloves to avoid contamination of the parathyroid with cancer. The excised parathyroid gland should be minced into one millimeter pieces.",
"   </p>",
"   <p>",
"    A small pocket or pockets should be prepared in the ipsilateral neck muscle. Two to three pieces of parathyroid tissue are inserted into each pocket; alternatively, some surgeons transplant all fragments into a single pocket. The pockets should be sealed and marked with a permanent suture and can also be marked with small titanium clips, should re-exploration of the neck be required. The pockets should not have any bleeding, as a small hematoma would likely preclude neovascularization of the parathyroid pieces, and lead to loss of the implant. Some loss of implanted tissue will occur naturally, such that an implanted gland will likely reach only approximately half the functional capacity of a healthy in situ gland [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/43\">",
"     43",
"    </a>",
"    ]. It may take six to eight weeks for an autotransplanted parathyroid gland to function clinically.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6320613\">",
"    <span class=\"h2\">",
"     Parathyroid gland enlargement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normocalcemic patients undergoing thyroid surgery are occasionally found to have enlarged incidental parathyroid glands. Resection of a single incidentally encountered enlarged parathyroid gland is usually appropriate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/44\">",
"     44",
"    </a>",
"    ]. Alternatively, an intraoperative parathyroid hormone level could be obtained, if available, to document occult hyperparathyroidism.",
"   </p>",
"   <p>",
"    If all four glands appear enlarged and the patient is known to be normocalcemic and have normal renal function, vitamin D deficiency may be suspected. Subtotal resection of these glands is not recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Extent of dissection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extent of initial thyroidectomy for certain thyroid diseases, such as papillary thyroid cancer and Graves' disease, remains controversial. However, there is growing consensus that total thyroidectomy is the procedure of choice for most thyroid malignancies and Graves' disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=see_link\">",
"     \"Overview of the management of differentiated thyroid cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=see_link\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link\">",
"     \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The minimum acceptable operation is complete ipsilateral lobectomy. Thyroid \"nodulectomy\", partial lobectomy, and subtotal thyroidectomy are no longer performed because these incomplete resections subject patients to an unacceptably high risk of nerve injury should subsequent thyroidectomy later be required. When bilateral thyroidectomy is indicated, the purported benefits of less extensive surgery must be balanced against the greater risk of recurrent disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/45-47\">",
"     45-47",
"    </a>",
"    ] and increased risks of reoperative cervical surgery, such as hypoparathyroidism and recurrent laryngeal nerve injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/9,12,13\">",
"     9,12,13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Lymphadenectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extent of lymphadenectomy is based on the type of thyroid malignancy and the risk for lymph node metastasis. All patients with preoperative confirmation of medullary or well-differentiated thyroid cancer and clinically or radiologically detected lymphadenopathy should undergo an initial therapeutic compartment oriented lymphadenectomy (",
"    <a class=\"graphic graphic_figure graphicRef67441 \" href=\"mobipreview.htm?19/20/19782\">",
"     figure 15",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef54099 \" href=\"mobipreview.htm?8/3/8244\">",
"     figure 16",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The central compartment (level VI) nodes should be removed prophylactically in patients with medullary thyroid cancer. A prophylactic central neck lymphadenectomy can be considered in patients with papillary thyroid cancer [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/5\">",
"     5",
"    </a>",
"    ]. This approach results in a local recurrence rate of only 5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/48\">",
"     48",
"    </a>",
"    ]. Follicular thyroid cancer spreads hematogenously and there is little role for cervical lymphadenectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link&amp;anchor=H9#H9\">",
"     \"Surgical treatment of differentiated thyroid cancer\", section on 'Approach to neck dissection'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=see_link\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Intraoperative frozen section",
"    </span>",
"    &nbsp;&mdash;&nbsp;Frozen section analysis during thyroid surgery should only be employed when it will have an impact on surgical decision making [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/49\">",
"     49",
"    </a>",
"    ]. In general, frozen section analysis can be helpful for confirmation of parathyroid tissue or thyroid malignancy intraoperatively when the preoperative cytology was atypical or suspicious.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Parathyroid tissue &ndash; If a parathyroid gland is devascularized or resected during thyroidectomy, a frozen section should be obtained before autotransplantation to ensure that the specimen is indeed parathyroid tissue and not a metastatic lymph node or a portion of thyroid tissues. If the parathyroid is involved with tumor, it should be sacrificed. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Identification of parathyroid glands'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Papillary thyroid lesions &ndash; Fine needle aspiration (FNA) has high diagnostic accuracy for papillary lesions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/49\">",
"       49",
"      </a>",
"      ]. The use of frozen section analysis is rarely required for intraoperative assessment of lesions that are confirmed as papillary thyroid cancer by preoperative FNA. However, frozen section analysis can be useful in the diagnosis of papillary thyroid cancer in lesions in which the preoperative FNA was suspicious or indeterminate, as the diagnosis may rely on nuclear features alone. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8440?source=see_link\">",
"       \"Overview of papillary thyroid cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Follicular thyroid lesions &ndash; Follicular neoplasms include nonpapillary follicular lesions, such as adenomatoid nodules, follicular adenomas, and follicular cancers that give rise to the same cytologic picture and are therefore indeterminate follicular lesions. Only about 20 percent of cases will be malignant on histologic examination [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/50\">",
"       50",
"      </a>",
"      ]. Preoperative FNA is an accurate means of detecting papillary and medullary thyroid carcinomas, but it cannot distinguish between benign and malignant nonpapillary follicular lesions due to the inability to determine the presence of capsular",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      vascular invasion. A notable exception is follicular variant papillary thyroid cancer which is difficult to diagnose on both FNA and frozen section. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?21/11/21688?source=see_link\">",
"       \"Overview of follicular thyroid cancer\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The use of routine frozen section analysis to guide the intraoperative management of follicular thyroid lesions is controversial [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/49\">",
"       49",
"      </a>",
"      ]. Some centers find routine frozen section analysis during thyroid lobectomy to be an effective method for avoiding thyroid reoperation as well as a valued aide to decision-making about central compartment node dissection. However, multiple sections of the tumor capsule are needed for definitive diagnosis of follicular lesions, making definitive diagnosis by intraoperative frozen section analysis impractical and unreliable at most institutions [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/49\">",
"       49",
"      </a>",
"      ]. Pathologic expertise and timeliness of frozen section analysis are critical factors, and variations in such expertise likely account for some of the controversy. The expert thyroid surgeon needs to work closely with his or her own endocrine pathologists.",
"      <br/>",
"      <br/>",
"      In a retrospective review of 120 patients undergoing thyroid surgery for follicular lesions, definitive diagnosis was deferred to permanent histology in 87 percent of cases [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/51\">",
"       51",
"      </a>",
"      ]. In 5 percent of cases, an incorrect frozen section misled the surgeon, resulting in unwarranted completion thyroidectomy. The frozen section correctly modified the procedure in only 3.3 percent of cases. Similarly, another retrospective review of 152 patients undergoing thyroid surgery for follicular lesions found that 62 percent of cases were deferred to permanent histology [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Intraoperative nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a recurrent laryngeal nerve injury occurs and is identified intraoperatively, the RLN should be repaired [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/53\">",
"     53",
"    </a>",
"    ]. Avulsion or cautery injuries are more difficult to repair than a sharp transection. For repair, the damaged nerve should have clean, fresh edges with good hemostasis, and no tension on the two ends. The technique used may be direct end-to-end anastomosis (neurorrhaphy), direct implantation of a nerve ending into a muscle, or muscle-nerve pedicle grafts. A nonabsorbable fine suture is typically utilized for the repair.",
"   </p>",
"   <p>",
"    If the transected nerve appears foreshortened, an interposition graft can be used [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/54,55\">",
"     54,55",
"    </a>",
"    ]. Interposition grafts used in the neck should approximate the diameter of the native RLN. The ansa cervicalis nerve and hypoglossal nerve have been used successfully as interposition grafts.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Drains",
"    </span>",
"    &nbsp;&mdash;&nbsp;Routine drain placement after thyroid surgery is not necessary [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/56,57\">",
"     56,57",
"    </a>",
"    ]. A meta-analysis of 11 randomized clinical trials showed no significant difference in the incidence of hematoma or seroma between routine drainage and no drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/57\">",
"     57",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If the thyroid is very large, the dissection is extensive, or there is a persistently oozing thyroid bed, a closed-suction drain can be placed for the purpose of preventing a serous fluid collection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/57\">",
"     57",
"    </a>",
"    ]. The drain can be removed safely without concern for fluid re-accumulation if the drain output is serous and decreasing in volume.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Sealant devices",
"    </span>",
"    &nbsp;&mdash;&nbsp;Various vessel sealing systems, such as the harmonic scalpel and the LigaSure vessel sealing system, have been employed successfully in thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/58\">",
"     58",
"    </a>",
"    ]. In a meta-analysis of the harmonic scalpel and other hemostatic techniques, the harmonic scalpel significantly reduced operating time and blood loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/59\">",
"     59",
"    </a>",
"    ]. The harmonic scalpel uses mechanical vibration to cut and coagulate blood vessels, avoiding the high temperatures of electrocoagulation that can cause thermal injury. To avoid nerve injury, care should be taken not to employ these devices within 3 to 5 mm of the nerve. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may be observed overnight to facilitate the management of pain, nausea and hypocalcemia and exclude hematoma formation. Postoperative cervical hematomas can be life-threatening and require emergent intervention. Although cervical hematomas are rare after thyroid surgery, they are most commonly associated with postoperative nausea and vomiting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/60\">",
"     60",
"    </a>",
"    ]. All patients require examination for hematoma before hospital discharge. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Hematoma'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    There are reports of safe thyroid lobectomy and even total thyroidectomy performed in the outpatient setting by experienced thyroid surgeons, in selected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. As an example in a series of 1168 thyroidectomies, nearly 20 percent were performed as outpatient procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Thyroid hormone supplementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The recommendations for thyroid hormone supplementation will depend on the preoperative diagnosis and are discussed below.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Benign disease &ndash; Patients who undergo total thyroidectomy for benign disease should start a replacement dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"       levothyroxine",
"      </a>",
"      daily at an approximate dose of 1.6",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      body weight. Patients over 65 years should be started at a somewhat lower dose, and men sometimes need considerably higher doses. Serum TSH should be tested in about six weeks after starting the replacement therapy. The TSH should be kept in a normal range. Symptoms of hypo- or hyperthyroidism should be evaluated, and the dose of levothyroxine adjusted accordingly. An annual TSH is sufficient long-term if patients are well clinically.",
"      <br/>",
"      <br/>",
"      Patients who undergo thyroid lobectomy for benign disease may require levothyroxine supplementation to maintain a normal TSH level. This can be expected to occur in about a third of patients; thus a TSH level should be obtained about six weeks postoperatively. The possibility of permanent hypothyroidism should be discussed with patients prior to thyroid lobectomy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/65\">",
"       65",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=see_link\">",
"       \"Treatment of hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hyperthyroidism &ndash; Patients who have undergone thyroidectomy for hyperthyroidism should have their antithyroid medications stopped promptly after surgery. Beta blockade should be weaned over seven days.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"       Levothyroxine",
"      </a>",
"      replacement can be started within a week. A serum TSH should be checked at six to seven weeks, and the dose of levothyroxine should be adjusted accordingly. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=see_link&amp;anchor=H9#H9\">",
"       \"Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up\", section on 'Follow-up and monitoring'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignant disease &ndash; Patients who undergo total thyroidectomy for malignant disease will require thyroid hormone replacement that is dependent on the stage of their disease, the aggressiveness of the cancer, and the need for radioiodine ablation (RAI) postoperatively. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link&amp;anchor=H18#H18\">",
"       \"Surgical treatment of differentiated thyroid cancer\", section on 'Postoperative thyroid hormone therapy'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      For patients who will need RAI, thyroid hormone withdrawal remains the standard approach to raising TSH levels for adequate radioiodine uptake. Thus, patients who are able to receive RAI within two to three weeks may be discharged home postoperatively on no thyroid hormone replacement. However, if RAI treatment will not take place within two or three weeks, patients may be discharged on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=see_link\">",
"       liothyronine",
"      </a>",
"      (T3). Liothyronine has a short half life, and the hormone levels can be manipulated to maintain good energy levels for the patient. Based on the patient's weight and age, liothyronine dose is usually 10 to 25 mcg twice a day. Symptoms of dizziness, palpitations, or insomnia should prompt a lowering of the dose immediately. Liothyronine is discontinued one to two weeks prior to RAI treatment. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=see_link&amp;anchor=H10#H10\">",
"       \"Radioiodine treatment of differentiated thyroid cancer\", section on 'Patient preparation'",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=see_link\">",
"       \"Liothyronine: Drug information\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      For those patients with low risk differentiated thyroid cancer, an alternative method of achieving adequate elevation of TSH prior to RAI is to be started on",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/43/41656?source=see_link\">",
"       levothyroxine",
"      </a>",
"      immediately postoperatively and receive recombinant human thyrotropin (rhTSH), an exogenous form of TSH that activates the TSH receptor, just prior to RAI [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/66\">",
"       66",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=see_link&amp;anchor=H12#H12\">",
"       \"Radioiodine treatment of differentiated thyroid cancer\", section on 'Recombinant hTSH'",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?19/18/19749?source=see_link\">",
"       \"Thyrotropin alfa (recombinant human thyrotropin): Drug information\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Once the patient has undergone RAI, he or she should be maintained on levothyroxine at a dose of approximately 1.6",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      body weight. The actual TSH suppression levels will depend on the patient's age, cancer aggressiveness, and stage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/67\">",
"       67",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview of the management of differentiated thyroid cancer\", section on 'Thyroid hormone suppression'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Calcium supplementation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing total thyroidectomy may be at risk for developing transient or permanent hypoparathyroidism postoperatively. Some surgeons provide calcium supplementation based upon postoperative serum calcium or PTH levels whereas others prescribe calcium supplementation routinely after thyroidectomy to prevent symptoms of hypocalcemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/68\">",
"     68",
"    </a>",
"    ]. In either case, patients should be counseled to call the surgeon for postoperative paresthesias (\"tingling in the lips and fingertips\") as dose escalation can be required.",
"   </p>",
"   <p>",
"    Supplementation therapy with oral calcium and vitamin D has been found to decrease development of hypocalcemic symptoms and intravenous calcium requirement, thus allowing for safer early discharge [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/69\">",
"     69",
"    </a>",
"    ]. This is effective for managing both temporary and persistent hypoparathyroidism, which can be seen in approximately 8.3 and 1.7 percent of thyroidectomy patients, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"     39",
"    </a>",
"    ]. Calcium supplementation can be accomplished with oral calcium, usually calcium carbonate, 1250 to 2500 mg daily total, divided in two to four doses and then tapered based on symptoms and calcium levels. Patients who are taking proton pump inhibitors or who have had gastric bypass surgery may need to take calcium citrate because an acidic environment is necessary for optimal absorption of calcium carbonate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=see_link&amp;anchor=H16#H16\">",
"     \"Surgical treatment of differentiated thyroid cancer\", section on 'Hypoparathyroidism'",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H30\">",
"     'Hypocalcemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with undetectable or very low PTH levels may also need the active form 1,25-dihydroxyvitamin D (calcitriol) to adequately absorb calcium. This can be started prior to surgery and then tapered postoperatively according to the PTH or calcium levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=see_link\">",
"     \"Treatment of hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients who are on high dose oral calcium and calcitriol can develop hypercalcemia; thus, high doses should be short term and weekly checks of serum calcium should be obtained until standard doses are resumed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=see_link\">",
"     \"Clinical manifestations of hypercalcemia\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;A postoperative surgical follow-up visit in one to two weeks is optimal to evaluate the patient for any unusual voice changes, subtle hypocalcemic symptoms, and overall recovery. Medications and thyroid hormone replacement doses should be checked. The surgical pathology should be reviewed with the patient, and plans for the next steps in treatment or recovery should be discussed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     POSTOPERATIVE COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rates of complications from thyroidectomy, particularly recurrent laryngeal nerve injury, hypoparathyroidism, and dysphagia, are lower in patients who undergo surgery by high-volume surgeons and are lower at high-volume centers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/23-25,70-72\">",
"     23-25,70-72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Hematoma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative hematoma necessitating emergent surgical evacuation is a rare but dreaded complication of thyroidectomy. A cervical hematoma is characteristically a large, tense, firm, immobile anterior or lateral cervical swelling under the incision. The operating team should routinely examine the patient after surgery to check for hematoma formation. The incidence of postoperative hematoma after thyroidectomy is low (0.05 to 1.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39,60,73\">",
"     39,60,73",
"    </a>",
"    ]. There are no substitutes for meticulous hemostasis during thyroidectomy to prevent this complication. In addition, patients should stop all anticoagulants before surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=see_link\">",
"     \"Management of anticoagulation before and after elective surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    If a hematoma develops, emergent return to the operating room is essential. The patient should be maintained awake in order to allow the patient to protect the airway. Preparation of the neck and opening of the incision prior to intubation is advocated in order to evacuate the blood which may distort the larynx and make intubation more difficult.",
"   </p>",
"   <p>",
"    The hematoma is usually in the paratracheal area. Therefore, opening the strap muscle closure is necessary to evacuate this compartment. Once the airway has been secured, meticulous irrigation and preservation of the recurrent laryngeal nerves and the parathyroid glands (if visualized) is necessary to avoid a secondary injury. Blind electrocautery near the ligament of Berry should be avoided to prevent cautery injury to the RLN. Overnight intubation is sometimes recommended to allow supraglottic edema to resolve before extubation. Placement of a drain facilitates prompt evacuation of serous fluid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Seroma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wound seromas are typically superficial and mobile. A seroma usually will resolve without intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Hypocalcemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypocalcemia as a result of hypoparathyroidism is the most common complication of thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/74\">",
"     74",
"    </a>",
"    ]. Transient hypoparathyroidism is seen after 0.3 to 49 percent of thyroidectomies while permanent hypoparathyroidism is less likely and has been reported in up to 13 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/74\">",
"     74",
"    </a>",
"    ]. Patients should be counseled preoperatively about the risk of permanent hypoparathyroidism after total thyroidectomy, which in experienced hands is about 2 percent.",
"   </p>",
"   <p>",
"    Symptoms of hypocalcemia after total or near total thyroidectomy range from mild symptoms, such as paresthesias around the lips, mouth, hands, and feet, to muscle twitches and frank cramps with worsening hypocalcemia, to severe morbidity, such as trismus and tetany with severe hypocalcemia.",
"   </p>",
"   <p>",
"    There are no absolute serum calcium levels that correspond with symptoms, as patients will have differing set points and sensitivities. Nonetheless, successful prediction of calcium status after surgery can be facilitated using postoperative calcium levels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/75\">",
"     75",
"    </a>",
"    ]. In a study of 120 patients a 16 hour calcium level identified 94.5 percent of patients that needed supplementation (total calcium &lt;7.2",
"    <span class=\"nowrap\">",
"     mg/dL,",
"    </span>",
"    or ionized calcium &lt;1.0",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/75\">",
"     75",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36646?source=see_link\">",
"     \"Clinical manifestations of hypocalcemia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34005?source=see_link\">",
"     \"Diagnostic approach to hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Postoperative parathyroid hormone (PTH) levels can also be used to predict the likelihood of hypocalcemia. Low PTH levels (&lt;10 to 15",
"    <span class=\"nowrap\">",
"     ng/L)",
"    </span>",
"    in the immediate postoperative setting may predict symptomatic hypocalcemia and need for",
"    <span class=\"nowrap\">",
"     calcium/vitamin",
"    </span>",
"    D supplementation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/76,77\">",
"     76,77",
"    </a>",
"    ]. Most patients with hypocalcemia can be treated with increased oral calcium, while some patients will also require calcitriol. Intravenous calcium is occasionally required for patients with persistently low calcium levels and symptoms that do not resolve with oral calcium. In such cases, peripheral IV infusion sites must be monitored carefully to avoid infiltration of the soft tissues with IV calcium, which can result in soft tissue loss. Persistent hypocalcemia should prompt measurement of serum magnesium with repletion if necessary. Patients can be discharged if they are asymptomatic and their serum calcium levels are 7.8",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    or above and stable. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=see_link\">",
"     \"Treatment of hypocalcemia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122523\">",
"    <span class=\"h2\">",
"     Nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve injury can result from the disease process, surgery, or airway access for anesthesia. Endotracheal intubation or laryngeal mask airway ventilation can cause recurrent laryngeal nerve (RLN) injury as well as arytenoid dislocation, vocal cord edema, and other causes of postoperative hoarseness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/78-80\">",
"     78-80",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    High division of the vagus nerve near the carotid bulb will paralyze both the superior laryngeal nerve (SLN) and the RLN resulting in both sensory and motor deficits, with significant risk for aspiration. Injury to the SLN results in voice weakness or fatigue as well as changes to both voice quality and pitch [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/81\">",
"     81",
"    </a>",
"    ]. Injury to the RLN may result in paresis or paralysis of the true vocal cord to a paramedian or lateral position. Intrinsic muscles of the larynx, aside from the cricothyroid muscle, can be impaired and the patient may have swallowing dysfunction with an aspiration risk.",
"   </p>",
"   <p>",
"    The possibility of recurrent and superior laryngeal nerve injuries should be discussed with the patient preoperatively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H122759\">",
"    <span class=\"h3\">",
"     Superior laryngeal nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superior laryngeal nerve injury is difficult to diagnose accurately and the expected rate of this complication is therefore not well documented. Some report that superior laryngeal nerve injury is seen in approximately 3.7 percent of cases and leads to vocal fatigue and changes in voice quality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"     39",
"    </a>",
"    ]. Patients should be counseled preoperatively that they may experience permanent pitch change, difficult singing high notes, and difficulty speaking at loud volumes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Recurrent laryngeal nerve injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hoarseness, uncontrolled coughing when the patient is talking, dyspnea persisting for more than 24 to 48 hours after thyroid surgery, or aspiration pneumonia should lead to suspicion for potential vocal cord motion abnormalities. Symptomatic voice changes may improve after the immediate postoperative period. In patients with a hoarse but easily audible voice who are protecting their airway, referral for further evaluation is generally deferred for approximately 6 weeks after surgery.",
"   </p>",
"   <p>",
"    Arytenoid dislocation should be considered in cases of hoarseness, vocal fatigue and dysphagia. Arytenoid dislocation is an unusual consequence of intubation which should be treated promptly with reduction and repositioning of the arytenoid cartilage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/82\">",
"     82",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Patients with dyspnea or at risk for aspiration should be referred immediately for direct laryngoscopy for evaluation of vocal cord motion as well as a complete neurolaryngeal evaluation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/83\">",
"     83",
"    </a>",
"    ]. Neurolaryngeal evaluation can include several specialized procedures such as rigid and flexible videostroboscopy and laryngeal electromyography [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/83\">",
"     83",
"    </a>",
"    ]. Aerodynamic assessment of voice production and objective acoustic voice evaluation is helpful for following improvement over time. These studies also can identify superior laryngeal nerve injuries, which can present with more subtle voice changes, such as timber, pitch, and voice projection changes. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16009?source=see_link\">",
"     \"Hoarseness in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=see_link\">",
"     \"Surgical anatomy of the thyroid gland\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h4\">",
"     Vocal cord paresis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transient postoperative hoarseness is common after endotracheal intubation. Persisting or severe hoarseness is usually due to vocal cord paresis from RLN injury. Most injuries to the RLN are traction in type, transient, and no intervention is necessary. However, referral to a voice or speech therapist can help protect the patient's voice, reduce strain, reduce anxiety, and improve vocalization. Re-evaluation of the vocal cord by various laryngeal examinations at three and six months is usually undertaken. Temporary vocal cord paresis usually resolves by six months. If the vocal cord is immobile at this point, permanent paralysis is likely. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16009?source=see_link\">",
"     \"Hoarseness in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h4\">",
"     Unilateral vocal cord paralysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a vocal cord is immobile in an abducted position, RLN injury should be suspected. In a study of 14,934 patients who underwent thyroid surgery, permanent unilateral paresis of the RLN was documented in 1 percent, transient paresis in 2 percent and bilateral paresis in 0.4 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"     39",
"    </a>",
"    ]. Speech therapy to improve the voice and swallowing mechanics can also be beneficial in patients with a recurrent laryngeal injury. &nbsp;",
"   </p>",
"   <p>",
"    Patients who have significant symptoms may undergo an injection of fat into the vocal cord for temporary augmentation and medialization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/84\">",
"     84",
"    </a>",
"    ]. Medialization positions the paralyzed vocal cord medially so that the contralateral functioning vocal cord can close off the larynx during swallowing and phonating. This procedure improves both voice and swallowing. In patients with permanent deficits (persisting for more than 6 to 12 months after surgery), collagen can be injected for medialization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/85\">",
"     85",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgery to medialize the vocal cord is another option. Early surgical treatment is indicated in cases with severe functional problems such as aspiration pneumonia, disabling breathy hypophonia, ineffective cough, or disabling dyspnea. Surgical therapy at 6 to 9 months after injury may be indicated in patients who demonstrate evidence of denervation or little activity on laryngeal electromyography, and have a poor response to a reasonable trial of",
"    <span class=\"nowrap\">",
"     voice/speech",
"    </span>",
"    therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h4\">",
"     Bilateral vocal cord paralysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bilateral vocal cord paralysis from injury of both RLNs is a rare (0.4 percent of cases) and devastating complication of initial total thyroidectomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"     39",
"    </a>",
"    ]. It is more common with reoperative thyroid surgery. This complication is devastating and is usually recognized immediately postoperatively when the patient has difficulty breathing with stridor after extubation. Immediate reintubation is usually possible but may not be achieved if the vocal cords are both in the adducted position. Tracheostomy may need to be performed it the patient cannot maintain an adequate airway and cannot be orotracheally intubated. Laryngeal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cord edema is by far the most common cause of stridor after extubation and responds to racemic epinephrine administration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=see_link\">",
"     \"Overview of tracheostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients who have permanent bilateral vocal cord paralysis, to avoid long-term tracheostomy, partial posterior cordectomy using laser surgery can restore sufficient laryngeal airflow with minimal vocal sequelae. Early management of this complication by teams of specialists may allow appropriate and less invasive surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Horner's syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The symptoms of Horner's syndrome are miosis, ptosis, and anhidrosis. Horner's syndrome is a very rare (0.2 percent) complication of thyroidectomy, when lateral neck dissection is performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/87\">",
"     87",
"    </a>",
"    ]. This can be a result of postoperative hematoma, ischemic nerve damage or stretching of the cervical sympathetic chain by the retractor. Injury to the sympathetic chains can be avoided with careful dissection around the prevertebral fascia and carotid sheath. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/32/32262?source=see_link\">",
"     \"Horner's syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Chyle fistula",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chyle fistula is reported in 1.8 to 8.3 percent of thyroidectomies, when a lateral lymph node dissection has been performed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/87,88\">",
"     87,88",
"    </a>",
"    ]. Chyle leaks and fistulas are caused by injury to the thoracic duct. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37192?source=see_link\">",
"     \"Etiology, clinical presentation, and diagnosis of chylothorax\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thoracic duct injuries can lead to severe fluid and electrolyte imbalances and even death if not treated properly. They are generally detected by milky drainage, a bulging supraclavicular fossa and induration or erythema of the skin. Low output fistulas (&lt;500",
"    <span class=\"nowrap\">",
"     ml/day)",
"    </span>",
"    can be managed conservatively, while high output fistulas may require surgical intervention for closure of the fistula [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/87\">",
"     87",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Tracheal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tracheal necrosis is rare but has been reported after thyroidectomy and is likely due to excessive use of cautery on and around the trachea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/89\">",
"     89",
"    </a>",
"    ]. The blood supply to the upper trachea is primarily from small branches of the inferior thyroid artery and damage to these can cause ischemia and necrosis. Tracheal disruption leads to an air leak with subcutaneous emphysema which is potentially life-threatening. Tracheal injury requires re-exploration of the neck and tracheostomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=see_link\">",
"     \"Overview of tracheostomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h2\">",
"     Esophageal injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;While rare, esophageal and pharyngeal injury can occur with thyroid surgery. The finding of extensive crepitance in the surgical tissues postoperatively should prompt immediate evaluation for pharyngeal or esophageal perforation",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H40\">",
"    <span class=\"h1\">",
"     ALTERNATIVE ACCESS THYROIDECTOMY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Endoscopic thyroidectomy &ndash; Endoscopic or endoscopic-assisted thyroidectomy is also termed minimally invasive video assisted thyroidectomy (MIVAT). This approach employs an incision in the central neck 2 cm above the sternal notch using small conventional retractors and 2 mm dissecting instruments [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/90,91\">",
"       90,91",
"      </a>",
"      ]. Hemostasis is achieved by using a harmonic scalpel [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/90\">",
"       90",
"      </a>",
"      ]. Matched comparisons between endoscopic-assisted and conventional thyroidectomy in patients with low to intermediate risk papillary thyroid carcinoma show comparable surgical and oncologic outcomes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/91,92\">",
"       91,92",
"      </a>",
"      ]. The main advantage over conventional thyroidectomy is a smaller incision.",
"     </li>",
"     <li>",
"      Robotic surgery &ndash; Endoscopic thyroid surgery can be performed with robotic assistance. The robotic technology allows for improved mobility of the endoscopic instruments and better ergonomics for the surgeon. A transaxillary approach is being done in some institutions for both benign and malignant thyroid disease.",
"      <br/>",
"      <br/>",
"      Preliminary results in a highly select group of patients show complication rates comparable to conventional thyroidectomy (transient hoarseness in 4 percent, permanent recurrent laryngeal nerve injury in 1 percent, and transient hypocalcemia in 41 percent) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?30/57/31642/abstract/92\">",
"       92",
"      </a>",
"      ]. There is a steep learning curve, significantly longer operating room times, and higher expense for robotic technology. This technology is currently experimental and limited to a very small group of patients. The oncologic outcomes of robotic-assisted endoscopic surgery compared to conventional thyroidectomy have yet to be determined.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H41\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thyroidectomy is usually an elective operation and any major medical conditions should be addressed before proceeding with surgery. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Treatment of hyperthyroidism should be optimized with antithyroid medications and, if indicated, beta-blockade prior to thyroid surgery to avoid the risk of thyroid storm. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic thyroid ultrasound should be performed in all patients with a suspected malignancy, thyroid nodule, nodular goiter, or abnormality detected on other imaging modalities. Routine use of other imaging modalities, such as CT or MRI, is not recommended. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preoperative laryngoscopy should be performed for patients with preoperative hoarseness or voice changes and for all patients undergoing reoperative surgery. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine visual identification of the recurrent laryngeal nerve (RLN) decreases the incidence of injury and is regarded as the standard of care in thyroid surgery. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Intraoperative neuromonitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Frozen section analysis during thyroid surgery should only be employed when it will have an impact on surgical decision making. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Operative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The recommendations for thyroid hormone supplementation will depend on the postoperative diagnosis. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Postoperative care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients undergoing total thyroidectomy are at risk for developing transient or permanent hypoparathyroidism postoperatively. Some surgeons prescribe calcium supplementation routinely after thyroidectomy to prevent symptoms of hypocalcemia, whereas others rely upon postoperative serum calcium levels. Patients should be counseled to call the surgeon for postoperative paresthesias. (See",
"      <a class=\"local\" href=\"#H23\">",
"       'Postoperative care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Hoarseness, uncontrolled coughing when the patient is talking, dyspnea persisting for more than 24 to 48 hours after thyroid surgery, or aspiration pneumonia should lead to suspicion of nerve injury and potential vocal cord motion abnormalities. Patients with dyspnea or those at risk for aspiration should be referred for direct laryngoscopy for evaluation of vocal cord motion as well as a complete neuro-laryngeal evaluation. (See",
"      <a class=\"local\" href=\"#H27\">",
"       'Postoperative complications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/1\">",
"      Rogers-Stevane J, Kauffman GL Jr. A historical perspective on surgery of the thyroid and parathyroid glands. Otolaryngol Clin North Am 2008; 41:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/2\">",
"      Miralli&eacute; E, Rigaud J, Mathonnet M, et al. Management and prognosis of metastases to the thyroid gland. J Am Coll Surg 2005; 200:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/3\">",
"      Nixon IJ, Whitcher M, Glick J, et al. Surgical management of metastases to the thyroid gland. Ann Surg Oncol 2011; 18:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/4\">",
"      Erbil Y, Ozluk Y, Giri M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 2007; 92:2182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/5\">",
"      American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer, Cooper DS, Doherty GM, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009; 19:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/6\">",
"      Ukkat J, Gimm O, Brauckhoff M, et al. Single center experience in primary surgery for medullary thyroid carcinoma. World J Surg 2004; 28:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/7\">",
"      Schulte KM, Machens A, Fugazzola L, et al. The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A. J Clin Endocrinol Metab 2010; 95:E92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/8\">",
"      American Thyroid Association Guidelines Task Force, Kloos RT, Eng C, et al. Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 2009; 19:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/9\">",
"      Shaha AR. Revision thyroid surgery - technical considerations. Otolaryngol Clin North Am 2008; 41:1169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/10\">",
"      Steurer M, Passler C, Denk DM, et al. Advantages of recurrent laryngeal nerve identification in thyroidectomy and parathyroidectomy and the importance of preoperative and postoperative laryngoscopic examination in more than 1000 nerves at risk. Laryngoscope 2002; 112:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/11\">",
"      Randolph GW, Kamani D. The importance of preoperative laryngoscopy in patients undergoing thyroidectomy: voice, vocal cord function, and the preoperative detection of invasive thyroid malignancy. Surgery 2006; 139:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/12\">",
"      Lefevre JH, Tresallet C, Leenhardt L, et al. Reoperative surgery for thyroid disease. Langenbecks Arch Surg 2007; 392:685.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/13\">",
"      Levin KE, Clark AH, Duh QY, et al. Reoperative thyroid surgery. Surgery 1992; 111:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/14\">",
"      Tan MP, Agarwal G, Reeve TS, et al. Impact of timing on completion thyroidectomy for thyroid cancer. Br J Surg 2002; 89:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/15\">",
"      Avenia N, Sanguinetti A, Cirocchi R, et al. Antibiotic prophylaxis in thyroid surgery: a preliminary multicentric Italian experience. Ann Surg Innov Res 2009; 3:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/16\">",
"      Leaper DJ, Melling AG. Antibiotic prophylaxis in clean surgery: clean non-implant wounds. J Chemother 2001; 13 Spec No 1:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/17\">",
"      Gagliardi AR, Fenech D, Eskicioglu C, et al. Factors influencing antibiotic prophylaxis for surgical site infection prevention in general surgery: a review of the literature. Can J Surg 2009; 52:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/18\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/19\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/20\">",
"      Braxton CC, Gerstenberger PA, Cox GG. Improving antibiotic stewardship: order set implementation to improve prophylactic antimicrobial prescribing in the outpatient surgical setting. J Ambul Care Manage 2010; 33:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/21\">",
"      Worni M, Schudel HH, Seifert E, et al. Randomized controlled trial on single dose steroid before thyroidectomy for benign disease to improve postoperative nausea, pain, and vocal function. Ann Surg 2008; 248:1060.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/22\">",
"      Kern KA. Medicolegal analysis of errors in diagnosis and treatment of surgical endocrine disease. Surgery 1993; 114:1167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/23\">",
"      Tuggle CT, Roman SA, Wang TS, et al. Pediatric endocrine surgery: who is operating on our children? Surgery 2008; 144:869.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/24\">",
"      Sosa JA, Mehta PJ, Wang TS, et al. A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? J Am Coll Surg 2008; 206:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/25\">",
"      Boudourakis LD, Wang TS, Roman SA, et al. Evolution of the surgeon-volume, patient-outcome relationship. Ann Surg 2009; 250:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/26\">",
"      Dralle H, Sekulla C, Lorenz K, et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 2008; 32:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/27\">",
"      Hermann M, Alk G, Roka R, et al. Laryngeal recurrent nerve injury in surgery for benign thyroid diseases: effect of nerve dissection and impact of individual surgeon in more than 27,000 nerves at risk. Ann Surg 2002; 235:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/28\">",
"      Angelos P. Recurrent laryngeal nerve monitoring: state of the art, ethical and legal issues. Surg Clin North Am 2009; 89:1157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/29\">",
"      Grubbs EG, Rich TA, Li G, et al. Recent advances in thyroid cancer. Curr Probl Surg 2008; 45:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/30\">",
"      Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/31\">",
"      Chan WF, Lang BH, Lo CY. The role of intraoperative neuromonitoring of recurrent laryngeal nerve during thyroidectomy: a comparative study on 1000 nerves at risk. Surgery 2006; 140:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/32\">",
"      Thomusch O, Sekulla C, Walls G, et al. Intraoperative neuromonitoring of surgery for benign goiter. Am J Surg 2002; 183:673.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/33\">",
"      Shindo M, Chheda NN. Incidence of vocal cord paralysis with and without recurrent laryngeal nerve monitoring during thyroidectomy. Arch Otolaryngol Head Neck Surg 2007; 133:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/34\">",
"      Sturgeon C, Sturgeon T, Angelos P. Neuromonitoring in thyroid surgery: attitudes, usage patterns, and predictors of use among endocrine surgeons. World J Surg 2009; 33:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/35\">",
"      Lo Gerfo P, Ditkoff BA, Chabot J, Feind C. Thyroid surgery using monitored anesthesia care: an alternative to general anesthesia. Thyroid 1994; 4:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/36\">",
"      Spanknebel K, Chabot JA, DiGiorgi M, et al. Thyroidectomy using monitored local or conventional general anesthesia: an analysis of outpatient surgery, outcome and cost in 1,194 consecutive cases. World J Surg 2006; 30:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/37\">",
"      Spanknebel K, Chabot JA, DiGiorgi M, et al. Thyroidectomy using local anesthesia: a report of 1,025 cases over 16 years. J Am Coll Surg 2005; 201:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/38\">",
"      Arora N, Dhar P, Fahey TJ 3rd. Seminars: local and regional anesthesia for thyroid surgery. J Surg Oncol 2006; 94:708.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/39\">",
"      Rosato L, Avenia N, Bernante P, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World J Surg 2004; 28:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/40\">",
"      Brunaud L, Zarnegar R, Wada N, et al. Incision length for standard thyroidectomy and parathyroidectomy: when is it minimally invasive? Arch Surg 2003; 138:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/41\">",
"      Olson JA Jr, DeBenedetti MK, Baumann DS, Wells SA Jr. Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 1996; 223:472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/42\">",
"      Carter WB, Uy K, Ward MD, Hoying JB. Parathyroid-induced angiogenesis is VEGF-dependent. Surgery 2000; 128:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/43\">",
"      Kikumori T, Imai T, Tanaka Y, et al. Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 1999; 125:504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/44\">",
"      Carnaille BM, Pattou FN, Oudar C, et al. Parathyroid incidentalomas in normocalcemic patients during thyroid surgery. World J Surg 1996; 20:830.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/45\">",
"      Barczyski M, Konturek A, Hubalewska-Dydejczyk A, et al. Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter. World J Surg 2010; 34:1203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/46\">",
"      Wilhelm SM, McHenry CR. Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States. World J Surg 2010; 34:1261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/47\">",
"      Bilimoria KY, Zanocco K, Sturgeon C. Impact of surgical treatment on outcomes for papillary thyroid cancer. Adv Surg 2008; 42:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/48\">",
"      Grant CS, Stulak JM, Thompson GB, et al. Risks and adequacy of an optimized surgical approach to the primary surgical management of papillary thyroid carcinoma treated during 1999-2006. World J Surg 2010; 34:1239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/49\">",
"      Osamura RY, Hunt JL. Current practices in performing frozen sections for thyroid and parathyroid pathology. Virchows Arch 2008; 453:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/50\">",
"      Baloch ZW, Livolsi VA. Follicular-patterned lesions of the thyroid: the bane of the pathologist. Am J Clin Pathol 2002; 117:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/51\">",
"      Chen H, Nicol TL, Udelsman R. Follicular lesions of the thyroid. Does frozen section evaluation alter operative management? Ann Surg 1995; 222:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/52\">",
"      Callcut RA, Selvaggi SM, Mack E, et al. The utility of frozen section evaluation for follicular thyroid lesions. Ann Surg Oncol 2004; 11:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/53\">",
"      Yumoto E, Sanuki T, Kumai Y. Immediate recurrent laryngeal nerve reconstruction and vocal outcome. Laryngoscope 2006; 116:1657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/54\">",
"      Paniello RC. Laryngeal reinnervation. Otolaryngol Clin North Am 2004; 37:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/55\">",
"      Crumley RL. Repair of the recurrent laryngeal nerve. Otolaryngol Clin North Am 1990; 23:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/56\">",
"      Khanna J, Mohil RS, Bhatnagar D, et al. Is the routine drainage after surgery for thyroid necessary? A prospective randomized clinical study [ISRCTN63623153]. BMC Surg 2005; 5:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/57\">",
"      Sanabria A, Carvalho AL, Silver CE, et al. Routine drainage after thyroid surgery--a meta-analysis. J Surg Oncol 2007; 96:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/58\">",
"      Pons Y, Gauthier J, Ukkola-Pons E, et al. Comparison of LigaSure vessel sealing system, harmonic scalpel, and conventional hemostasis in total thyroidectomy. Otolaryngol Head Neck Surg 2009; 141:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/59\">",
"      Ecker T, Carvalho AL, Choe JH, et al. Hemostasis in thyroid surgery: harmonic scalpel versus other techniques--a meta-analysis. Otolaryngol Head Neck Surg 2010; 143:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/60\">",
"      Bononi M, Amore Bonapasta S, Vari A, et al. Incidence and circumstances of cervical hematoma complicating thyroidectomy and its relationship to postoperative vomiting. Head Neck 2010; 32:1173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/61\">",
"      Hopkins B, Steward D. Outpatient thyroid surgery and the advances making it possible. Curr Opin Otolaryngol Head Neck Surg 2009; 17:95.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/62\">",
"      Snyder SK, Roberson CR, Cummings CC, Rajab MH. Local Anesthesia With Monitored Anesthesia Care vs General Anesthesia in Thyroidectomy: A Randomized Study. Arch Surg 2006; 141:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/63\">",
"      Snyder SK, Hamid KS, Roberson CR, et al. Outpatient thyroidectomy is safe and reasonable: experience with more than 1,000 planned outpatient procedures. J Am Coll Surg 2010; 210:575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/64\">",
"      Tuggle CT, Roman S, Udelsman R, Sosa JA. Same-day thyroidectomy: a review of practice patterns and outcomes for 1,168 procedures in New York State. Ann Surg Oncol 2011; 18:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/65\">",
"      Phitayakorn R, McHenry CR. Follow-up after surgery for benign nodular thyroid disease: evidence-based approach. World J Surg 2008; 32:1374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/66\">",
"      Haugen BR, Cooper DS, Emerson CH, et al. Expanding indications for recombinant human TSH in thyroid cancer. Thyroid 2008; 18:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/67\">",
"      Escobar-Morreale HF, Botella-Carretero JI, Escobar del Rey F, Morreale de Escobar G. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine. J Clin Endocrinol Metab 2005; 90:4946.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/68\">",
"      Wang TS, Cheung K, Roman SA, Sosa JA. To supplement or not to supplement: a cost-utility analysis of calcium and vitamin D repletion in patients after thyroidectomy. Ann Surg Oncol 2011; 18:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/69\">",
"      Bellantone R, Lombardi CP, Raffaelli M, et al. Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? Surgery 2002; 132:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/70\">",
"      Sosa JA, Bowman HM, Tielsch JM, et al. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 1998; 228:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/71\">",
"      Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine surgery. Surgery 2007; 142:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/72\">",
"      Mitchell J, Milas M, Barbosa G, et al. Avoidable reoperations for thyroid and parathyroid surgery: effect of hospital volume. Surgery 2008; 144:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/73\">",
"      Harding J, Sebag F, Sierra M, et al. Thyroid surgery: postoperative hematoma--prevention and treatment. Langenbecks Arch Surg 2006; 391:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/74\">",
"      Lee YS, Nam KH, Chung WY, et al. Postoperative complications of thyroid cancer in a single center experience. J Korean Med Sci 2010; 25:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/75\">",
"      Bentrem DJ, Rademaker A, Angelos P. Evaluation of serum calcium levels in predicting hypoparathyroidism after total/near-total thyroidectomy or parathyroidectomy. Am Surg 2001; 67:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/76\">",
"      Sywak MS, Palazzo FF, Yeh M, et al. Parathyroid hormone assay predicts hypocalcaemia after total thyroidectomy. ANZ J Surg 2007; 77:667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/77\">",
"      Noordzij JP, Lee SL, Bernet VJ, et al. Early prediction of hypocalcemia after thyroidectomy using parathyroid hormone: an analysis of pooled individual patient data from nine observational studies. J Am Coll Surg 2007; 205:748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/78\">",
"      Audu P, Artz G, Scheid S, et al. Recurrent laryngeal nerve palsy after anterior cervical spine surgery: the impact of endotracheal tube cuff deflation, reinflation, and pressure adjustment. Anesthesiology 2006; 105:898.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/79\">",
"      Chan TV, Grillone G. Vocal cord paralysis after laryngeal mask airway ventilation. Laryngoscope 2005; 115:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/80\">",
"      Cinar SO, Seven H, Cinar U, Turgut S. Isolated bilateral paralysis of the hypoglossal and recurrent laryngeal nerves (Bilateral Tapia's syndrome) after transoral intubation for general anesthesia. Acta Anaesthesiol Scand 2005; 49:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/81\">",
"      Teitelbaum BJ, Wenig BL. Superior laryngeal nerve injury from thyroid surgery. Head Neck 1995; 17:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/82\">",
"      Norris BK, Schweinfurth JM. Arytenoid dislocation: An analysis of the contemporary literature. Laryngoscope 2011; 121:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/83\">",
"      Finck C. Laryngeal dysfunction after thyroid surgery: diagnosis, evaluation and treatment. Acta Chir Belg 2006; 106:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/84\">",
"      Laccourreye O, Papon JF, Kania R, et al. Intracordal injection of autologous fat in patients with unilateral laryngeal nerve paralysis: long-term results from the patient's perspective. Laryngoscope 2003; 113:541.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/85\">",
"      Remacle M, Lawson G. Results with collagen injection into the vocal folds for medialization. Curr Opin Otolaryngol Head Neck Surg 2007; 15:148.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/86\">",
"      Hartl DM, Travagli JP, Leboulleux S, et al. Clinical review: Current concepts in the management of unilateral recurrent laryngeal nerve paralysis after thyroid surgery. J Clin Endocrinol Metab 2005; 90:3084.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/87\">",
"      Cozzaglio L, Coladonato M, Doci R, et al. Horner's syndrome as a complication of thyroidectomy: report of a case. Surg Today 2008; 38:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/88\">",
"      Roh JL, Kim DH, Park CI. Prospective identification of chyle leakage in patients undergoing lateral neck dissection for metastatic thyroid cancer. Ann Surg Oncol 2008; 15:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/89\">",
"      Chauhan A, Ganguly M, Saidha N, Gulia P. Tracheal necrosis with surgical emphysema following thyroidectomy. J Postgrad Med 2009; 55:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/90\">",
"      Miccoli P, Berti P, Ambrosini CE. Perspectives and lessons learned after a decade of minimally invasive video-assisted thyroidectomy. ORL J Otorhinolaryngol Relat Spec 2008; 70:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/91\">",
"      Miccoli P, Pinchera A, Materazzi G, et al. Surgical treatment of low- and intermediate-risk papillary thyroid cancer with minimally invasive video-assisted thyroidectomy. J Clin Endocrinol Metab 2009; 94:1618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?30/57/31642/abstract/92\">",
"      Kang SW, Lee SC, Lee SH, et al. Robotic thyroid surgery using a gasless, transaxillary approach and the da Vinci S system: the operative outcomes of 338 consecutive patients. Surgery 2009; 146:1048.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2157 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-218.7.204.208-7855FF150B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31642=[""].join("\n");
var outline_f30_57_31642=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H41\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      INTRAOPERATIVE NEUROMONITORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6320596\">",
"      Technique of nerve monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Efficacy of nerve monitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ANESTHESIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      General anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Cervical block",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      OPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Exposure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Identification of parathyroid glands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Parathyroid autotransplantation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6320613\">",
"      Parathyroid gland enlargement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Extent of dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Lymphadenectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Intraoperative frozen section",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Intraoperative nerve injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Drains",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Sealant devices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      POSTOPERATIVE CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Thyroid hormone supplementation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Calcium supplementation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      POSTOPERATIVE COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Hematoma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Seroma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H122523\">",
"      Nerve injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H122759\">",
"      - Superior laryngeal nerve injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Recurrent laryngeal nerve injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Vocal cord paresis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Unilateral vocal cord paralysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Bilateral vocal cord paralysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Chyle fistula",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Tracheal injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      Esophageal injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H40\">",
"      ALTERNATIVE ACCESS THYROIDECTOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H41\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/2157\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/2157|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/5/2131\" title=\"figure 1\">",
"      Cervical block",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/23/10608\" title=\"figure 2\">",
"      Patient positioning for thyroid and parathyroid surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?7/46/7906\" title=\"figure 3\">",
"      Incision site",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/1/1046\" title=\"figure 4\">",
"      Superior flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/27/8628\" title=\"figure 5\">",
"      Middle thyroid vein",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/52/2887\" title=\"figure 6\">",
"      Medial retraction thyroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/42/20134\" title=\"figure 7\">",
"      Superior pole vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/1/25624\" title=\"figure 8\">",
"      Superior pole thyroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?4/37/4694\" title=\"figure 9\">",
"      Anterior retraction thyroid",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/25/12692\" title=\"figure 10\">",
"      Ligament of Berry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/37/24146\" title=\"figure 11\">",
"      Dissection of recurrent laryngeal nerve lateral view",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/13/10455\" title=\"figure 12\">",
"      Dissection isthmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?29/6/29795\" title=\"figure 13\">",
"      Division isthmus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?9/47/9972\" title=\"figure 14\">",
"      Parathyroid location",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/20/19782\" title=\"figure 15\">",
"      Central neck dissection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?8/3/8244\" title=\"figure 16\">",
"      Lymph node levels of the neck",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/10/23721?source=related_link\">",
"      Anaplastic thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/56/33669?source=related_link\">",
"      Clinical manifestations of hypercalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/50/36646?source=related_link\">",
"      Clinical manifestations of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/26/5545?source=related_link\">",
"      Diagnosis and differential diagnosis of primary hyperparathyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/53/28506?source=related_link\">",
"      Diagnostic approach to and treatment of thyroid nodules",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34005?source=related_link\">",
"      Diagnostic approach to hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/14/28906?source=related_link\">",
"      Direct laryngoscopy and tracheal intubation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/20/37192?source=related_link\">",
"      Etiology, clinical presentation, and diagnosis of chylothorax",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=related_link\">",
"      Evaluation of preoperative pulmonary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/40/16009?source=related_link\">",
"      Hoarseness in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/32/32262?source=related_link\">",
"      Horner's syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/33/3608?source=related_link\">",
"      Laboratory assessment of thyroid function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?1/51/1846?source=related_link\">",
"      Liothyronine: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=related_link\">",
"      Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=related_link\">",
"      Medullary thyroid cancer: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19817?source=related_link\">",
"      Overview of anesthesia and anesthetic choices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/2/33834?source=related_link\">",
"      Overview of complications occurring in the post-anesthesia care unit",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/11/21688?source=related_link\">",
"      Overview of follicular thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/15/8440?source=related_link\">",
"      Overview of papillary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/37/5719?source=related_link\">",
"      Overview of peripheral nerve blocks",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44313?source=related_link\">",
"      Overview of the management of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/42/11945?source=related_link\">",
"      Overview of tracheostomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/39/18042?source=related_link\">",
"      Peripheral nerve block: Techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/13/34010?source=related_link\">",
"      Radioiodine treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/8/12424?source=related_link\">",
"      Surgery in the treatment of hyperthyroidism: Indications, preoperative preparation, and postoperative follow-up",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/23/29045?source=related_link\">",
"      Surgical anatomy of the parathyroid glands",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/17/44310?source=related_link\">",
"      Surgical anatomy of the thyroid gland",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/6/41064?source=related_link\">",
"      Surgical treatment of differentiated thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/61/10200?source=related_link\">",
"      Thyroid hormone action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=related_link\">",
"      Thyroid hormone synthesis and physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/8/35974?source=related_link\">",
"      Thyroid lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?19/18/19749?source=related_link\">",
"      Thyrotropin alfa (recombinant human thyrotropin): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44632?source=related_link\">",
"      Treatment of hypocalcemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/53/43865?source=related_link\">",
"      Treatment of hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/62/32742?source=related_link\">",
"      Treatment of obstructive or substernal goiter",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f30_57_31643="Outcome of triplet pregnancy";
var content_f30_57_31643=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F52490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F52490&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Fetal and infant death rates in triplet gestations (all three fetuses alive at 20 weeks of gestation, n=5240)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Outcome",
"       </td>",
"       <td class=\"subtitle1\">",
"        Percent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three surviving infants",
"       </td>",
"       <td>",
"        87.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two surviving infants, one infant death",
"       </td>",
"       <td>",
"        4.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three infant deaths",
"       </td>",
"       <td>",
"        2.6",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One fetal death, two surviving infants",
"       </td>",
"       <td>",
"        1.8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One surviving infant, two infant deaths",
"       </td>",
"       <td>",
"        1.4",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Three fetal deaths",
"       </td>",
"       <td>",
"        1.0",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One fetal death, two infant deaths",
"       </td>",
"       <td>",
"        0.7",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two fetal deaths, one surviving infant",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Two fetal deaths, one infant death",
"       </td>",
"       <td>",
"        0.3",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        One fetal and one infant death, one surviving infant",
"       </td>",
"       <td>",
"        0.2",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Based upon the Matched Multiple Birth File from the US National Center for Health Statistics. Adapted from Johnson, CD, Zhang, J. Obstet Gynecol 2002; 99:698.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31643=[""].join("\n");
var outline_f30_57_31643=null;
var title_f30_57_31644="FDA categories of immunosuppressive drugs in pregnancy";
var content_f30_57_31644=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F54317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F54317&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    FDA categories of immunosuppressive drugs in pregnancy",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Category",
"       </td>",
"       <td class=\"subtitle1\">",
"        Interpretation",
"       </td>",
"       <td class=\"subtitle1\">",
"        Immunosuppressive drug",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        A",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Controlled studies show no risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Adequate, well-controlled studies in pregnant women have failed to demonstrate risk to the fetus",
"       </td>",
"       <td class=\"sublist1_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        B",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        No evidence of risk in humans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Either animal findings show risk (but human findings do not) or, if no adequate human studies have been done, animal findings are negative.",
"       </td>",
"       <td class=\"sublist1_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        C",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Risk cannot be ruled out",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Human studies are lacking and animal studies are either positive for fetal risk or lacking as well. However, potential benefits may justify the potential risk.",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Cyclosporine",
"        </p>",
"        <p>",
"         Tacrolimus",
"        </p>",
"        <p>",
"         Sirolimus",
"        </p>",
"        <p>",
"         Prednisone",
"        </p>",
"        <p>",
"         OKT3",
"        </p>",
"        <p>",
"         Thymoglobulin",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        D",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Positive evidence of risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Investigational or postmarketing data show risk to fetus. Nevertheless, potential benefits may outweight the risk.",
"       </td>",
"       <td class=\"sublist_other\">",
"        <p>",
"         Azathioprine",
"        </p>",
"        <p>",
"         Mycophenolate (MMF/MPA)",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        X",
"       </td>",
"       <td class=\"sublist1_start\" colspan=\"2\">",
"        Contraindicated in pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Studies in animals or humans, or investigational or postmarketing reports have shown fetal risk which clearly outweighs any possible benefit to the patient.",
"       </td>",
"       <td class=\"sublist1_other\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     <p>",
"      1. Although sirolimus is considered a category C drug by the FDA, because of embryotoxic effects in animals, we recommend avoiding its use in pregnancy, and prefer azathioprine, cyclosporine, or tacrolimus.",
"      <br>",
"       <br>",
"        2.&nbsp;Although mycophenolate (MMP/MPA) is classified as a category D&nbsp;agent by the FDA, given compelling evidence for teratogenicity, we believe it should not be given during pregnancy.",
"       </br>",
"      </br>",
"     </p>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31644=[""].join("\n");
var outline_f30_57_31644=null;
var title_f30_57_31645="Algorithm for vascular testing in asymptomatic PAD";
var content_f30_57_31645=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F85752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F85752&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Algorithm for vascular testing in asymptomatic PAD",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 251px; background-image: url(data:image/gif;base64,R0lGODlhMwH7AMQAAP///wAAAIiIiLu7u0RERCIiIpmZmTMzM2ZmZt3d3REREczMzO7u7lVVVXd3d6qqqu/v7x8fH19fXz8/P8/Pz5+fn39/fw8PD7+/v4+Pj9/f3wAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAAzAfsAAAX/ICCOZGmeaKqubOu+cCzPdG3feK7vfO//wKBwSCwaj8ikcslsOp/QqHRKrVqv2Kx2y+16v+CweEwum8/otHrNbrvf8Lh8Fqjb7/i8fs/v+/+AgYKDhIWFc0MBiIsyiow/jo+SKpGTOpWWmSKYmjWcnZKfoDGio4ilpi2oLAEDRAOrLbBNsyYCBDEEAjixqSm9IwwBBSOtr8AqtTS3NcokzDC6vL40yAACBwquAMZDzjTfMdAz4de40bs31tTFMAUCCAibB3UGAAT0AfIJ+Q4AsLAMDKuDoM4BAAnsHGDwTYDBBdwMFJAnIqFBhgHoFVjAgEAdBf8K1LuXD4FFfSQy/44cIDKAPZZ2ABQcOe6fyo0CRcS7J6Djx5D1fAYAeWIdO24mWtojAYuhAgbcdgkASQAXrAQNGgBYoA1WugC7EBRIkHAbwgAPnC0IABEBrgBaTyRMyxZA1qYjFNh7QNVqgAQ1N0kFqRcAXwAKdjlDcLAmLIhZc8qUpwuviMJ8LaMwyg7ZzJHGrkpLmKDAUgIGlBmD1mqBx3rOJIpgyc2sCNd2UjsSQMzBUAEn6yQY/TdwbZvB//61eU1BHWKOd5t2tFOa78TJE1xPZ4IzNWAMFDwQge24A2LEsWpdO0C1K9YDGAMQppvEWshvbcs8SL/WAYpb/VXYCOmVV4Ix5yG21P9lUik3XoLRifDfVfxQxt1aCQxo33LdHUWKCwYQddZaz7mSHj91+OOeOZu055xI9T3z0HFMvegSLAYlgCNKMA3D01kJcIVSMSUC5aNAKt3zHHTnzKZQAkoq8B9PO8rTYwFVbuYhDN750o0O5fjQZSpjmvJlDmH2UOYoa27JRZudwOlmFnJmUuecVtw5iZ54TsHnI3/2CUWgixAqaBOGzpHooUosGoc1whCTQ3YousRoNZcWBQM22sgwEUQn8GaXVg8EAFWmXKJ6oDvwUORQHVYpZcsBB3AnQnj2iNfiCGXZxMCrGwHQUrAuTeRbHaCaqWpKSY3ElKkDPLXWeMxgJmL/CThCKYIDB9Fo6Qg7xcMVRA7EJUIB/sC1yXidLduOC5+5JJs52ZWATa0k9IoYu2dGSxqSzzHwmTzd8KbPqcq6i1QL4bGLzX124aJhCZ+a0ECTWRlmagn4rKdAsgJBNeWZCnqp8MIshMgrWzMVEOtzFOMB5WO85rPgCKVu86o+lU50XHgXmaxwmw0AGIRx7joKx5ivHaBtEBmye/ImJys9tZpVXz2G1W5wrXUOXrMR9tc2jK2G2WTTkXXaXqCNhttmfENyEaWB9QLcZkDqo6d2WPVisiTMpJhIEz8ht23GSbODA026gHcZ1nCqXwumkZAYANyaIFayl2tmOCZzm6C4/w4N2KrK2i68s9M1fRt5s7A5rgXVN8KYJUw6ulYUmqnAQjQsRMUicGxdI/zOjc1Ggo48M8PvnJpzhelCwETnEODPCK8esADAT7OCevHOjtBUtAxMy6K1JzBwQAO1XDUTArA4Z/erzkk92WTjYm6usOnGhZYK6IrKNYjROdBJhUnckJriLheijjgNSKQZAcTc8qNUDe0F8TLAvG5RL1sQQHbM2ZAISvU0iIlPAf+6QwEEZgeC6UwkCEAYCwlyHIlE8HAAkA0zDBbD9GxiONzRhQOMNi/ajM5x31NBw8ijvbpcrGQmGAABGKC+XVwucyXAzMYQcoDGiaBjW/nYCEIGgP+R6UdDZDRjDgnYoAO5QoeN04v1GNScjnCHJWKUoBNxccTTXbAFKtPdAlr2sr1VJB9T/Mffokg4eyCpAQjDWcFa2DMXzkd+C6nZcywpGyTRw41rNAfQMsIAJD1vKPY4YhdtMaM+eu+PNyhaE5CGhvBMDmxJzEWOmBC1N2BRTLlkGxYeRwZiCpMSwTxmFYwphkS5UgjPdFLCkkaEI4ZuB9KYW5p2JQdmhsGZphtCNEP4i1uKLZknGN4CDJaRfFCrlWFxWitgQQ8x9ggT2QOeRIzWADvsohUnWQg9hwGR3n0GMM9ZwALysb+tobM7UuMNWezmlgnyER7nmKcxCCAPBaj/qBIW5UZDJfqjL82FZlnJX7mOo9LSdettD7UXDH+V0fegRlJGVAAKW1SLeNywEkUkBslWl80B4AY20gGYj4yh1LH08wCva2ZMT6AX+JgDYk+0nligpFGddLSNesQPjbC3Qga8ozby6Y8j/pO/Yoynrc+QFOSmeitM0nRXO4SnTDbS1fshSST2mhHJ1DeUs87TRrrZ5c7kMROEEsR5Z/AmGLwpKmVSDZZQoJ85ySbZL3TWspelJmiHSdfRLuGzXUCtZVW7BdYe07V0MoRsZ0vb2tr2trjdg2mXttveHgG2vj0UcIPbp+ESd07GPe6WkqvcozC3ud+BrnRnoAEKXJYC/xqYrnZXAIEATKACAajABAIAge2aFwUSwIMEzsveElAAD9Ztr3wBMN46TGC+8wVvHSqA3/leIAAX6O98LRAACwhYvhoIQHYP3F4MMPjBEI6whImQ2wpb+MIYzvAfSjvhV4q2w+rgMIh/IeIRawqzJm5EiVPMLBRroSbjJI8X77ZZEsS4KDU+wQOCFQN/dQjFDllKkKUA43Daa8aOQxySj0jLYuQ4KVLzjZDtgCVuCIdFqwJyRs71rcw27sZNXsE1OWZkSjyZBAZ4aXiqQh5JEcB/2xBG91C2LHwWAEsP8Ig9+knKgJaPob2SjfTGUpKYEfR4NMGFRKTYoEPH1TkCbf9FsRLKOmSpxFLM+EwqbcUMfNCwUsbg80KmQpaJCW+MKFxOZfE1Vla/68NthkcDBGIAbIiMO3Mx0FneiJ4HyjJDgCteug5ojjRDSRctPQlgyvoOr1DMAewpBrFrIh8m89EvWKmprcu4C265+osLmqM0dnbWsSLAdM+Vgp0TAhKXxAsBR3UJVjJigECjJx0tCd8MUcJU6NTviwJo6pG/CD9H7BsB89oVHJsDM2v/iDSVQ+sdKFKAlxJoKcGBjqTM96VzZxnWA7TLP2udSZ3wp8uistT0KihLE6SRk9CB6kYFANeBZyhGL4+2wpk0F8zd+xkXBVLG2LPtETCu3OC6noH/GlbZaH/p23RWlZ1TsufcRGsgtc5NpQ/wcy7a4WmVrCECaT3uFga2DlqpRdh3Fu2Fv+bOFZTxw/+yAJHQwxV8dglvytflHHYL6Qgo3R3+eWU5f7zODy6A/TY143RHwfGP2HGwZbHTw0udxZhyMeb9CPLNcx7xnrdg50OPzKFp+PSoT73qAUF6JEC+9W2DvWlfL/vW1h60tL89aXX/Wt733vdsy71vV0/84hv/+HwQGiiEnwjlx4lRzC/bNIvrfE1EPwjXz/zyoV99O3GfTNPHU/bVxqbvh9/7wgUFBSKQge5CIAMRiC8j1t9+8sJf/tSgv/vvn4nx/ve/9zUJ/gdg/97lJgMIgJqgX3bAX5OggPvlJg4YXp0QAXYQAZpAgXVggXOCgQGggZpAYHVgYJkAggWGJyQogprQXXVQXpmgguSFJy7Igp2QXus1gwFQg3hCg6aAAQHgYJ3Agz6IJ0CYCjg4g4xShMCXhEqIe8g3WzvQhBl2WlDIehTmWU94NqdFJ0UAXHKSe2HzWYvChVeYBl+ohVUYe5eAhY1ihs2HhrhEhlm4e22YWmMIU2soh0IghmkIh3d4BWGoY0NiZWhXaUaTAtkTSXYBK7OzSJYnfSUQKUQyiDgiV+QRNCTAZ4mEEJ0iF5toYx+hH2VoApC4CXaQdjDzDChQKqKISXMWdf9A8AlV8RSb8BJ10WSDhAsQcwDX02ZQMUdXZHGhNQ32kg3bYCk08w25uIsD1Iv+8Cq35Iwp8EvB+FuhQoyzaBMQEQ6+oYxKggq6+GNzuDJ1txSWsmNQgTTnwWoGUhPncY5NNDuc0IVJ0SrXaI7kxERyZ3QrdA0vNWZj1nKv5nonoDoUUY77WA4sFEPiUwpmFVV/OIxYdgcNUFBeZBHdAw2VdUgfcQDtwyEBGWLP4hRQIZHZiE/nkJFeNxT9uA2ywk0lIBBj0YhbGEXQIoskeY/NspAoUBBI9pAkkG/L8S0N0BhIlo7psI5INiogFA7yGDh3YA9CeRAN0S20lDEu2R3/m4WSrjiTJZBBESECQ4mTt1IQCilNKQCQH/mK2LJFcySUuGCLFJSMMtE4DuEKvwiOwlhXDnMQbomTcklB2PMl/rgNOcEPUOIA17KVZxgMuVMefamNAcCN5JQTBhAX64OX2NeV5qIyd6A9r2I0yXGSQQOYIhFxV8djLfaGIhBII9KZCzCJZ5dJpDkMU0ZDZ4cSOcEAfFZlqSmQaCYiCUEiDwGbqCg6WpcTC7VLMglMbpiXkRWHfsiVdLiHdpgEYCidb1KHz9mHeYKdtked22mdbJiHVgieeQOd3bmY2Wmec8Wdy+SdWtCU1emb0UlhU3gIl3CfFSaF+pl8xXR+bjJ+/ypWfukHfgQqKAL6IQdKfQa6fQUKoHtifgtqfRLqoBbKoBAaChU6Cfpnf/EnCR36fh96FCHKf5ZwgAUogASIgFuCogFoCRHIgJIQoxCIBzJqCRzogZOQo3jCo51wgh9oByi4JUDaCTGYgnYgg1typKCggzaIhFvipKAwhD/Yg4JCpaMApZagpVG6hF76pcHXn4IgZmJapnhApmZKfNq3niQWoGKGfgM6nW26XG9qCd6hh3PqIauQoHkqemyqJW5aehFKfnIKqHQqqBpKqH96YkVwYy6AI2c2Vn7KqEbgqDSWEmd2p5qjEK6wTTWAkUmZlpYHC/sImDlgqSwAdSegOP9jhqiUugL51gCt6AKoqgq20aqi+nlepRPE8wNhtpwfSaqMFaoyUKsq0IkpwKqRCqzTCED2MBz7WKxlRge3mqlruqtg6QCzADD7kA8aVU/ZCD32oE4txAw9gm51upACER9+g0o8MT3sRCt1MB6a9iMAwTGFVinK2DKkCZUS8ZSX9qyFdgsOwayKOZALIh76ahMaATzIU3YEBRBd5mcDJUatoD5aEWqWaLB9ej8yFhumEpa1ca8chRi70ED/k4/VUmZ7upbQSkEM9BT4ACUSlRBh0TjVphgkw2ZXMXTIagz9KlIAJxgh92sfwxuT07L58nUUE24C4LPt4UQZOxg80VL/ziYXaEGyBPMArNYK26aqB5uu4AIgDaCtipBmXxdxfeVTHFIcMwWqEfSqmHkVJEIAcfsXimNVOyQ/XbequwBxp3EzQHsOldMNyhpKQFlrPSm2sJqwOxa4tZBynYq3AadC4RBvMbITKulk7ya3SNSVFFEQOqIIAURCQ7e2X1VHeUFycnc5ntubyCETASAxg2FH+bgadvs/CSIN9EFmQrceZ7IaxBAtULkNcyR2dmE0SKO0lPOsK3e6USshlrS7NJdHYplWN0IdBJNm2lZyhqqgTjkjswAsdFeaqKtIqDRKCyEk59audgO7c7scCdGu0XOUNcUib/dzOyY6f/sXC4up/whhd4XRDabUbylZHIvrqgBUilCxsDvyQFRmIo2mD+Fwmtm7qxdLK7WTiOEDv597AxgSjq8rBA4wrVTAvGgCOstKjYoqAztiwuzJsc+nwDaAQ+/ZwvHJuO1Cw6dwrTnMww36vYDiw+M5whnarIVCxKs6u06AwvG5wixwY05MBK/yBJrKAnyBiCnwwNpCD9oCMEinwwb7q2bpqR4kZtG7AmYsxWIcBBtsxUo8cI+6HG+mSKy2Qa7bxrmKPcSqk9gXqWsMw1MsBGvxeHG8MvWQTxHhM05Cs8QQePOScLoGxEiMyDxTaCFSB+yEJYrAG3YHFXnHaXyUr94avZUiqwphVv8wI2qg7E96XMkmcBh6pMoEFUjlwcotAT/i+q7v0BLyqrt2MHmTejctwAwhpS7PkgDqE0PiYUuhZJavHLZYZrSusYsdOUDKXFU75XA8+xdPNLKK8M1LSxdMdGskxcaUTALCsD1j8bQ/6QC4oiBfKwC1ELMO5MgTdbMJpJrgqwLMEFSSahMXoVTyIMnAKMSYecawY3X08EHXDA2mQVSiPHelQY7RG3Fb8RoXLLstJNHRjAy1AlWB1xMDYw77+26zcLdAdLs2NUAH44hx6s+4uEcBfRUEcj1NgcdRZcTSbCBoOQJFgxfjS7i1xmwTnR7QOwvijL264Y4Is3dmJcjR/Az/CtBRH/NyZ3FWRRdClzMVthuRLb26MN3PhiiaGQE8+mHTI1I8lfscO83Tq8C+oDYcCUVYnIxlpkFYw3DU/RskdtdVp2zBBmDXHOwShKUAYQzXLxBtCRJ2MiGLhR0jV1e/LC1KdjXWw1zECU0EDbmom93DOKzZMvyEsFKoPM1boY2Hpz3DHZvEqV2frd19o90GV2zanx3Eq901h3zDsY3bt91Nu33CU83aCI0CQPm+/0kHaeoHaLrcYjrcfhyeYOqcLBC5M9I7j0ZKEpt1BCUUIKFO/brdvePdxT3dLaxsNBkgbfFBYrRSZEVFzWY3VrtF+6wTRO1s863FHmzeMV3dlmeLU9NBZUBHcLUgcNvh0jEU3o5g4L9R3vyd2VusCFjF3sLMDDdXCzV3Gx5ZVcOrFxhuvXo0q3w6WtZg3WddaYGI4qYYmARRJerLAHWTDTGC4gVnm7/94LrqA2TsnjhO1jrex+jZ4z7u2kLe34ww4rgHp0UO4Yqy5I3g3Krn5FI+5VRe5VZ+5Vie5Vq+5Vze5V7+5TQQAgA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with diabetes or end-stage renal disease may have falsely elevated ABIs as a result of arterial calcification. The toe-brachial index may be more accurate.",
"    <div class=\"footnotes\">",
"     ABI: ankle brachial index; PAD: peripheral artery disease.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31645=[""].join("\n");
var outline_f30_57_31645=null;
var title_f30_57_31646="Heel to toe walk";
var content_f30_57_31646=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F54690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F54690&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Balance exercises: Heel to toe walk",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 369px; height: 297px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Having good balance is important for many everyday activities, such as going up and down stairs.",
"    <ol>",
"     <li>",
"      Position the heel of one foot just in front of the toes of the other foot. Your heel and toes should touch or almost touch.",
"     </li>",
"     <li>",
"      Choose a spot ahead of you and focus on it to keep you steady as you walk.",
"     </li>",
"     <li>",
"      Take a step. Put your heel just in front of the toe of your other foot.",
"     </li>",
"     <li>",
"      Repeat for 20 steps.",
"     </li>",
"    </ol>",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Go4Life. National Institute on Aging at the National Institutes of Health. Available at: file://go4life.niapublications.org (Accessed December 2, 2011).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31646=[""].join("\n");
var outline_f30_57_31646=null;
var title_f30_57_31647="Vaginal pull through procedure";
var content_f30_57_31647=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F60820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F60820&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Vaginal pull through procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 336px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    After drainage of obstructed lower vagina, the normal upper vaginal tissue is pulled through to the perineum to create a normal vagina.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      Reproduced with permission from: Laufer MR. Structural abnormalities of the female reproductive tract. In: Pediatric and adolescent gynecology, 6th ed, Emans SJ, Laufer MR, Goldstein DP (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2012. Copyright &copy; 2012 Lippincott Williams &amp; Wilkins.",
"     </p>",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f30_57_31647=[""].join("\n");
var outline_f30_57_31647=null;
